
<html lang="en"     class="pb-page"  data-request-id="cdde71c8-62d0-49fc-a6b2-e193d41e490e"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/acs.jmedchem.9b01206;issue:issue:10.1021/jmcmar.2019.62.issue-23"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors" /></meta><meta name="dc.Creator" content="Martin K.  Himmelbauer" /></meta><meta name="dc.Creator" content="Zhili  Xin" /></meta><meta name="dc.Creator" content="J. Howard  Jones" /></meta><meta name="dc.Creator" content="Istvan  Enyedy" /></meta><meta name="dc.Creator" content="Kristopher  King" /></meta><meta name="dc.Creator" content="Douglas J.  Marcotte" /></meta><meta name="dc.Creator" content="Paramasivam  Murugan" /></meta><meta name="dc.Creator" content="Joseph C.  Santoro" /></meta><meta name="dc.Creator" content="Thomas  Hesson" /></meta><meta name="dc.Creator" content="Kerri  Spilker" /></meta><meta name="dc.Creator" content="Joshua L.  Johnson" /></meta><meta name="dc.Creator" content="Michael J.  Luzzio" /></meta><meta name="dc.Creator" content="Rab  Gilfillan" /></meta><meta name="dc.Creator" content="Felix Gonzalez-Lopez  de Turiso" /></meta><meta name="dc.Description" content="Structural analysis of a known apoptosis signal-regulating kinase 1 (ASK1) inhibitor bound to its kinase domain led to the design and synthesis of the novel macrocyclic inhibitor 8 (cell IC50 = 1.2..." /></meta><meta name="Description" content="Structural analysis of a known apoptosis signal-regulating kinase 1 (ASK1) inhibitor bound to its kinase domain led to the design and synthesis of the novel macrocyclic inhibitor 8 (cell IC50 = 1.2..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="November 11, 2019" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.9b01206" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2019 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01206" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.9b01206" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.9b01206" /></link>
        
    
    

<title>Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.9b01206" /></meta><meta property="og:title" content="Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0003.jpeg" /></meta><meta property="og:description" content="Structural analysis of a known apoptosis signal-regulating kinase 1 (ASK1) inhibitor bound to its kinase domain led to the design and synthesis of the novel macrocyclic inhibitor 8 (cell IC50 = 1.2 μM). The profile of this compound was optimized for CNS penetration following two independent strategies: a rational design approach leading to 19 and a parallel synthesis approach leading to 26. Both analogs are potent ASK1 inhibitors in biochemical and cellular assays (19, cell IC50 = 95 nM; 26, cell IC50 = 123 nM) and have moderate to low efflux ratio (ER) in an MDR1-MDCK assay (19, ER = 5.2; 26, ER = 1.5). In vivo PK studies revealed that inhibitor 19 had moderate CNS penetration (Kpuu = 0.17) and analog 26 had high CNS penetration (Kpuu = 1.0)." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.9b01206"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01206">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.9b01206&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.9b01206&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.9b01206&amp;href=/doi/10.1021/acs.jmedchem.9b01206" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2019</span><span class="cit-fg-volume">, 62</span><span class="cit-fg-issue">, 23</span><span class="cit-fg-pageRange">, 10740-10756</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/62/23" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.9b01194" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.9b01227" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Martin K. Himmelbauer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Martin K. Himmelbauer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Martin+K.++Himmelbauer">Martin K. Himmelbauer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Zhili Xin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Zhili Xin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Zhili++Xin">Zhili Xin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">J. Howard Jones</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">J. Howard Jones</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=J.+Howard++Jones">J. Howard Jones</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Istvan Enyedy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Istvan Enyedy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Istvan++Enyedy">Istvan Enyedy</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kristopher King</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kristopher King</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Metabolism and Pharmacokinetics, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kristopher++King">Kristopher King</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Douglas J. Marcotte</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Douglas J. Marcotte</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Physical Biochemistry and Molecular Design, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Douglas+J.++Marcotte">Douglas J. Marcotte</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Paramasivam Murugan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Paramasivam Murugan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioassays, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Paramasivam++Murugan">Paramasivam Murugan</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joseph C. Santoro</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joseph C. Santoro</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioassays, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+C.++Santoro">Joseph C. Santoro</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Hesson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Hesson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Bioassays, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Hesson">Thomas Hesson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kerri Spilker</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kerri Spilker</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Physical Biochemistry and Molecular Design, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kerri++Spilker">Kerri Spilker</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Joshua L. Johnson</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Joshua L. Johnson</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Metabolism and Pharmacokinetics, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Joshua+L.++Johnson">Joshua L. Johnson</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael J. Luzzio</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael J. Luzzio</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael+J.++Luzzio">Michael J. Luzzio</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Rab Gilfillan</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Rab Gilfillan</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Rab++Gilfillan">Rab Gilfillan</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Felix Gonzalez-Lopez de Turiso</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Felix Gonzalez-Lopez de Turiso</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicinal Chemistry, Biotherapeutic and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#681c1d1a011b07280f05090104460b0705"><span class="__cf_email__" data-cfemail="235756514a504c63444e424a4f0d404c4e">[email protected]</span></a>. Phone: 617-914-1295.</span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Felix+Gonzalez-Lopez++de+Turiso">Felix Gonzalez-Lopez de Turiso</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9736-0907" title="Orcid link">http://orcid.org/0000-0001-9736-0907</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01206&amp;href=/doi/10.1021%2Facs.jmedchem.9b01206" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2019</span></span><span class="cit-volume">, 62</span><span class="cit-issue">, 23</span><span class="cit-pageRange">, 10740–10756</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">November 11, 2019</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>25 July 2019</li><li><span class="item_label"><b>Published</b> online</span>11 November 2019</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 12 December 2019</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.9b01206" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01206</a></div><div class="article_header-article-copyright"><strong>Copyright © 2019 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D10740%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMartin%2BK.%2BHimmelbauer%252C%2BZhili%2BXin%252C%2BJ.%2BHoward%2BJones%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D62%26issueNum%3D23%26contentID%3Dacs.jmedchem.9b01206%26title%3DRational%2BDesign%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BMacrocyclic%2BApoptosis%2BSignal-Regulating%2BKinase%2B1%2BInhibitors%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D10756%26publicationDate%3DDecember%2B2019">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.9b01206"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1569</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">8</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.9b01206" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Rational Design and Optimization of a Novel Class of Macrocyclic Apoptosis Signal-Regulating Kinase 1 Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Martin&quot;,&quot;last_name&quot;:&quot;K. Himmelbauer&quot;},{&quot;first_name&quot;:&quot;Zhili&quot;,&quot;last_name&quot;:&quot;Xin&quot;},{&quot;first_name&quot;:&quot;J.&quot;,&quot;last_name&quot;:&quot;Howard Jones&quot;},{&quot;first_name&quot;:&quot;Istvan&quot;,&quot;last_name&quot;:&quot;Enyedy&quot;},{&quot;first_name&quot;:&quot;Kristopher&quot;,&quot;last_name&quot;:&quot;King&quot;},{&quot;first_name&quot;:&quot;Douglas&quot;,&quot;last_name&quot;:&quot;J. Marcotte&quot;},{&quot;first_name&quot;:&quot;Paramasivam&quot;,&quot;last_name&quot;:&quot;Murugan&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;C. Santoro&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Hesson&quot;},{&quot;first_name&quot;:&quot;Kerri&quot;,&quot;last_name&quot;:&quot;Spilker&quot;},{&quot;first_name&quot;:&quot;Joshua&quot;,&quot;last_name&quot;:&quot;L. Johnson&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;J. Luzzio&quot;},{&quot;first_name&quot;:&quot;Rab&quot;,&quot;last_name&quot;:&quot;Gilfillan&quot;},{&quot;first_name&quot;:&quot;Felix&quot;,&quot;last_name&quot;:&quot;Gonzalez-Lopez de Turiso&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2019&quot;,&quot;month&quot;:&quot;11&quot;,&quot;day&quot;:&quot;11&quot;,&quot;issue&quot;:&quot;23&quot;,&quot;volume&quot;:&quot;62&quot;,&quot;pages&quot;:&quot;10740-10756&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.9b01206&quot;},&quot;abstract&quot;:&quot;Structural analysis of a known apoptosis signal-regulating kinase 1 (ASK1) inhibitor bound to its kinase domain led to the design and synthesis of the novel macrocyclic inhibitor 8 (cell IC50 = 1.2 μM). The profile of this compound was optimized for CNS penetration following two independent strategies: a rational design approach leading to 19 and a parallel synthesis approach leading to 26. Both analogs are potent ASK1 inhibitors in biochemical and cellular assays (19, cell IC50 = 95 nM; 26, cell IC50 = 123 nM) and have moderate to low efflux ratio (ER) in an MDR1-MDCK assay (19, ER = 5.2; 26, ER = 1.5). In vivo PK studies revealed that inhibitor 19 had moderate CNS penetration (Kpuu = 0.17) and analog 26 had high CNS penetration (Kpuu = 1.0).&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01206&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01206" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01206&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01206" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.9b01206&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01206" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.9b01206&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.9b01206&amp;href=/doi/10.1021/acs.jmedchem.9b01206" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.9b01206" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.9b01206" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01206&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.9b01206%26sid%3Dliteratum%253Aachs%26pmid%3D31710475%26genre%3Darticle%26aulast%3DHimmelbauer%26date%3D2019%26atitle%3DRational%2BDesign%2Band%2BOptimization%2Bof%2Ba%2BNovel%2BClass%2Bof%2BMacrocyclic%2BApoptosis%2BSignal-Regulating%2BKinase%2B1%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D62%26issue%3D23%26spage%3D10740%26epage%3D10756%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291011" title="High-performance liquid chromatography">High-performance liquid chromatography</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/62/23" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/jmcmar.2019.62.issue-23/20191212/jmcmar.2019.62.issue-23.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Structural analysis of a known apoptosis signal-regulating kinase 1 (ASK1) inhibitor bound to its kinase domain led to the design and synthesis of the novel macrocyclic inhibitor <b>8</b> (cell IC<sub>50</sub> = 1.2 μM). The profile of this compound was optimized for CNS penetration following two independent strategies: a rational design approach leading to <b>19</b> and a parallel synthesis approach leading to <b>26</b>. Both analogs are potent ASK1 inhibitors in biochemical and cellular assays (<b>19</b>, cell IC<sub>50</sub> = 95 nM; <b>26</b>, cell IC<sub>50</sub> = 123 nM) and have moderate to low efflux ratio (ER) in an MDR1-MDCK assay (<b>19</b>, ER = 5.2; <b>26</b>, ER = 1.5). In vivo PK studies revealed that inhibitor <b>19</b> had moderate CNS penetration (<i>K</i><sub>puu</sub> = 0.17) and analog <b>26</b> had high CNS penetration (<i>K</i><sub>puu</sub> = 1.0).</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73248" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73248" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Apoptosis signal-regulating kinase 1 (ASK1, MAP3K5) is a mitogen-activated protein kinase kinase kinase (MAP3K) that plays a central role in the cellular stress response by modulating inflammation and apoptosis.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Mechanistically, activation of ASK1 leads to downstream phosphorylation of the mitogen-activated protein kinase kinases (MAP2Ks) MKK3/6 and MKK4/7, which in turn phosphorylate the downstream mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK), respectively.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> These two kinases are ultimately responsible for the inflammatory and apoptotic stress responses, and modulation of ASK1 activity might be relevant in the treatment of neurological disorders including amyotrophic lateral sclerosis (ALS),<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> multiple sclerosis (MS),<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> ischemic stroke,<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Parkinson’s disease (PD),<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> and Alzheimer’s disease (AD).<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> To test the potential benefit of modulating this pathway in neurological disease, several research groups have performed in vivo studies with small molecules designed to inhibit the kinase activity of ASK1 in the CNS.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Specifically, two ASK1 inhibitors: K811 (<b>1</b>) and K812 (<b>2</b>) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) have been reported to be efficacious in an SOD1 ALS model of a disease.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> In this study, chronic treatment of an SOD1G93A-transgenic mouse with <b>1</b> (at 100 mg/kg) or <b>2</b> (at 30 mg/kg) starting at disease onset (week 28) led to increased survival and decreased motor-neuron death in the spinal cord of the treated animals.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> In a separate report, the CNS penetrant ASK1 inhibitor MSC2032964A (<b>3</b>) was tested in an experimental autoimmune encephalomyelitis (EAE) model of MS demonstrating that animals treated with <b>3</b> (at 30 mg/kg) had reduced inflammation in the spinal cord and optic nerve thus positioning ASK1 as a potential target for the treatment of MS.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> Despite this data, the hypothesis that modulation of the ASK1 pathway might be beneficial for the treatment of neurological diseases has not been tested in the clinic, and the main focus has been centered on peripheral human diseases.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Specifically, the ASK1 inhibitor Selonsertib (GS-4997, <b>4</b>), developed by Gilead Sciences, is being tested in phase II clinical trials for the treatment of liver fibrosis.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0015.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Profile of selected ASK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_30384" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_30384" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With the goal of identifying a novel series of ASK1 inhibitors with a suitable profile for the treatment of human neurological diseases, we initiated a medicinal chemistry program by profiling a selected number of known compounds from the literature (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). Among these, compound <b>4</b> had the best overall profile with excellent biochemical (IC<sub>50</sub> = 5.9 nM)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and cellular potency (IC<sub>50</sub> = 20 nM).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> This analog also had a favorable pharmacokinetic (PK)<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> profile (rat Cl/Cl<sub>u</sub> = 0.18/14.7 L/h/kg),<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> but, in contrast to compounds <b>2</b> and <b>3</b>, it was a substrate of P-glycoprotein (P-gp) in an MDR1-MDCK assay as evidenced by its high efflux ratio (ER) making it unsuitable for CNS indications.<a onclick="showRef(event, 'ref16 ref17'); return false;" href="javascript:void(0);" class="ref ref16 ref17">(16,17)</a> To enable a structure-based drug design approach, the X-ray cocrystal structure of compound <b>4</b> bound to the ASK1 kinase domain was elucidated (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> This X-ray confirmed the previously proposed binding mode<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> in which <b>4</b> interacts via the carbonyl group of the amide with the backbone NH of Val757 in the hinge region of ASK1. In addition, a hydrogen bond interaction between one of the N atoms of the triazole ring in <b>4</b> and the catalytic Lys709 was observed, while the cyclopropyl-imidazole substituent appeared to be solvent-exposed.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> An intramolecular hydrogen bond between the amide NH and the fluoro substituent in its ortho position also contributed to locking the conformation of <b>4</b> into this favorable binding pose.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Cocrystal structure of <b>4</b> (GS-4997, green) with the kinase domain of ASK1 highlighting key interactions in the active site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYT">6OYT</a>). (b) Schematic representation of the binding mode of GS-4997 to the kinase domain of ASK1. The solvent-exposed region is in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">At the outset, the design strategy involved optimization of compound <b>4</b> for CNS penetration by deconstructing the solvent-exposed substituents and attempting to regain binding affinity via macrocyclization of the resulting simplified pharmacophore (i.e., analog <b>8</b>, <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). Conceptually, this approach relied on the observation that the phenyl group and triazole ring are in close spatial proximity and on the insight that macrocyclic structures typically have reduced conformational freedom, which can result in ligands with increased binding affinity.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a></div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy for the design of novel ASK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To test this hypothesis, initial truncation of the solvent-exposed imidazole and methyl groups in <b>4</b> revealed an analog (<b>5</b>) that retained some potency in the biochemical assay and had low ER (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, IC<sub>50</sub> = 76 nM, ER = 1.6). Subsequent evaluation of functional groups with the ability to form an intramolecular hydrogen bond with the amide and link the phenyl and triazole rings was performed. These studies showed that replacement of the fluoro substituent in <b>5</b> with a methoxy group led to an analog (<b>6</b>) with improved potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, cell IC<sub>50</sub> = 299 nM). This modification also enabled implementation of our macrocyclization strategy and compounds with a range of differently sized tethers were synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, analogs <b>7–9</b>). It was found that all the macrocyclic compounds synthesized were potent ASK1 inhibitors in a biochemical assay (IC<sub>50</sub> = 11–161 nM, <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, entries 3–5), and the 14-member inhibitor <b>8</b> had the best balance of cellular potency (IC<sub>50</sub> = 1.2 μM) and ER (2.9). Comparison of analog <b>8</b> with its corresponding open form (<b>10</b>) revealed that the alkoxy-tether had contributed to an 8-fold improvement in biochemical potency (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>, compound <b>8</b>, IC<sub>50</sub> = 11 nM vs compound <b>10</b>, IC<sub>50</sub> = 92 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Identification of the New ASK1 Pharmacophore</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0007.gif" alt="" id="gr10" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">Results represent the geometric mean of a minimum of two determinations.</p></div><div class="footnote" id="t1fn2"><sup><sup>b</sup></sup><p class="last">Inhibition of ASK1 autophosphorylation.</p></div><div class="footnote" id="t1fn3"><sup><sup>c</sup></sup><p class="last">MDR1-MDCK human P-gp transfected cell line. P<sub>app</sub>: apparent permeability apical-to-basolateral (10<sup>–6</sup> cm/s); ER = B-A/A-B, efflux ratio.</p></div></div><div></div></div><div class="NLM_p">To mimic the role of the isopropyl group present in analog <b>6</b>, a methyl group α to the triazole was first introduced in the macrocyclic analog <b>8</b> (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, analog <b>11</b>). This compound was synthesized as the racemic form, and when the enantiomers were separated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, analogs <b>11</b> and <b>12</b>), a 4-fold improvement in cellular potency was observed with the more potent enantiomer (<b>11</b>, cell IC<sub>50</sub> = 73 nM vs <b>6</b>, cell IC<sub>50</sub> = 299 nM). The absolute stereochemistry of compound <b>11</b> was determined by an X-ray with human ASK1 (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). This cocrystal structure also revealed a binding mode in which the same H-bond interactions of the carbonyl group of the amide to the backbone NH of Val757 and the triazole N to the catalytic Lys observed in <b>4</b> were also present with <b>11</b> (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the cocrystal structure of <b>11</b> (magenta) with <b>4</b> (GS-4997, green) in the kinase domain of ASK1. (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYW">6OYW</a>.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Optimization of the Tether</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0006.gif" alt="" id="gr11" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Results represent the geometric mean of a minimum of two determinations.</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Inhibition of ASK1 autophosphorylation.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">MDR1-MDCK human P-gp transfected cell line. P<sub>app</sub>: apparent permeability apical-to-basolateral (10<sup>–6</sup> cm/s); ER = B-A/A-B, efflux ratio.</p></div><div class="footnote" id="t2fn4"><sup><sup>d</sup></sup><p class="last">The compounds were synthesized as racemates, and the enantiomers were separated and tested. Only the more potent enantiomer is shown. The absolute stereochemistry of compounds <b>13–15</b> was arbitrarily assigned.</p></div></div><div></div></div><div class="NLM_p">To systematically evaluate the impact of substituting other positions of the tether in analog <b>8</b>, all the methylated compounds were synthesized as the racemates, and the enantiomers were separated (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, analogs <b>13–15</b>, only the more potent enantiomers are shown). This optimization effort revealed that analog <b>13</b> in which the methyl group had been incorporated at the β position of the triazole also had improved cellular potency relative to <b>6</b> (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>, cell IC<sub>50</sub> = 232 nM).</div><div class="NLM_p">Despite the significantly improved properties of analogs <b>11</b> and <b>13</b>, these macrocyclic inhibitors suffered from poor microsomal stability. Comprehensive metabolite profiling of the parent unsubstituted compound <b>8</b> revealed that, after 1 h of incubation in rat or human liver microsomes, the main metabolic soft spots were in the salicylate and butylene linker (in rat liver microsomes) or in the amide bond (in human liver microsomes). To block the metabolic soft spots in the salicylate, analogs <b>16</b> and <b>17</b> in which different positions of the phenyl group had been fluorinated were synthesized (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Notably, both compounds had improved microsomal stability and cellular potency relative to analog <b>8</b>. A follow-up rat PK experiment showed that analog <b>17</b> had superior in vivo clearance relative to <b>16</b> (and <b>8</b>), and this substitution pattern was used in subsequent optimization efforts. Having improved the PK properties of compound <b>8</b>, introduction of the methyl group at both the α or β position of the triazole in <b>17</b> was carried out. It was found that both analogs had good cellular potency (<b>18</b>, cell IC<sub>50</sub> = 43 nM; <b>19</b>, cell IC<sub>50</sub> = 95 nM) and good in vivo clearance (compound <b>18</b>, Cl/Cl<sub>u</sub> = 0.82/18 L/h/kg; compound <b>19</b>, Cl/Cl<sub>u</sub> = 0.5/30 L/h/kg) while retaining a moderate ER (compound <b>18</b>, ER = 4.9; compound <b>19</b>, ER = 5.2).<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a></div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Improving Microsomal Stability by Fluorination</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0005.gif" alt="" id="gr12" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">Results represent the geometric mean of a minimum of two determinations.</p></div><div class="footnote" id="t3fn2"><sup><sup>b</sup></sup><p class="last">Inhibition of ASK1 autophosphorylation.</p></div><div class="footnote" id="t3fn3"><sup><sup>c</sup></sup><p class="last">MDR1-MDCK human P-gp transfected cell line. P<sub>app</sub>: apparent permeability apical-to-basolateral (10<sup>–6</sup> cm/s); ER = B-A/A-B, efflux ratio.</p></div><div class="footnote" id="t3fn4"><sup><sup>d</sup></sup><p class="last">IV dosing using a DMA:EtOH:PG:water (1:1:3:5) formulation for compound <b>8</b> and DMSO:PG (1:1) for analogs <b>16–19</b>.</p></div><div class="footnote" id="t3fn5"><sup><sup>e</sup></sup><p class="last">The absolute stereochemistry was assigned by VCD experiments using the less potent enantiomer (see the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a>).</p></div></div><div></div></div><div class="NLM_p">Concurrent with this rational design effort, an alternative approach that relied on the parallel synthesis of a small library of compounds starting with the bromo intermediate <b>20</b> was pursued. The structure–activity relationship (SAR) for some representative compounds from these studies is summarized in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, and it showed that introduction of a morpholine or a 2-oxa-6-azaspiro[3,3]heptane substituent onto the salicylate led to compounds with improved potency and microsomal stability (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>). Unfortunately, despite the improved microsomal stability, analogs <b>21</b> and <b>22</b> had high in vivo clearance in rodents (analog <b>21</b>, rat Cl = 4.1 L/h/kg and analog <b>22</b>, rat Cl = 3.0 L/h/kg). Compounds with a sulfone group intended to establish an interaction with Gln756 led to analogs that were potent in a biochemical assay but had poor cellular potency (i.e., analog <b>23</b>), likely due to diminished permeability.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> In contrast, introduction of a substituted imidazole ring (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>, compound <b>24</b>) led to a compound with good potency in biochemical and cellular assays (IC<sub>50</sub> = 4 nM and cell IC<sub>50</sub> = 28 nM), which also had improved in vivo PK (Cl/Cl<sub>u</sub> = 0.65/74 L/h/kg). This analog was found to be a P-gp substrate (<b>24</b>, ER = 69), thus limiting its ability to enter the CNS and making it a good candidate for targeting therapeutic indications for which brain penetration is not desired.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Interestingly, the pyrazole analog <b>25</b> was found to be one of the more potent analogs in the cellular assay (IC<sub>50</sub> = 25 nM), and analog <b>26</b> on which a dimethylamino group attached to the pyrazole had been introduced had the lowest ER in this series (analog <b>26</b>, ER = 1.5). Surprisingly, attempts to combine the best features of the optimized macrocyclic structures (from <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>) with the optimized substituents in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> did not lead to compounds with improved CNS-like properties (i.e., analog <b>27</b>, <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>).</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Parallel Synthesis Effort</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0004.gif" alt="" id="gr13" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">Results represent the geometric mean of a minimum of two determinations.</p></div><div class="footnote" id="t4fn2"><sup><sup>b</sup></sup><p class="last">Inhibition of ASK1 autophosphorylation.</p></div><div class="footnote" id="t4fn3"><sup><sup>c</sup></sup><p class="last">MDR1-MDCK human P-gp transfected cell line. P<sub>app</sub>: apparent permeability apical-to-basolateral (10<sup>–6</sup> cm/s); ER = B-A/A-B, efflux ratio.</p></div><div class="footnote" id="t4fn4"><sup><sup>d</sup></sup><p class="last">IV dosing using a solutol:PEG:EtOH:water (1:1:1:1) vehicle for <b>21</b> and DMA:EtOH:PEG:water (1:1:3:5) for <b>25</b> and <b>26</b>.</p></div><div class="footnote" id="t4fn5"><sup><sup>e</sup></sup><p class="last">The absolute stereochemistry was arbitrarily assigned.</p></div></div><div></div></div><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">The synthesis of analogs <b>5</b>, <b>6</b>, and <b>10</b> was carried starting with the readily available picolinate (<b>28</b>), which after hydrazide formation and condensation with <i>N</i>,<i>N</i>-dimethylformamide-dimethylacetal (DMF-DMA) afforded intermediate <b>29</b>. This compound was then heated under acidic conditions in the presence of either methylamine or isopropylamine and hydrolyzed with aqueous NaOH to provide intermediates <b>30</b> and <b>31</b>, respectively (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). The ASK1 inhibitors (<b>5</b>) were accessed by a reaction of aminopyridine (<b>30</b>) with 2-fluoro-benzoylchloride in the presence of DMAP. Inhibitors <b>6</b> and <b>10</b> were synthesized by coupling of 2-methoxybenzoic acid with aminopyridine <b>30</b> and <b>31</b> and using propylphosphonic anhydride (T<sub>3</sub>P).</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0011.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Linear Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, MeOH, reflux, 5 h then DMF-DMA, reflux 2 d, 64% over 2 steps; (b) compound <b>30</b>: MeNH<sub>2</sub>, CH<sub>3</sub>CN/AcOH 4/1, μW 110 <i>°</i>C, 1 h then NaOH, MeOH, reflux, 3 h, 68%; compound <b>31</b>: isopropylamine, CH<sub>3</sub>CN/AcOH 4/1, reflux, 12 h then 1 M aq NaOH, 54%; (c) compound <b>5</b>: 2-fluoro-benzoylchloride, DMAP, DCM, rt, 4 h, 63%; and compounds <b>6</b> and <b>10</b>: 2-methoxybenzoic acid, Et<sub>3</sub>N, T<sub>3</sub>P, 60 <i>°</i>C, 2 h, 35–40%.</p></p></figure><div class="NLM_p">The synthesis of macrocyclic compounds was carried out following two strategies: a macrolactamization approach of an amino acid precursor (<b>60–68</b>, <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>) or a ring-closing metathesis (RCM) of a bis-olefin precursor (<b>86</b> and <b>87</b>, <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). The synthesis of macrocyclic inhibitors following a macrolactamization approach started with installation of the linker via a Mitsunobu reaction between readily available building blocks <b>32</b> or <b>33</b> and protected aminoalcohols <b>34–41</b> to provide intermediates <b>42–50</b> (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). Deprotection of these intermediates using TFA, hydrazine or CAN, and TFA gave the desired amines <b>51–59</b> in good yields. A reaction of primary free amines <b>51–59</b> with dimethylhydrazonamide <b>29</b> by refluxing in acetic acid gave the desired condensation products as an inseparable mixture with other partially hydrolyzed intermediates. This mixture was saponified with sodium hydroxide to provide the desired amino acid <b>60–68</b> in acceptable overall yields. Amide coupling conditions with propylphosphonic acid anhydride proved to be most reliable for the formation of the 13- to 15-membered macrocycles. In particular, the desired 14-membered macrolactam (<i>rac</i>)-<b>71</b> was obtained in a 25% isolated yield without formation of any undesired intramolecular amide bond or dimerization. Chiral separation of intermediates <b>72</b>, <b>74</b>, and <b>76</b> followed by Pd-mediated reduction of the precursors of the more potent enantiomers led to <b>13</b>, <b>15</b>, and <b>19</b>. Reduction of bromo intermediates <b>20</b>, <b>69–71</b>, <b>73</b>, and <b>75</b> led to analogs <b>7</b>–<b>12</b>, <b>14</b>, and <b>18</b> after chiral separation of the racemic intermediates.</div><figure id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Macrocyclic Analogs Following a Macrolactamization Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>34–41</b>, PPh<sub>3</sub>, DIAD, THF, 0–25 °C, 12 h, 46–100%; (b) <b>42–45</b>, <b>47</b> or <b>49</b>, TFA, DCM, 40 °C, 5 h, 89%–94%; (c) <b>46</b> or <b>48</b>, NH<sub>2</sub>NH<sub>2</sub>, EtOH, reflux, 70–90%; (d) <b>50</b>, 1. CAN; 2. TFA, 67%; (e) <b>29</b>, AcOH, CH<sub>3</sub>CN, reflux, 24 h, 60%; (f) NaOH, MeOH, THF, 70 °C, 10 h; (g) T<sub>3</sub>P, Et<sub>3</sub>N, EtOAc, 80 °C, 4 h, 23–45% over 2 steps; (h) <b>72</b>, <b>74</b>, and <b>76</b>, chiral separation by SFC; (i) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C, 2 h; and (j) chiral separation by SFC.</p></p></figure><figure id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Macrocyclic Analogs Following a Ring-Closing Metathesis Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH, allyl amine, reflux, 38%; (b) allyl bromide, NaH, DMF, 46–88%; (c) NaOH (aq), MeOH; (d) (COCl)<sub>2</sub>, DCM, DMF (cat), 99–100% over 2 steps; (e) DMAP, DCM, 32–47%; (f) Boc<sub>2</sub>O, DMAP, DCM, 72–79%; (g) HG first generation, toluene, reflux, 8–35%; (h) H<sub>2</sub>(g), Pd/C, 100%; and (i) TFA, DCM, 29–32%.</p></p></figure><figure id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Derivatization of Macrocyclic Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) analogs <b>21</b> and <b>22</b>: amine, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, Na<i>t</i>BuO, 21–35%; (b) analog <b>23</b>: MeSO<sub>2</sub>Na, CuI, <span class="smallcaps smallerCapital">l</span>-proline sodium salt, 22%; and (c) analogs <b>24</b>–<b>27</b>: 4-methyl-1-imidazole, K<sub>2</sub>CO<sub>3</sub>, Pd(dtbpf)Cl<sub>2</sub> (<b>24</b>) or Boronic ester, Pd(dppf)Cl<sub>2</sub> (<b>25</b>–<b>27</b>), 13–66%.</p></p></figure><div class="NLM_p">The synthesis of <b>16</b> and <b>17</b> started with the preparation of triazole <b>77</b> by condensation of <b>29</b> with allylamine in refluxing acetic acid (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>). Fragments <b>82</b> and <b>83</b> were synthesized by deprotonation of commercially available phenols <b>78</b> and <b>79</b> with NaH followed by a reaction with allyl bromide. The corresponding esters <b>80</b> and <b>81</b> were converted to the acyl chlorides <b>82</b> and <b>83</b> in a two-step procedure involving saponification and reaction of the acid intermediates with oxalyl chloride with catalytic DMF. Amide bond formation between <b>77</b> and <b>82</b> (or <b>83</b>) was carried out in DCM with DMAP to provide intermediates <b>84</b> and <b>85</b>. Initial attempts to carry out the RCM with these precursors were unsuccessful and a Boc protecting group was installed using Boc<sub>2</sub>O and DMAP to provide intermediates <b>86</b> and <b>87</b>. The desired macrocyclic compounds <b>88</b> and <b>89</b> as a mixture of <i>E</i>- and <i>Z</i>-isomers were obtained by refluxing <b>86</b> and <b>87</b> in toluene in the presence of a Hoveyda–Grubbs first-generation (HG 1st) catalyst. Hydrogenation of macrocyclic intermediates <b>88</b> and <b>89</b> with Pd/C under a H<sub>2</sub> atmosphere followed by deprotection of the Boc group with TFA furnished analogs <b>16</b> and <b>17</b>.</div><div class="NLM_p last">The synthesis of intermediate <b>20</b> was scaled up early in the project for a parallel synthesis effort according to the route described in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. With large quantities of intermediate <b>20</b> in hand, analogs featuring a new carbon–nitrogen bond such as <b>21</b>–<b>23</b> were generally accessed from primary or secondary amines via a Buchwald–Hartwig coupling using a Pd<sub>2</sub>dba<sub>3</sub> and Xphos catalyst system (<a class="ref internalNav" href="#sch4" aria-label="Scheme 4">Scheme 4</a>). The sulfone compound <b>23</b> was synthesized using a Cu-mediated coupling with the corresponding sodium sulfinate salt. Pd-mediated coupling between macrocycle <b>20</b> or <b>76b</b> and the corresponding heterocycles provided access to analogs <b>24</b>–<b>26</b> and <b>27</b>, respectively.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> CNS Penetration</h3><div class="NLM_p">To evaluate the CNS penetration of this series of inhibitors, several compounds with satisfactory profiles were selected for in vivo rat <i>K</i><sub>puu</sub> studies. In these experiments, the compounds were administered via an IV infusion<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> in the carotid artery for a period of 4 h (1 mg/kg, 0.1 mg/mL) to reach a steady state. After this time, the plasma and brain concentration levels were quantified, and the values were adjusted by the measured protein binding in plasma and brain homogenates to calculate the <i>K</i><sub>puu</sub>.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> This experiment was conducted with analogs <b>18</b>, <b>19</b>, <b>24</b>, <b>26</b>, and <b>27</b> (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>), and, as expected, analogs <b>24</b> and <b>27</b>, which had a high ER in the MDR1-MDCK assay, were found to be peripherally restricted. In contrast, analog <b>26</b> with an ER = 1.5 had a <i>K</i><sub>puu</sub> of 1. The data for analogs <b>18</b> and <b>19</b> revealed that analog <b>19</b> had superior CNS penetration relative to <b>18</b> (<i>K</i><sub>puu</sub> = 0.17 for analog <b>19</b> vs <i>K</i><sub>puu</sub> = 0.09 for compound <b>18</b>).</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo K<sub>puu</sub> Studies with Selected Compounds</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0001.gif" alt="" id="gr14" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">Biochemical assay as the geometric mean of at least two measurements.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">Inhibition of ASK1 autophosphorylation.</p></div><div class="footnote" id="t5fn3"><sup><sup>c</sup></sup><p class="last">MDR1-MDCK human P-gp transfected cell line. P<sub>app</sub> − Apparent permeability Apical-to-Basolateral (10<sup>−6</sup> cm/s); ER = B-A/A-B efflux ratio.</p></div><div class="footnote" id="t5fn4"><sup><sup>d</sup></sup><p class="last">The absolute stereochemistry was arbitrarily assigned.</p></div></div><div></div></div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73630" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73630" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In summary, the X-ray cocrystal structure of compound <b>4</b> bound to the kinase domain of human ASK1 led to the design and synthesis of the novel macrocyclic ASK1 inhibitor <b>8</b> following a deconstruction-cyclization approach (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The profile of analog <b>8</b> was optimized by alkylating the tether to improve potency and by fluorinating the salicylate ring to improve microsomal stability. Combination of these two structural modifications led to the identification of compounds <b>18</b> and <b>19</b>, which had good cellular potency and PK as well as low to moderate CNS penetration. Alternatively, the brain permeability of macrocyclic compound <b>8</b> was modulated by the substituent attached to the salicylate. This strategy led to the identification of compounds with good cellular potency and PK properties that were peripherally restricted (such as analog <b>24</b>) and compounds with good cellular potency and excellent brain exposure (such as analog <b>26</b>). These compounds might be useful tools to further understand the role of ASK1 inhibition in neurodegenerative diseases.</div><figure id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0002.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of identification and optimization of novel ASK1 macrocyclic inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_54535" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_54535" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All solvents and chemicals used were of reagent grade. Anhydrous solvents were purchased from Sigma-Aldrich and used as received. Analytical thin-layer chromatography (TLC) and silica gel column chromatography were performed on Merck silica gel 60 (230–400 mesh). Removal of solvents was conducted by using a rotary evaporator and residual solvents were removed from non-volatile compounds using a vacuum manifold maintained at approximately 1 Torr. NMR spectra were recorded on a Bruker Avance 400 MHz and 500 MHz NMR spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) relative to a residual undeuterated solvent as internal reference and coupling constants (<i>J</i>) are reported in hertz (Hz). Splitting patterns are indicated as follows: s = singlet; d = doublet; t = triplet; q = quartet; qn = quintet; dd = doublet of doublets; dt = doublet of triplets; tt = triplet of triplets; m = multiplet; br = broad peak. All yields reported are isolated yields. All final compounds were purified to ≥95% purity as determined by LC/MS analysis (using a lineal gradient of elution: 90% water in trifluoroacetic acid (containing 0.1% v/v)/10% CH<sub>3</sub>CN in trifluoroacetic acid (containing 0.1% v/v) to 10% water in trifluoroacetic acid (containing 0.1% v/v) and 90% CH<sub>3</sub>CN in trifluoroacetic acid (0.1% v/v) for 2 min and then held at 10% water in trifluoroacetic acid (0.1% v/v) and 90% CH<sub>3</sub>CN in trifluoroacetic acid (0.1% v/v) up to 3 min at a flow rate of 3 mL/min (injection volume of 5 μL and using a Waters Sunfire C18 3.5 μM 4.6 × 20 mm IS Column)). MS mode: MS:ESI+, scan range of 100–1000 Da, PDA detection of 210–400 nm. Final compounds were analyzed using UHPLC (Thermo Scientific Vanquish (Thermo Fisher Scientific Waltham, MA) coupled with a Fusion Lumos Tribrid Orbitrap mass spectrometer (Thermo Fisher Scientific). A Water’s (Milford, MA) Acquity BEH C18 (1.7um beads, 2.1 × 50mm) column was used for separation. Mobile phase A was 10 mM ammonium formate at pH 4.0, and mobile phase B was acetonitrile. The flow rate was 0.45 mL/min, and the following gradient was used from 0 to 0.5 min of 2% B and increased linearly to 50% B at 7.3 min, 95% at 10.3 min, remained there for 0.7 min, dropped back to 2% B over 0.1 min, and remained there for 0.9 min. The mass spectrometer was operated in the positive-ion mode with accurate mass measurements performed using the orbitrap set at 120,000 K resolution (at <i>m</i>/<i>z</i> = 200). A heated electrospray ionization source was used with the following parameters: spray voltage 3500 V, sheath gas 35 (arbitrary units), auxiliary gas 10 (arbitrary units), sweep gas 0 (arbitrary units), ion transfer tube temperature 350 <i>°</i>C, and vaporizer temperature 300 <i>°</i>C.</div><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> 2-Fluoro-<i>N</i>-(6-(4-isopropyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)benzamide (<b>5</b>)</h3><div class="NLM_p last">To a solution of amine <b>31</b> (41 mg, 0.2 mmol) and DMAP (29 mg, 2.4 mmol) in DCM (1 mL) was added 2-fluorobenzoyl chloride (25 μL, 0.2 mmol) at room temperature. The resulting reaction mixture was stirred at room temperature for 4 h upon which a white precipitate formed. The solids were filtered off and washed with CH<sub>3</sub>CN yielding the title compound (41 mg, 63%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.89 (s, 1H), 8.86 (s, 1H), 8.22 (d, <i>J</i> = 8.3 Hz, 1H), 8.03 (t, <i>J</i> = 7.9 Hz, 1H), 7.90 (d, <i>J</i> = 7.3 Hz, 1H), 7.73 (dt, <i>J</i> = 7.5, 1.6 Hz, 1H), 7.67–7.57 (m, 1H), 7.43–7.32 (m, 2H), 5.69 (qn, <i>J</i> = 6.7 Hz, 1H), 1.43 (d, <i>J</i> = 6.5 Hz, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>17</sub>H<sub>17</sub>FN<sub>5</sub>O: 326.1412; found: 326.1416. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.54 min (99% purity).</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> <i>N</i>-(6-(4-Isopropyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)-2-methoxybenzamide (<b>6</b>)</h3><div class="NLM_p last">To a solution of 2-methoxybenzoic acid (17 mg, 0.1 mmol), compound <b>31</b> (21 mg, 1.0 mmol), and triethylamine (140 μL, 1.0 mmol) in EtOAc (2 mL) was added propylphosphonic anhydride (190 μL, ≥50 wt % in EtOAc, 0.3 mmol). The resulting reaction mixture was heated at 60 <i>°</i>C for 2 h, cooled to room temperature, and quenched with MeOH (2 mL). The volatiles were removed, and the resulting residue was purified by column chromatography (12 g, SiO<sub>2</sub>, 0–100% EtOAc/EtOH 3/1 in heptane). The title compound (12 mg, 35%) was obtained as an off-white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.85 (s, 1H), 8.43 (dd, <i>J</i> = 8.4, 0.9 Hz, 1H), 8.09 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.99 (dd, <i>J</i> = 8.4, 7.7 Hz, 1H), 7.85–7.81 (m, 1H), 7.63–7.53 (m, 1H), 7.22 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 7.13 (dt, <i>J</i> = 7.7, 1.0 Hz, 1H), 5.54 (qn, <i>J</i> = 6.8 Hz, 1H), 4.06 (s, 3H), 1.63 (d, <i>J</i> = 6.8 Hz, 6H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub>: 338.1612; found: 338.1616. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.63 min (100% purity).</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> 1<sup>4</sup><i>H</i>-6-Oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclononaphan-4-one (<b>7</b>)</h3><div class="NLM_p last">The reaction was carried out following general procedure 5 and using compound <b>69</b> (12 mg 0.03 mmol), Pd(dppf)Cl<sub>2</sub> (5 mg) yielding the title compound (6 mg, 65%) as a colorless residue. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 9.30 (br s, 1H), 8.27 (s, 1H), 8.01–7.91 (m, 2H), 7.88 (dd, <i>J</i> = 7.6, 1.5 Hz, 1H), 7.70 (d, <i>J</i> = 8.5 Hz, 1H), 7.51 (dt, <i>J</i> = 7.9, 1.8 Hz, 1H), 7.16–7.10 (m, 1H), 6.96 (d, <i>J</i> = 8.5 Hz, 1H), 4.35–4.16 (m, 2H), 2.55 (br s, 2H), 1.62 (br s, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 164.4, 157.7, 151.4, 150.8, 145.4, 142. 9, 139.5, 133.9, 131.3, 121.1, 121.0, 119.6, 114.0, 111.9, 55.6, 49.1, 22.2. MS (ESI): 322.1 [(M + H)]<sup>+</sup>. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 0.71 min (99% purity).</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> 1<sup>4</sup><i>H</i>-6-Oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>8</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 5 and using compound <b>20</b> (25 mg, 0.06 mmol) to give the title compound (13 mg, 48%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.41 (s, 1H), 8.49 (s, 1H), 8.21 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 8.05 (dd, <i>J</i> = 7.9, 0.9 Hz, 1H), 7.92 (d, <i>J</i> = 0.7 Hz, 1H), 7.90–7.85 (m, 1H), 7.51–7.42 (m, 1H), 7.11 (t, <i>J</i> = 7.6 Hz, 1H), 6.97 (d, <i>J</i> = 8.3 Hz, 1H), 4.34–4.20 (m, 4H), 2.74–2.60 (m, 2H), 2.08–1.98 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 163.0, 157.2, 151.8, 150.8, 145.8, 144.5, 140.3, 134.0, 132.4, 122.1, 121.3, 118.0, 114.0, 113.1, 68.2, 48.8, 27.1, 26.3. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>18</sub>N<sub>5</sub>O<sub>2</sub>: 336.1455; found: 336.1460. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.56 min (100% purity).</div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 1<sup>4</sup><i>H</i>-6-Oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacycloundecaphan-4-one (<b>9</b>)</h3><div class="NLM_p last">To a suspension of compound <b>70</b> (40 mg, 0.09 mmol) in THF (2 mL) was added <i>n</i>-BuLi in hexane (0.37 mL of a 2.5 M solution, 0.93 mmol) at −78 <i>°</i>C. After 2 h at this temperature, MeOH (1 mL) was added. The reaction mixture was then allowed to warm to room temperature and concentrated under vacuum. The resulting residue was purified by column chromatography (4 g of SiO<sub>2</sub>, using a gradient of elution of MeOH and DCM from 0 to 15%) to give the title compound (8 mg, 25%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.76 (s, 1H), 8.60 (dd, <i>J</i> = 8.4, 0.9 Hz, 1H), 8.39 (d, <i>J</i> = 6.0 Hz, 1H), 8.32 (s, 1H), 8.16 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.94 (s, 1H), 7.60–7.51 (m, 1H), 7.19 (td, <i>J</i> = 7.6, 0.9 Hz, 1H), 7.07–7.01 (m, 1H), 4.38–4.30 (m, 2H), 4.29–4.22 (m, 2H), 2.34–2.17 (m, 2H), 2.15–2.03 (m, 2H), 2.03–1.91 (m, 2H). MS (ESI): 350.2 [M + H]<sup>+</sup>. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.34 min (95% purity).</div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> <i>N</i>-(6-(4-Methyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)-2-methoxybenzamide (<b>10</b>)</h3><div class="NLM_p last">The reaction was carried out according to the procedure for compound <b>6</b> and using compound <b>30</b> (192 mg, 1.1 mmol) and 2-methoxybenzoic acid (201 mg, 1.3 mmol) to give the title compound (136 mg, 40%) as an off-white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.44 (s, 1H), 8.47 (dd, <i>J</i> = 8.3, 0.8 Hz, 1H), 8.30 (dd, <i>J</i> = 7.9, 1.9 Hz, 1H), 8.19 (s, 1H), 8.06 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.92–7.83 (m, 1H), 7.60–7.50 (m, 1H), 7.21–7.13 (m, 1H), 7.07 (d, <i>J</i> = 8.3 Hz, 1H), 4.14 (s, 3H), 4.08 (s, 3H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 163.5, 157.4, 151.5, 151.1, 146.3, 145.8, 139.5, 133.9, 132.6, 121.8, 121.2, 119.3, 115.0, 11.7, 56.2, 33.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>16</sub>H<sub>16</sub>N<sub>5</sub>O<sub>2</sub>: 310.1299; found: 310.1304. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.45 min (100% purity).</div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> <i>rac</i>-10-Methyl-14H-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<i>rac</i>-11)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 5 and using compound <b>71</b> (61 mg, 0.14 mmol) to give the title compound (20 mg, 40%) as a white solid. MS (ESI): 350.1 [M + H]<sup>+</sup>. Step 2: chiral separation. Compound <i>rac</i><b>-11</b> (11 mg) was purified by SFC (using a Chiralpak OD-H, 5 μm 250 × 300 mm column and 45% MeOH (containing 0.1% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 100 mL/min (ABPR 120 BAR, MBPR 40 PSI)) to give the following in order of elution: peak 1, (<i>S</i>)-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>11</b>, 4 mg, 36%, absolute stereochemistry was arbitrarily assigned) and peak 2 (<i>R</i>)-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>12</b>, 4 mg, 36%, absolute stereochemistry was arbitrarily assigned). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.44 (s, 1H), 8.30 (s, 1H), 8.19 (dd, <i>J</i> = 7.8, 1.8 Hz, 1H), 7.96–7.92 (m, 1H), 7.91–7.87 (m, 1H), 7.84 (d, <i>J</i> = 7.8 Hz, 1H), 7.45 (ddd, <i>J</i> = 8.3, 7.4, 1.9 Hz, 1H), 7.12–7.06 (m, 1H), 6.94 (d, <i>J</i> = 7.8 Hz, 1H), 4.74–4.63 (m, 1H), 4.39 (dt, <i>J</i> = 9.2, 3.2 Hz, 1H), 4.14–4.07 (m, 1H), 3.40–3.34 (m, 1H), 2.24–2.10 (m, 1H), 1.88–1.68 (m, 2H), 1.57 (d, <i>J</i> = 7.0 Hz, 3HMS (ESI): 350.1 [M + H]<sup>+</sup>). HPLC/MS (Chiralpak AD-H 5 μm, 4.6 mm × 250 mm; 45% MeOH in 0.1% DEA in CO<sub>2</sub>, flow rate: 3 mL/min), (<b>11</b>) <i>t</i><sub>R</sub> = 4.20 min (100% purity), (<b>12</b>) <i>t</i><sub>R</sub> = 4.87 min (100% purity).</div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-9-Methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>13</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 5 and using chiral <b>72a</b> (12 mg, 0.03 mmol), Pd(dppf)Cl<sub>2</sub> (5 mg), yielding the title compound (2 mg, 15%) as a colorless residue. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 11.46 (br s, 1H), 8.30 (dd, <i>J</i> = 7.3, 1.8 Hz, 1H), 8.17 (s, 1H), 8.06 (dd, <i>J</i> = 9.5, 7.6 Hz, 2H), 7.95–7.89 (m, 1H), 7.54 (dt, <i>J</i> = 7.6, 1.8 Hz, 1H), 7.22–7.14 (m, 1H), 7.05 (d, <i>J</i> = 7.9 Hz, 1H), 4.62 (dd, <i>J</i> = 13.4, 3.1 Hz, 1H), 4.49 (td, <i>J</i> = 9.0, 3.4 Hz, 1H), 4.29–4.17 (m, 1H), 3.74 (dd, <i>J</i> = 13.4, 11.6 Hz, 1H), 3.59–3.43 (m, 1H), 2.20–2.12 (m, 1H), 1.86–1.75 (m, 1H), 1.12 (d, <i>J</i> = 6.1 Hz, 3H). MS (ESI): 350.1 [M + H]<sup>+</sup>. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 0.34 min (99% purity).</div></div><div id="sec4_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> <i>rac</i>-8-Methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>14</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 5 and using compound <b>73</b> (63 mg, 0.15 mmol) to give the title compound (30 mg, 44%). MS (ESI): 350.1 [M + H]<sup>+</sup>. Step 2: Chiral separation. Compound <i>rac</i>-<b>14</b> (24 mg) was purified by SFC (using a Chiralpak OD-H, 5 μm 250 × 30 mm column and 45% MeOH (containing 0.1% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 100 mL/min (ABPR 120 bar, MBPR 40 psi)) to give the following in order of elution: (<i>R</i>)-8-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>14</b>, 8 mg, 33%, absolute stereochemistry arbitrarily assigned) and (<i>S</i>)-8-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (8 mg, 33%, absolute stereochemistry arbitrarily assigned). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.41 (s, 1H), 8.25 (br d, <i>J</i> = 1.8 Hz, 1H), 8.24 (s, 1H), 8.02 (d, <i>J</i> = 8.0 Hz, 1H), 7.99 (d, <i>J</i> = 7.5 Hz, 1H), 7.90 (d, <i>J</i> = 8.0 Hz, 1H), 7.55–7.47 (m, 1H), 7.16 (t, <i>J</i> = 7.4 Hz, 1H), 7.02 (d, <i>J</i> = 8.3 Hz, 1H), 4.40 (dt, <i>J</i> = 12.9, 4.0 Hz, 1H), 4.30–4.15 (m, 2H), 3.92 (t, <i>J</i> = 9.7 Hz, 1H), 3.55–3.41 (m, 1H), 2.11 (br d, <i>J</i> = 7.0 Hz, 1H), 1.73–1.58 (m, 1H), 1.24 (d, <i>J</i> = 7.0 Hz, 3H). MS (ESI): 350.1 [M + H]<sup>+</sup>. HPLC (Chiralpak AD-H 5 μm, 4.6 mm × 250 mm; 45% MeOH in 0.1% DEA in CO<sub>2</sub>, flow rate: 3 mL/min): (<b>14</b>) <i>t</i><sub>R</sub> = 2.40 (100% purity).</div></div><div id="sec4_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> (<i>S</i>)-7-Methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>15a</b>)</h3><div class="NLM_p last">A mixture of compound <b>74a</b> (100 mg, 0.23 mmol) and Pd (100 g, 10% on C) in MeOH (20 mL) was stirred under H<sub>2</sub> (15 psi) at 18 <i>°</i>C for 4 h. After this time, the mixture was filtered and concentrated to give the crude product, which was purified by SFC (using a 250 mm × 30 mm × 5μm in o.d. column and 40% EtOH (with 0.1% ammonium hydroxide) in CO<sub>2</sub> as the mobile phase at a flow rate of 50 mL/min) to give the title compound (50 mg, 61%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.31 (s, 1H), 8.70 (s, 1H), 8.06 (d, <i>J</i> = 6.8 Hz, 2H), 7.97–7.84 (m, 2H), 7.62 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (s, 1H), 5.08 (s, 1H), 4.27 (s, 2H), 3.01 (s, 1H), 1.95 (s, 3H), 1.35 (d, <i>J</i> = 6.0 Hz, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub>: 350.1612; found: 350.1618. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 3.35 min (98% purity).</div></div><div id="sec4_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> (<i>R</i>)-7-Methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>15b</b>)</h3><div class="NLM_p last">A mixture of compound <b>74b</b> (100 mg, 0.23 mmol) and Pd (100 mg, 10% on C) in MeOH (10 mL) was stirred under H<sub>2</sub> at 18 <i>°</i>C for 4 h. After this time, the mixture was filtered, and the filtrate was concentrated to provide the title compound (30 mg, 37%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.31 (s, 1H), 8.70 (s, 1H), 8.06 (d, <i>J</i> = 6.8 Hz, 2H), 7.97–7.84 (m, 2H), 7.62 (s, 1H), 7.30 (d, <i>J</i> = 8.0 Hz, 1H), 7.15 (s, 1H), 5.08 (s, 1H), 4.27 (s, 2H), 3.01 (s, 1H), 1.95 (s, 3H), 1.35 (d, <i>J</i> = 6.0 Hz, 3H). <sup>13</sup>C NMR (100 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 163.1, 156.5, 151.2, 150.5, 147.6, 145.7, 141.0, 134.8, 132.0, 121.4, 121.2, 117.6, 114.3, 113.1, 75.1, 48.4, 32.1, 23.7, 16.8. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>2</sub>: 350.1612; found: 350.1618. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 3.33 min (99% purity).</div></div><div id="sec4_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 5<sup>5</sup>-Fluoro-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>16</b>)</h3><div class="NLM_p last">The title compound was prepared according to procedure <b>12</b> and using <b>90</b> (300 mg, 0.7 mmol). The product was purified by HPLC (using a Phenomenex Synergi C18, 4 μm 150 × 30 mm column and water (containing 0.05% HCl)/CH<sub>3</sub>CN from 36% to 46% as the mobile phase at a flow rate of 25 mL/min) to give the title compound (60 mg, 29%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.33 (s, 1H), 8.84 (s, 1H), 8.16–8.03 (m, 1H), 7.94–7.86 (m, 2H), 7.73 (dd, <i>J</i> = 9.2, 3.5 Hz, 1H), 7.54–7.46 (m, 1H), 7.37 (dd, <i>J</i> = 9.2, 4.4 Hz, 1H), 4.39–4.25 (m, 4H), 2.46–2.41 (m, 2H), 2.03–1.93 (m, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>5</sub>O<sub>2</sub>: 354.1361; found: 354.1366. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.67 min (100% purity).</div></div><div id="sec4_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 5<sup>4</sup>-Fluoro-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>17</b>)</h3><div class="NLM_p last">The title compound was prepared according to general procedure 12 and using <b>91</b> (400 mg, 0.89 mmol) to give the title compound (100 mg, 32%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.06 (s, 1H), 8.91 (s, 1H), 8.05–8.00 (m, 2H), 7.89–7.84 (m, 2H), 7.20 (m, 1H), 6.98 (m, 1H), 4.32–4.24 (m, 4H), 2.43–2.41 (m, 2H), 1.93–1.92 (m, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>18</sub>H<sub>17</sub>FN<sub>5</sub>O<sub>2</sub>: 354.1361; found: 354.1367. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.64 min (100% purity).</div></div><div id="sec4_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (<i>S</i>)-5<sup>4</sup>-Fluoro-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>18</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 5 and using compound <b>75</b> (500 mg, 1.3 mmol) to give (85 mg, 18%) of the racemic title compound. Step 2: Chiral separation. Compound <i>rac</i>-<b>18</b> (85 mg) was purified by SFC (Chiralcel AD-H 5 μm, 30 × 250 mm and using 50% ethanol (containing 0.1% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 100 mL/min (ABPR 120 bar, MBPR 40 psi)) to give the following in order of elution: (<i>S</i>)-5<sup>4</sup>-fluoro-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>18</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.13 (s, 1H), 8.86 (s, 1H), 8.07 (t, <i>J</i> = 7.8 Hz, 1H), 8.02 (t, <i>J</i> = 7.4 Hz, 1H), 7.88–7.80 (m, 2H), 7.19 (dd, <i>J</i> = 11.2, 2.4, Hz, 1H), 7.00 (dt, <i>J</i> = 8.4, 2.3 Hz, 1H), 4.59 (dt, <i>J</i> = 6.5, 2.4 Hz, 1H), 4.50–4.45 (m, 1H), 4.16 (t, <i>J</i> = 10.0 Hz, 1H), 2.18–2.04 (m, 2H), 1.85–1.65 (m, 2H), 1.54 (d, <i>J</i> = 6.8 Hz, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>5</sub>O<sub>2</sub>: 368.1517; found: 368.1524. HPLC (Chiralcel AD-H 5 μm, 4.6 × 250 mm; 50% EtOH in 0.1% DEA in CO<sub>2</sub>, flow rate: 3 mL/min): <i>t</i><sub>R</sub> = 2.48 min (100% purity). (30 mg, 35%) and (<i>R</i>)-5<sup>4</sup>-fluoro-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>18b</b>) (32 mg, 38%, absolute stereochemistry was assigned by VCD). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.13 (s, 1H), 8.86 (s, 1H), 8.07 (t, <i>J</i> = 7.8 Hz, 1H), 8.02 (t, <i>J</i> = 7.4 Hz, 1H), 7.88–7.80 (m, 2H), 7.19 (dd, <i>J</i> = 11.2, 2.4, Hz, 1H), 7.00 (dt, <i>J</i> = 8.4, 2.3 Hz, 1H), 4.59 (dt, <i>J</i> = 6.5, 2.4 Hz, 1H), 4.50–4.45 (m, 1H), 4.16 (t, <i>J</i> = 10.0 Hz, 1H), 2.18–2.04 (m, 2H), 1.85–1.65 (m, 2H), 1.54 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 368.1 [M + H]<sup>+</sup>. HPLC (Chiralcel AD-H 5 μm, 4.6 × 250 mm; 50% EtOH in 0.1% DEA in CO<sub>2</sub>, flow rate: 3 mL/min): <i>t</i><sub>R</sub> = 2.48 min (100% purity).</div></div><div id="sec4_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>R</i>)-5<sup>4</sup>-Fluoro-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>19</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 5 and using compound <b>76b</b> to give the title compound (23 mg, 27%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.13 (s, 1H), 8.87 (s, 1H), 8.07 (t, <i>J</i> = 7.8 Hz, 1H), 8.02 (t, <i>J</i> = 7.6 Hz, 1H), 7.85 (d, <i>J</i> = 7.9 Hz, 1H), 7.82 (d, <i>J</i> = 7.3 Hz, 1H), 7.19 (dd, <i>J</i> = 11.0, 2.4 Hz, 1H), 7.00 (dt, <i>J</i> = 8.4, 2.1, 1H), 4.60 (ddd, <i>J</i> = 10.4, 7.0, 3.4 Hz, 1H), 4.50–4.46 (m, 1H), 4.16 (br t, <i>J</i> = 9.8 Hz, 1H), 3.68–3.57 (m, 1H), 2.16–2.09 (m, 1H), 1.84–1.74 (m, 2H), 1.54 (d, <i>J</i> = 6.7 Hz, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>19</sub>FN<sub>5</sub>O<sub>2</sub>: 368.1517; found: 368.1524. HPLC (Chiralpak AD-H 5 μm, 4.6 mm × 250 mm; 40% MeOH in 0.1% DEA in CO<sub>2</sub>, flow rate: 3 mL/min): <i>t</i><sub>R</sub> = 3.14 min (100% purity).</div></div><div id="sec4_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> 5<sup>5</sup>-Bromo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>20</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>61</b> (16.5 g, 95.4 mmol) to give the title compound (9.0 g, 41%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.32 (s, 1H), 8.37 (s, 1H), 8.20 (s, 1H), 8.01 (d, <i>J</i> = 7.8 Hz, 2H), 7.94–7.86 (m, 1H), 7.59 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.91 (d, <i>J</i> = 8.6 Hz, 1H), 4.33–4.21 (m, 4H), 2.67 (s, 2H), 2.12–2.01 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 160.5, 155.1, 150.7, 149.3, 145.1, 144.1, 139.2, 135.4, 134.0, 122.0, 117.1, 113.9, 113.7, 112.6, 67.7, 47.4, 26.0, 25.2. HRMS (<i>m</i>/<i>z</i>): [M + H (<sup>81</sup>Br)]<sup>+</sup> calcd for C<sub>18</sub>H<sub>17</sub>BrN<sub>5</sub>O<sub>2</sub>: 414.0560; found: 414.0568. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.89 min (94% purity).</div></div><div id="sec4_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 5<sup>5</sup>-Morpholino-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>21</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 13 and using compound <b>20</b> (130 mg, 0.3 mmol) and morpholine. Purification by column chromatography (4 g silica gel, 5–40% MeOH in DCM) gave the title compound (46 mg, 35%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.49 (s, 1H), 8.14 (s, 1H), 7.95 (d, <i>J</i> = 8.3 Hz, 1H), 7.93–7.89 (m, 1H), 7.84–7.78 (m, 1H), 7.74 (d, <i>J</i> = 3.0 Hz, 1H), 6.99 (dd, <i>J</i> = 8.9, 3.1 Hz, 1H), 6.90 (d, <i>J</i> = 8.8 Hz, 1H), 4.22–4.14 (m, 4H), 3.83–3.77 (m, 4H), 3.13–3.05 (m, 4H), 2.56 (br dd, <i>J</i> = 2.8, 1.5 Hz, 2H), 2.02–1.93 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ ppm 162.8, 152.5, 151.7, 151.6, 150.6, 146.0, 145.6, 145.0, 140.1, 122.0, 119.3, 117.9, 115.2, 113.6, 69.0, 63.8, 50.3, 48.4, 27.2, 26.3. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>25</sub>N<sub>6</sub>O<sub>3</sub>: 421.1983; found: 421.1989. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.31 min (95% purity).</div></div><div id="sec4_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 5<sup>5</sup>-(2-Oxa-6-azaspiro[3.3]heptan-6-yl)-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>22</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 13 and using compound <b>20</b> (150 mg, 0.4 mmol) and morpholine 2-oxa-6-azaspiro[3.3]heptane and heating at reflux for 8 h. Purification by column chromatography (4 g silica gel, MeOH in DCM 1–15%) gave the title compound (33 mg, 21%) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 11.60 (s, 1H), 8.27 (s, 1H), 8.05 (d, <i>J</i> = 8.5 Hz, 1H), 8.00 (d, <i>J</i> = 7.4 Hz, 1H), 7.96–7.87 (m, 1H), 7.36 (d, <i>J</i> = 3.0 Hz, 1H), 6.95 (d, <i>J</i> = 8.8 Hz, 1H), 6.62 (dd, <i>J</i> = 8.8, 3.3 Hz, 1H), 4.85 (s, 4H), 4.32–4.25 (m, 2H), 4.22 (t, <i>J</i> = 4.9 Hz, 2H), 4.05 (s, 4H), 2.66 (br s, 2H), 2.12–1.99 (m, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>23</sub>H<sub>25</sub>N<sub>6</sub>O<sub>3</sub>: 433.1983; found: 433.1989. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.30 min (100% purity).</div></div><div id="sec4_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 5<sup>5</sup>-(Methylsulfonyl)-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>23</b>)</h3><div class="NLM_p last">A suspension of compound <b>20</b> (50 mg, 0.12 mmol), sodium methanesulfinate (15 mg, 0.15 mmol), copper iodide (2 mg, 0.01 mmol), and <span class="smallcaps smallerCapital">l</span>-proline sodium salt (3 mg, 0.02 mol) in NMP (1 mL) was degassed by purging with N<sub>2</sub> for 15 min. The resulting mixture was heated at 100 °C for 8 h. After this time, the reaction mixture was filtered and purified by HPLC (using a Sunfire Prep C18 OBD, 5 μm 30 × 50 mm column and water/CH<sub>3</sub>CN (containing 0.1% TFA) from 90/10 to 30/70 as the mobile phase at a flow rate of 50 mL/min) to give the title compound (14 mg, 22%). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>CN) δ ppm 11.26 (br s, 1H), 8.64 (d, <i>J</i> = 2.8 Hz, 1H), 8.50–8.44 (m, 1H), 8.14–8.07 (m, 1H), 8.06–7.99 (m, 2H), 7.99–7.93 (m, 1H), 7.43–7.36 (m, 1H), 4.48–4.43 (m, 2H), 4.35–4.25 (m, 2H), 3.12 (s, 3H), 2.71–2.58 (m, 2H), 2.12–2.02 (m, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>19</sub>H<sub>20</sub>N<sub>5</sub>O<sub>4</sub>S: 414.1231; found: 414.1239. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.26 min (95% purity).</div></div><div id="sec4_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> 5<sup>5</sup>-(4-Methyl-1<i>H</i>-imidazol-1-yl)-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>24</b>)</h3><div class="NLM_p last">A reaction vial was charged with compound <b>20</b> (300 mg, 0.7 mmol), sodium <i>tert</i>-butoxide (209 mg, 2.2 mmol) and 4-methyl-1<i>H</i>-imidazole (178 mg, 2.2 mmol). The reaction vial was purged with N<sub>2</sub>, <i>tert</i>-butanol (3 mL) was added, and the mixture was heated at 85 °C. Simultaneously, a vial containing a solution of dtbpf (70 mg, 0.14 mmol) and Pd<sub>2</sub>dba<sub>3</sub> (66 mg, 0.07 mmol) in toluene (1.5 mL) was heated at reflux for 15 min, cooled to room temperature, and then added to the first vial. The resulting mixture was heated at reflux for 4 h. After this time, the reaction was cooled to room temperature and MeOH (2 mL) was added, and the reaction mixture was filtered. The resulting product was washed with MeOH (2 × 4 mL), and the combined organic extracts were evaporated under vacuum and purified by HPLC (using an XTerra Prep RP18 OBD, 10 μm 50 × 250 mm column and water (containing 0.1% TFA)/CH<sub>3</sub>CN from 90/10 to 10/90 as the mobile phase at a flow rate of 50 mL/min) to give the title compound (48 mg, 16%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.34 (d, <i>J</i> = 1.8 Hz, 1H), 8.76 (s, 1H), 8.31 (d, <i>J</i> = 3.0 Hz, 1H), 8.05–7.96 (m, 2H), 7.85 (s, 2H), 7.79 (d, <i>J</i> = 1.5 Hz, 1H), 7.44 (d, <i>J</i> = 9.0 Hz, 1H), 4.43 (t, <i>J</i> = 4.9 Hz, 2H), 4.39–4.31 (m, 2H), 2.62 (br d, <i>J</i> = 6.3 Hz, 2H), 2.46 (d, <i>J</i> = 1.0 Hz, 3H), 2.09 (br s, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>: 416.1829; found: 416.1836. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.09 min (100% purity).</div></div><div id="sec4_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 5<sup>5</sup>-(1-Methyl-1<i>H</i>-pyrazol-4-yl)-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>25</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 14 and using compound <b>20</b> (300 mg, 0.72 mmol) and 1-methyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazole (151 mg, 0.72 mmol). Purification by reverse phase HPLC (using a Phenomenex Synergi C18, 4 μm 150 × 30 mm column and water (containing 0.05% HCl)/CH<sub>3</sub>CN from 22 to 42% as the mobile phase at a flow rate of 25 mL/min) gave the title compound (40 mg, 13%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.27 (s, 1H), 8.85 (s, 1H), 8.15 (s, 1H), 8.09–8.06 (m, 2H), 7.91–7.89 (m, 1H), 7.85–7.84 (m, 2H), 7.77–7.74 (m, 1H), 7.28–7.26 (m, 1H), 4.32–4.29 (m, 4H), 3.82 (s, 3H), 2.48–2.46 (m, 2H), 1.94–1.93 (m, 2H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>22</sub>H<sub>22</sub>N<sub>7</sub>O<sub>2</sub>: 416.1829; found: 416.1837. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.45 min (100% purity).</div></div><div id="sec4_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5<sup>5</sup>-(1-(2-(Dimethylamino)ethyl)-1<i>H</i>-pyrazol-4-yl)-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>26</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 14 and using compound <b>20</b> (700 mg, 1.7 mmol) and <i>N</i>,<i>N</i>-dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazol-1-yl)ethan-1-amine in dioxane/H<sub>2</sub>O (0.08 M, 10/1 v/v) with heating at 90 <i>°</i>C under a N<sub>2</sub> atmosphere for 3 h. Purification by column chromatography on silica gel using DCM/MeOH (from 100/1 to 1/1) as the eluent gave the title compound (600 mg, 66%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.61 (s, 1H), 8.21 (d, <i>J</i> = 2.4 Hz, 1H), 8.00 (s, 1H), 7.98–7.94 (m, 2H), 7.85 (d, <i>J</i> = 6.0 Hz, 1H), 7.81 (s, 1H), 7.64 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 7.13 (d, <i>J</i> = 8.8 Hz, 1H), 4.38–4.26 (m, 6H), 2.95 (t, <i>J</i> = 6.8 Hz, 2H), 2.62–2.47 (m, 2H), 2.40 (s, 6H), 2.08–2.05 (m, 2H). <sup>13</sup>C NMR (100 MHz, CD<sub>3</sub>OD) δ ppm 162.0, 156.1, 151.3, 150.3, 144.3, 140.0, 136.8, 130.4, 127.5, 127.3, 125.4, 121.9, 120.5, 117.3, 114.2, 113.5, 113.2, 68.8, 56.8, 49.4, 45.7, 42.4, 26.6, 25.7. HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>25</sub>H<sub>29</sub>N<sub>8</sub>O<sub>2</sub>: 473.2408; found: 473.2415. HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.18 min (100% purity).</div></div><div id="sec4_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (<i>R</i>)-5<sup>5</sup>-(1-(2-(Dimethylamino)ethyl)-1<i>H</i>-pyrazol-4-yl)-5<sup>4</sup>-fluoro-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>27</b>)</h3><div class="NLM_p last">To a stirred solution of compound <b>76b</b> (150 mg, 0.34 mmol) in EtOH (5 mL) and H<sub>2</sub>O (0.5 mL) were added <i>N</i>,<i>N</i>-dimethyl-2-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1<i>H</i>-pyrazol-1-yl)ethan-1-amine (91 mg, 0.34 mmol), PEPPSI (46 mg, 0.07 mmol), and K<sub>2</sub>CO<sub>3</sub> (116 mg, 0.84 mmol), and the reaction mixture was stirred at 90 <i>°</i>C for 2 h. After this time, the reaction suspension was poured into water (20 mL) and extracted with EtOAc (3 × 25 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by HPLC (using an Xtimate C18, 5 μm 150 × 25 mm column and water (containing 10 mM NH<sub>4</sub>HCO<sub>3</sub>)/CH<sub>3</sub>CN from 30% to 60% as the mobile phase at a flow rate of 25 mL/min) to give the title compound (31 mg, 18%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.11 (s, 1H), 8.67 (s, 1H), 8.26–8.21 (m, 2H), 8.07–8.05 (m, 1H), 7.91–7.87 (m, 3H), 7.32–7.28 (m, 1H), 4.54–4.42 (m, 2H), 4.29–4.22 (m, 3H), 3.92–3.85 (m, 1H), 3.26–3.22 (m, 1H), 2.70–2.66 (m, 2H), 2.18 (s, 6H), 2.08–2.01 (m, 1H), 1.70–1.64 (m, 1H), 0.95 (d, <i>J</i> = 6.4 Hz, 3H). HRMS (<i>m</i>/<i>z</i>): [M + H]<sup>+</sup> calcd for C<sub>26</sub>H<sub>29</sub>FN<sub>8</sub>O<sub>2</sub>: 505.2470; found: 505.2477.HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 1.28 min (100% purity). HPLC (CH<sub>3</sub>CN in 0.1% TFA): <i>t</i><sub>R</sub> = 2.88 min (100% purity).</div></div><div id="sec4_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>E</i>)-<i>N</i>′-(6-(2-((<i>E</i>)-(Dimethylamino)methylene)hydrazine-1-carbonyl)pyridin-2-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide (<b>29</b>)</h3><div class="NLM_p last">Step 1: A mixture of methyl 6-aminopyridine-2-carboxylate (6.0 g, 39.4 mmol) and hydrazine hydrate (7.2 g, 78.9 mmol, 7.0 mL) was refluxed in MeOH (50 mL) for 5 h. The reaction mixture was concentrated under vacuum, and the resulting pale-yellow residue was recrystallized from MeOH (220 mL). Filtration resulted in 4.4 g of a white solid. MS (ESI): 153.1 [(M + H)]<sup>+</sup>. Step 2: A mixture of the white solid (3.9 g, 25.3 mmol) and <i>N</i>,<i>N</i>-dimethylformamide-dimethylacetal (DMF-DMA,16.75 mL, 126.5 mmol) was heated to reflux for 2 days. The volatiles were removed, and the resulting residue was taken up in EtOAc (15 mL) and refluxed for 2 h. The mixture was gradually cooled to 0 °C before filtration to yield the title compound (5.8 g, 64% over two steps) as a pale-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.67 (s, 1H), 8.85 (s, 1H), 8.06 (s, 1H), 7.73–7.60 (m, 1H), 7.48 (dd, <i>J</i> = 7.3, 1.0 Hz, 1H), 6.91 (dd, <i>J</i> = 1.0, 8.0 Hz, 1H), 3.14 (s, 3H), 3.00 (s, 3H), 2.86 (s, 6H). MS (ESI): 263.2 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 6-(4-Methyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-amine (<b>30</b>)</h3><div class="NLM_p last">A solution of compound <b>29</b> (1.0 g, 3.8 mmol) in CH<sub>3</sub>CN/AcOH (4/1, 1.25 mL) and methylamine (2 M in THF, 11.4 mmol) was heated in a microwave (Biotage) at 110 <i>°</i>C for 1 h. The volatiles were removed under reduced pressure. The resulting residue was dissolved in MeOH (10 mL), and sodium hydroxide (610 mg, 15.2 mmol) was added; the resulting mixture was heated at reflux for 3 h. The volatiles were removed, and the resulting residue was purified by column chromatography (24 g, SiO<sub>2</sub>, 0–100% EtOAc/EtOH 3/1 in heptane). The title compound (450 mg, 68%) was obtained as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 9.66 (br s, 2H), 8.20 (s, 1H), 7.59 (d, <i>J</i> = 0.8 Hz, 1H), 7.58 (d, <i>J</i> = 6.3 Hz, 1H), 6.57 (dd, <i>J</i> = 7.2, 1.9 Hz, 1H), 4.05 (s, 3H). MS (ESI): 176.1 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 6-(4-Isopropyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-amine (<b>31</b>)</h3><div class="NLM_p last">To a solution of compound <b>29</b> (200 g, 0.760 mol) in CH<sub>3</sub>CN/AcOH (4/1 ratio, 1.25 L), isopropylamine (330 mL, 3.81 mol) was added dropwise at room temperature followed by heating at reflux overnight. The volatiles were removed under reduced pressure, and 1 M aq NaOH was added until pH 8 was reached. The precipitate was collected by filtration, and the filtrate was repeatedly extracted with EtOAc. The combined organic layers were dried over sodium sulfate and concentrated to a volume of 50 mL. A precipitate was formed upon the addition of heptane yielding the title compound (84.2 g, 54%) as a white solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.28 (s, 1H), 7.77 (dd, <i>J</i> = 8.8, 7.3 Hz, 1H), 7.24 (dd, <i>J</i> = 7.3, 0.8 Hz, 1H), 6.90 (dd, <i>J</i> = 8.5, 0.8 Hz, 1H), 5.39 (qn, <i>J</i> = 6.7 Hz, 1H), 1.60 (s, 3H), 1.58 (s, 3H). MS (ESI): 204.1 [(M + H)]<sup>+</sup>.</div></div><div id="sec4_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> Methyl 5-Bromo-2-(3-((<i>tert</i>-butoxycarbonyl)amino)propoxy)benzoate (<b>42</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using compounds <b>32</b> (2.5 g) and <b>34</b> to give the title compound (3.7 g, 89%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.77 (d, <i>J</i> = 2.8 Hz, 1H), 7.69 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.11 (d, <i>J</i> = 9.0 Hz, 1H), 6.85 (br t, <i>J</i> = 5.1 Hz, 1H), 4.07–4.01 (m, 2H), 3.82–3.79 (m, 3H), 3.14–3.07 (m, 2H), 1.82 (qn, <i>J</i> = 6.5 Hz, 2H), 1.36 (s, 9H). MS (ESI): 388.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Methyl 5-Bromo-2-(4-((<i>tert</i>-butoxycarbonyl)amino)butoxy)benzoate (<b>43</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using compounds <b>32</b> (100 g) and <b>35</b>. The product was purified by column chromatography on silica gel using a gradient of elution, petroleum ether/EtOAc (100/1 to 5/1), to give the title compound (130 g, 75%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.91 (d, <i>J</i> = 2.5 Hz, 1H), 7.53 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 6.84 (d, <i>J</i> = 9.0 Hz, 1H), 4.82 (br s, 1H), 4.04 (t, <i>J</i> = 6.0 Hz, 2H), 3.84–3.97 (m, 3H), 3.20 (q, <i>J</i> = 6.4 Hz, 2H), 1.83–1.91 (m, 2H), 1.63–1.75 (m, 2H), 1.40–1.49 (m, 9H). MS (ESI): 424.1 [(M + Na) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Methyl 5-Bromo-2-((5-((<i>tert</i>-butoxycarbonyl)amino)pentyl)oxy)benzoate (<b>44</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using <b>32</b> (2.5 g) and <b>36</b> (2.2 g) to give the crude title compound, which was used without further purification in the Boc-deprotection leading to compound <b>54</b> as a yellow oil. MS (ESI): 416.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> <i>rac</i>-Methyl 5-Bromo-2-((4-((<i>tert</i>-butoxycarbonyl)amino)pentyl)oxy)benzoate (<b>45</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using <b>32</b> (5 g) and <b>37</b> to give the title compound (5.8 g, 64%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.90 (d, <i>J</i> = 2.5 Hz, 1H), 7.53 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.85 (d, <i>J</i> = 8.8 Hz, 1H), 4.62–4.43 (m, 1H), 4.03 (t, <i>J</i> = 6.0 Hz, 2H), 3.89 (s, 3H), 3.70 (br s, 1H), 1.94–1.80 (m, 2H), 1.71–1.61 (m, 1H), 1.43 (s, 9H), 1.33–1.25 (m, 1H), 1.17 (d, <i>J</i> = 6.5 Hz, 3H). MS (ESI): 438.0 [(M + Na) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> <i>rac</i>-Methyl 5-Bromo-2-(4-(1,3-dioxoisoindolin-2-yl)-3-methylbutoxy)benzoate (<b>46</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using <b>32</b> (0.5 g) and <b>38</b>. The crude product was purified by column chromatography on silica gel using a gradient of elution, petroleum ether/EtOAc (10/1 to 3/1), to give the title compound as a colorless oil (0.6 g, 63%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.84 (d, <i>J</i> = 2.5 Hz, 1H), 7.83–7.80 (m, 2H), 7.74–7.68 (m, 2H), 7.49 (dd, <i>J</i> = 9.0, 2.5 Hz, 1H), 6.82 (d, <i>J</i> = 9.0 Hz, 1H), 4.18–4.02 (m, 2H), 3.86 (s, 3H), 3.70–3.56 (m, 2H), 2.37–2.27 (m, 1H), 1.98–1.91 (m, 1H), 1.71–1.65 (m, 1H), 1.01 (d, <i>J</i> = 6.5 Hz, 3H). MS (ESI): 448.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> <i>rac</i>-Methyl 5-Bromo-2-(4-((<i>tert</i>-butoxycarbonyl)amino)-2-methylbutoxy)benzoate (<b>47</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using <b>32</b> (10 g) and <b>39</b> to give the title compound (8.8 g, 49%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.08–7.80 (m, 1H), 7.64–7.41 (m, 1H), 6.96–6.71 (m, 1H), 4.93–4.79 (m, 1H), 3.89 (s, 3H), 3.88–3.79 (m, 2H), 3.30–3.13 (m, 2H), 2.17–2.10 (m, 1H), 1.80–1.65 (m, 1H), 1.59–1.50 (m, 1H), 1.43 (s, 9H), 1.08 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 438.0 [(M + Na) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> <i>rac</i>-Methyl 5-Bromo-2-((5-(1,3-dioxoisoindolin-2-yl)pentan-2-yl)oxy)benzoate (<b>48</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using <b>32</b> (110 mg, 0.5 mmol) and <b>40</b>. The crude product was purified by column chromatography on silica gel using a gradient of elution, petroleum ether/EtOAc (10/1 to 3/1), to give the title compound as a colorless oil (140 mg, 73%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.86–7.79 (m, 3H), 7.73–7.67 (m, 2H), 7.46 (dd, <i>J</i> = 8.8, 2.4 Hz, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 1H), 4.50–4.38 (m, 1H), 3.86 (s, 3H), 3.71 (t, <i>J</i> = 6.6 Hz, 2H), 1.95–1.75 (m, 3H), 1.74–1.64 (m, 1H), 1.30 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): 467.8 [(M + Na) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>rac</i>-Methyl 5-Bromo-2-((4-((<i>tert</i>-butoxycarbonyl)amino)pentyl)oxy)-4-fluorobenzoate (<b>49</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using compounds <b>33</b> (30 g) and <b>37</b>. The product (52 g) was isolated as a brown gum and used without further purification in the next step. MS (ESI): 456.1 [(M + Na) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>rac</i>-Methyl 5-Bromo-2-(4-((<i>tert</i>-butoxycarbonyl)(4-methoxybenzyl)amino)-3-methylbutoxy)-4-fluorobenzoate (<b>50</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 1 and using compounds <b>33</b> (4 g) and <b>40</b>. The product was purified by column chromatography on silica gel using petroleum ether/EtOAc (10/1 to 3/1) as an eluent to give the title compound (5 g, 46%) as a colorless gum. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.04 (d, <i>J</i> = 8.4 Hz, 1H), 7.14–7.13 (m, 2H), 6.85–6.80 (m, 2H), 6.71–6.70 (m, 1H), 4.45–4.37 (m, 2H), 3.99–3.98 (m, 2H), 3.85 (s, 3H), 3.78 (s, 3H), 3.16–3.08 (m, 2H), 2.12–2.11 (m, 1H), 1.88–1.87 (m, 1H), 1.62–1.61 (m, 1H), 1.46 (s, 9H), 0.94 (d, <i>J</i> = 6.8 Hz, 3H).</div></div><div id="sec4_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl 2-(3-Aminopropoxy)-5-bromobenzoate (<b>51</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>42</b> (1.6 g) to give the title compound (1.1 g, 93%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.83 (d, <i>J</i> = 2.8 Hz, 1H), 7.80 (br s, 2H), 7.74 (dd, <i>J</i> = 9.0, 2.8 Hz, 1H), 7.15 (d, <i>J</i> = 9.0 Hz, 1H), 4.15 (t, <i>J</i> = 5.8 Hz, 2H), 3.81 (s, 3H), 3.03 (sxt, <i>J</i> = 6.3 Hz, 2H), 2.02 (qn, <i>J</i> = 6.4 Hz, 2H). MS (ESI): 288.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl 2-(4-Aminobutoxy)-5-bromobenzoate (<b>52</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>43</b> (130 g) to give the title compound (90 g, 92%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 7.77 (d, <i>J</i> = 2.8 Hz, 1H), 7.70 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 7.14 (d, <i>J</i> = 8.8 Hz, 1H), 4.11–4.01 (m, 2H), 3.81 (s, 3H), 3.71–3.10 (m, 2H), 2.92–2.77 (m, 2H), 1.85–1.61 (m, 4H). MS (ESI): 302.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl 2-((5-Aminopentyl)oxy)-5-bromobenzoate (<b>53</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>44</b> (16.6 g) to give the title compound (11.9 g, 94%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.18–7.93 (m, 2H), 7.89 (d, <i>J</i> = 2.5 Hz, 1H), 7.55 (dd, <i>J</i> = 8.8, 2.5 Hz, 1H), 6.84 (d, <i>J</i> = 9.0 Hz, 1H), 4.03 (t, <i>J</i> = 5.9 Hz, 2H), 3.86 (s, 3H), 3.14–2.99 (m, 2H), 1.90–1.79 (m, 4H), 1.71–1.57 (m, 2H). MS (ESI): 316.1 [M + H (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> <i>rac</i>-Methyl 2-((4-Aminopentyl)oxy)-5-bromobenzoate (<b>54</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>45</b> (16.6 g) to give the title compound (12.6 g, 99%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.94 (d, <i>J</i> = 2.8 Hz, 1H), 7.55 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 6.83 (d, <i>J</i> = 8.8 Hz, 1H), 6.39 (br s, 2H), 4.08–3.99 (m, 2H), 3.84 (s, 3H), 3.45–3.33 (m, 1H), 2.03–1.77 (m, 4H), 1.33 (d, <i>J</i> = 6.5 Hz, 3H). MS (ESI): 316.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> <i>rac</i>-Methyl 2-(4-Amino-3-methylbutoxy)-5-bromobenzoate (<b>55</b>)</h3><div class="NLM_p last">A mixture of compound <b>46</b> (400 mg, 0.9 mmol) and N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O (45 mg, 0.9 mmol) in MeOH (8 mL) was stirred at 50 <i>°</i>C for 47 h. After this time, the solvent was removed in vacuum to give the crude product, which was dissolved in H<sub>2</sub>O (10 mL) and extracted with DCM/MeOH (10/1, 3 × 20 mL). The separated organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum to give the crude title compound (200 mg, 70% crude) as colorless gum. MS (ESI): 318.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> <i>rac</i>-Methyl 2-(4-Amino-2-methylbutoxy)-5-bromobenzoate (<b>56</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>47</b> (12.7 g) to give the title compound (9.1 g, 94%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 7.96 (d, <i>J</i> = 2.5 Hz, 1H), 7.56 (dd, <i>J</i> = 8.9, 2.6 Hz, 1H), 6.85 (d, <i>J</i> = 9.0 Hz, 1H), 7.08–6.14 (m, 2H), 3.93–3.86 (m, 2H), 3.85 (s, 3H), 3.21–3.02 (m, 2H), 2.30–2.13 (m, 1H), 1.98–1.84 (m, 1H), 1.84–1.70 (m, 1H), 1.05 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 316.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> <i>rac</i>-Methyl 2-((5-Aminopentan-2-yl)oxy)-5-bromobenzoate (<b>57</b>)</h3><div class="NLM_p last">A mixture of compound <b>48</b> and N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O (944 mg, 18.5 mmol) in MeOH (50 mL) was stirred at 50 <i>°</i>C for 17 h. After this time, the volatiles were removed under vacuum, and the resulting residue was dissolved in H<sub>2</sub>O (20 mL). The pH was adjusted to 11–12 by addition of aq NaOH, and the mixture was extracted with EtOAc (3 × 50 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (3.5 g, 90%) as a brown solid. MS (ESI): 315.9 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> <i>rac</i>-Methyl 2-((4-Aminopentyl)oxy)-5-bromo-4-fluorobenzoate (<b>58</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 2 and using compound <b>49</b> (51 g) to give the title compound (44 g, 89%) as a white solid. MS (ESI): 333.9 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>rac</i>-Methyl 2-(4-Amino-3-methylbutoxy)-5-bromo-4-fluorobenzoate (<b>59</b>)</h3><div class="NLM_p last">Step 1: A mixture of compound <b>50</b> (4.5 g, 8.1 mmol) and CAN (13.2 g, 25 mmol) in CH<sub>3</sub>CN/water (1/1, 100 mL) was stirred at 10 <i>°</i>C for 30 min. After this time, water (500 mL) was added, and the mixture was extracted with EtOAc (3 × 200 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give the title compound (5 g) as a colorless gum. MS (ESI): 434.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 2 using the compound isolated in step 1 (3.5 g) to give the title compound (1.8 g, 67% over 2 steps) as an orange gum, which was used without purification in the next step. MS (ESI): 334.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> 2-(3-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)propoxy)-5-bromobenzoic Acid (<b>60</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>51</b> (1.18 g) and <b>29</b> (0.54 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (100/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (670 mg). The main product had MS (ESI): 460.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (476 mg) to give the title compound (275 mg, 30% over 2 steps) as a yellow oil. MS (ESI): 418.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> 2-(4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)butoxy)-5-bromobenzoic Acid (<b>61</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>52</b> (17 g) and <b>29</b> (15.5 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (100/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (26 g). The main product had MS (ESI): 474.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (26 g) to give the title compound (23 g, 97% over 2 steps) as a yellow oil. MS (ESI): 432.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> 2-((5-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)pentyl)oxy)-5-bromobenzoic Acid (<b>62</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compound <b>53</b> (4.8 g) and compound <b>29</b> (2.0 g). The product was purified by column chromatography using a gradient of elution: DCM/MeOH (100/1 to 1/1) to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (3.0 g). The main product had MS (ESI): 488.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (3.0 g) to give the title compound (495 mg, 19% over 2 steps) as a yellow oil. MS (ESI): 446.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>rac</i>-2-((4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)pentyl)oxy)-5-bromobenzoic Acid (<b>63</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>54</b> (12.6 g) and <b>29</b> (5.2 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (100/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (2.4 g). The main product had MS (ESI): 488.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (2.3 g) to give the title compound (1.1 g, 94% over 2 steps) as a yellow oil. MS (ESI): 446.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> <i>rac</i>-2-(4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)-3-methylbutoxy)-5-bromobenzoic Acid (<b>64</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>55</b> (200 mg) and <b>29</b> (138 mg). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (30/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (50 mg). The main product had MS (ESI): 490.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (50 mg) to give the title compound (60 mg, 19%) as a yellow oil. MS (ESI): 447.9 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> <i>rac</i>-2-(4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)-2-methylbutoxy)-5-bromobenzoic Acid (<b>65</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>56</b> (9.1 g, 1.0 equiv) and <b>29</b> (3.8 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (30/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (4.9 g). The main product had MS (ESI): 488.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (4.9 g) to give the title compound (4.4 g, 68%) as a yellow solid. MS (ESI): 446.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> <i>rac-</i>2-((5-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)pentan-2-yl)oxy)-5-bromobenzoic Acid (<b>66</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>57</b> (3.5 g) and <b>29</b> (4.9 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (30/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (2.0 g). The main product had MS (ESI): 480.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (2.0 g) to give the title compound (1.83 g, 48%) as a yellow solid. MS (ESI): 446.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> <i>rac</i>-2-((4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)pentyl)oxy)-5-bromo-4-fluorobenzoic Acid (<b>67</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>58</b> (15 g, 1.2 equiv) and <b>29</b> (4.9 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (30/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (16 g). The main product had MS (ESI): 508.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (9.0 g) to give the title compound (9.0 g, 100%) as a yellow solid. MS (ESI): 466.1 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> <i>rac</i>-2-(4-(3-(6-Aminopyridin-2-yl)-4<i>H</i>-1,2,4-triazol-4-yl)-3-methylbutoxy)-5-bromo-4-fluorobenzoic Acid (<b>68</b>)</h3><div class="NLM_p last">Step 1: The reaction was carried out according to general procedure 3, step 1, and using compounds <b>59</b> (1.8 g) and <b>29</b> (1.2 g). The product was purified by column chromatography using a gradient of elution, DCM/MeOH (30/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step (800 mg). The main product had MS (ESI): 508.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Step 2: The reaction was carried out according to general procedure 3, step 2, and using the product from step 1 (800 mg) to give the title compound (700 mg, 34%) as a yellow solid. MS (ESI): 464.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> 5<sup>5</sup>-Bromo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclononaphan-4-one (<b>69</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>60</b> (471 mg, 1.1 mmol) to give the title compound (140 mg, 31%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.42 (s, 1H), 8.73 (s, 1H), 7.95 (d, <i>J</i> = 7.8 Hz, 1H), 7.85 (dd, <i>J</i> = 7.5, 0.8 Hz, 1H), 7.46 (s, 1H), 7.44 (d, <i>J</i> = 2.5 Hz, 1H), 7.32 (d, <i>J</i> = 7.8 Hz, 1H), 7.01 (d, <i>J</i> = 9.0 Hz, 1H), 4.78 (br s, 2H), 4.07 (br s, 2H), 2.19 (br s, 2H). MS (ESI): 400.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> 5<sup>5</sup>-Bromo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacycloundecaphan-4-one (<b>70</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>62</b> (231 mg, 0.52 mmol) to give the desired product (100 mg, 45%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.62 (s, 1H), 8.53 (dd, <i>J</i> = 8.4, 0.9 Hz, 1H), 8.49 (d, <i>J</i> = 2.8 Hz, 1H), 8.21 (s, 1H), 8.17 (dd, <i>J</i> = 7.7, 0.9 Hz, 1H), 7.93 (t, <i>J</i> = 8.0 Hz, 1H), 7.62 (dd, <i>J</i> = 8.7, 2.6 Hz, 1H), 6.92 (d, <i>J</i> = 8.8 Hz, 1H), 4.33–4.26 (m, 2H), 4.25–4.19 (m, 2H), 2.29–2.17 (m, 2H), 2.11–2.02 (m, 2H), 1.99–1.89 (m, 2H). MS (ESI): 428.1[(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> <i>rac</i>-5<sup>5</sup>-Bromo-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>71</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>63</b> (0.5 g, 1.1 mmol) to give the desired product (178 mg, 39%) as a beige solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.14 (s, 1H), 8.13 (s, 1H), 8.06–8.01 (m, 1H), 7.97–7.93 (m, 1H), 7.86 (d, <i>J</i> = 7.3 Hz, 1H), 7.65 (br d, <i>J</i> = 8.8 Hz, 1H), 7.12 (d, <i>J</i> = 9.0 Hz, 1H), 4.82–4.71 (m, 1H), 4.52–4.42 (m, 1H), 4.24–4.13 (m, 1H), 3.31–3.23 (m, 1H), 2.33–2.17 (m, 1H), 1.95–1.82 (m, 2H), 1.68 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 428.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> <i>rac</i>-5<sup>5</sup>-Bromo-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>72</b>)</h3><div class="NLM_p last">A mixture of compound <b>64</b> (40 mg, 0.09 mmol) in T<sub>3</sub>P (1 mL, ≥50 wt % in EtOAc) and Et<sub>3</sub>N (1 mL) was stirred at 50 <i>°</i>C for 2 h. After this time, the solvent was removed in vacuum to give the crude product, which was dissolved in H<sub>2</sub>O (10 mL) and extracted with DCM (2 × 10 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuum. The crude product was purified by prep-TLC (DCM/MeOH = 10/1) to provide the title compound (15 mg, 33%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.07–8.05 (m, 2H), 7.91–7.87 (m, 2H), 7.80–7.78 (m, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 4.52–4.42 (m, 2H), 4.28–4.23 (m, 1H), 3.92–3.86 (m, 1H), 3.22–3.21 (m, 1H), 2.08–2.02 (m, 1H), 1.71–1.65 (m, 1H), 0.96 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 429.8 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Chiral separation: compound <b>72</b> (15 mg) was purified by SFC (using a Chiralpak AD-3 3 μm, 50 × 4.6 mm column and 40% ethanol (containing 0.05% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 4 mL/min (at a column temperature of 40 <i>°</i>C)) to give the following in order of elution. Peak 1 (absolute stereochemistry arbitrarily assigned): (<i>R</i>)-5<sup>5</sup>-bromo-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>72a</b>, 5 mg, 33%) as a white solid. δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.07–8.05 (m, 2H), 7.91–7.87 (m, 2H), 7.80–7.78 (m, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 4.52–4.42 (m, 2H), 4.28–4.23 (m, 1H), 3.92–3.86 (m, 1H), 3.22–3.21 (m, 1H), 2.08–2.02 (m, 1H), 1.71–1.65 (m, 1H), 0.96 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 429.8 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Peak 2 (absolute stereochemistry arbitrarily assigned): (<i>S</i>)-5<sup>5</sup>-bromo-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>72b</b>, 5 mg, 33%) as a white solid. δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.07–8.05 (m, 2H), 7.91–7.87 (m, 2H), 7.80–7.78 (m, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 4.52–4.42 (m, 2H), 4.28–4.23 (m, 1H), 3.92–3.86 (m, 1H), 3.22–3.21 (m, 1H), 2.08–2.02 (m, 1H), 1.71–1.65 (m, 1H), 0.96 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 430.0 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Compound <b>72a</b> was found to be more potent in the biochemical assay.</div></div><div id="sec4_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>rac</i>-5<sup>5</sup>-Bromo-8-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>73</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>65</b> (0.5 g, 1.1 mmol) to give the desired product (220 mg, 36%) as a beige solid. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 9.20 (s, 1H), 8.21 (d, <i>J</i> = 2.8 Hz, 1H), 8.13–8.01 (m, 2H), 7.95 (d, <i>J</i> = 7.3 Hz, 1H), 7.72 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.23 (d, <i>J</i> = 9.0 Hz, 1H), 4.52 (s, 2H), 4.41–4.34 (m, 1H), 4.06–3.96 (m, 1H), 2.24–2.10 (m, 1H), 1.86–1.70 (m, 1H), 1.38–1.30 (m, 1H), 1.27 (d, <i>J</i> = 7.0 Hz, 3H). MS (ESI): 428.1 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>rac</i>-5<sup>5</sup>-Bromo-7-methyl-1<sup>4</sup>H-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (74)</h3><div class="NLM_p last">A mixture of <b>66</b> (1.83 g, 4.1 mmol) in T<sub>3</sub>P (15 mL, ≥50 wt % in EtOAc) and Et<sub>3</sub>N (15 mL) was stirred at 70 <i>°</i>C for 3 h. After this time, the volatiles were removed under reduced pressure to give the crude product. H<sub>2</sub>O (50 mL) was then added, and the resulting solid was collected by filtration and dried under vacuum to give the title compound (1.0 g, 57%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.12–8.04 (m, 2H), 7.94–7.90 (m, 2H), 7.77 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 5.11–5.03 (m, 1H), 4.34–4.19 (m, 2H), 3.02–2.88 (m, 1H), 2.09–1.88 (m, 3H), 1.34 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): 429.9 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Chiral separation: Compound <b>74</b> (100 mg) was purified by SFC (using a Chiralpak AD-3 3 μm, 50 × 4.6 mm column and 40% ethanol (containing 0.05% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 4 mL/min (at a column temperature of 40 <i>°</i>C)) to give the following in order of elution. Peak 1 (absolute stereochemistry arbitrarily assigned): (<i>S</i>)-5<sup>5</sup>-bromo-7-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>74a</b>, 30 mg, 30%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.12–8.04 (m, 2H), 7.94–7.90 (m, 2H), 7.77 (dd, <i>J</i> = 8.8, 2.8 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 5.11–5.03 (m, 1H), 4.34–4.19 (m, 2H), 3.02–2.88 (m, 1H), 2.09–1.88 (m, 3H), 1.34 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): 429.9 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Peak 2 (absolute stereochemistry arbitrarily assigned): <i>(R</i>)-5<sup>5</sup>-bromo-7-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>74b</b>, 40 mg, 40%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.19 (s, 1H), 8.69 (s, 1H), 8.02–8.15 (m, 2H), 7.92 (d, <i>J</i> = 7.8 Hz, 2H), 7.77 (dd, <i>J</i> = 9.0, 2.7 Hz, 1H), 7.29 (d, <i>J</i> = 8.8 Hz, 1H), 5.12–5.01 (m, 1H), 4.35–4.19 (m, 2H), 3.03–2.88 (m, 1H), 2.09–1.88 (m, 3H), 1.33 (d, <i>J</i> = 5.9 Hz, 3H). MS (ESI): 427.9 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>rac-</i>5<sup>5</sup>-Bromo-5<sup>4</sup>-fluoro-10-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>75</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 4 and using <b>67</b> (4.2 g, 9 mmol) to give the desired product (1.0 g, 25%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 11.01 (s, 1H), 8.85 (s, 1H), 8.11–8.04 (m, 2H), 7.82–7.78 (m, 2H), 7.41 (d, <i>J</i> = 11.2 Hz, 1H), 4.53–4.43 (m, 2H), 4.15–4.10 (m, 1H), 3.11–3.09 (m, 1H), 2.06–2.04 (m, 1H), 1.78–1.69 (m, 2H), 1.50 (d, <i>J</i> = 6.8 Hz, 3H). MS (ESI): 446.0 [(M + H) (<sup>79</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>rac</i>-5<sup>5</sup>-Bromo-5<sup>4</sup>-fluoro-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>76</b>)</h3><div class="NLM_p last">A mixture of <b>68</b> (800 mg, 1.7 mmol) in T<sub>3</sub>P (20 mL, ≥50 wt % in EtOAc) and Et<sub>3</sub>N (20 mL) was stirred at 70 <i>°</i>C for 2 h. After this time, water (100 mL) was added, and the mixture was stirred until a solid was formed (30 min). The solid was filtered and dried under vacuum to give the crude product, which was purified by column chromatography on silica gel using DCM/MeOH (1/0 to 40/1) as an eluent to give the title compound (180 mg, 23%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.99 (s, 1H), 8.66 (s, 1H), 8.14 (d, <i>J</i> = 8.4 Hz, 1H), 8.06–8.02 (m, 1H), 7.88–7.84 (m, 2H), 7.44 (d, <i>J</i> = 10.8 Hz, 1H), 4.51–4.48 (m, 1H), 4.41–4.39 (m, 1H), 4.26–4.21 (m, 1H), 3.89–3.82 (m, 1H), 3.19–3.17 (m, 1H), 2.06–1.99 (m, 1H), 1.66–1.63 (m, 1H), 0.92 (d, <i>J</i> = 6.0 Hz, 3H). MS (ESI): 447.8 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. <b>Chiral separation:</b> Compound <b>76</b> (140 mg) was purified by SFC (using a Chiralpak AD-3 3 μm 50 × 4.6 mm column and 40% ethanol (containing 0.05% Et<sub>2</sub>NH) in CO<sub>2</sub> as the mobile phase at a flow rate of 4 mL/min with a column temperature of 40 <i>°</i>C) to give the following in order of elution. Peak 1 (absolute stereochemistry arbitrarily assigned): (<i>S</i>)-5<sup>5</sup>-Bromo-5<sup>4</sup>-fluoro-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>76a</b>, 50 mg, 36%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.98 (s, 1H), 8.67 (s, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 8.01–8.05 (m, 1H), 7.87–7.82 (m, 2H), 7.42 (d, <i>J</i> = 10.8 Hz, 1H), 4.50–4.48 (m, 1H), 4.41–4.38 (m, 1H), 4.25–4.20 (m, 1H), 3.87–3.82 (m, 1H), 3.17–3.15 (m, 1H), 2.05–1.99 (m, 1H), 1.66–1.60 (m, 1H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): 447.8 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>. Peak 2 (absolute stereochemistry arbitrarily assigned): (<i>R</i>)-5<sup>5</sup>-Bromo-5<sup>4</sup>-fluoro-9-methyl-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-4-one (<b>76b</b>, 50 mg, 36%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ ppm 10.98 (s, 1H), 8.67 (s, 1H), 8.13 (d, <i>J</i> = 8.4 Hz, 1H), 8.05–8.01 (m, 1H), 7.87–7.82 (m, 2H), 7.42 (d, <i>J</i> = 10.8 Hz, 1H), 4.50–4.48 (m, 1H), 4.41–4.38 (m, 1H), 4.25–4.20 (m, 1H), 3.87–3.82 (m, 1H), 3.17–3.15 (m, 1H), 2.05–1.99 (m, 1H), 1.66–1.60 (m, 1H), 0.92 (d, <i>J</i> = 6.4 Hz, 3H). MS (ESI): 447.8 [(M + H) (<sup>81</sup>Br)]<sup>+</sup>.</div></div><div id="sec4_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> 6-(4-Allyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-amine (<b>77</b>)</h3><div class="NLM_p last">To a solution of <b>29</b> (26.5 g, 101.0 mmol) in a 4:1 mixture of CH<sub>3</sub>CN/AcOH (174 mL/44 mL) was added allyl amine (5 mL, 661.0 mmol). The mixture was heated under reflux for 3 days. The reaction mixture was cooled down to room temperature, and the solvent was removed in vacuum. The residue was dissolved in H<sub>2</sub>O (200 mL), and 1 N aq NaHCO<sub>3</sub> was added until pH 8. The precipitate was filtered off, and the filtrate was extracted with EtOAc (3 × 150 mL). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvent was removed in vacuum. The crude residue was purified by column chromatography on silica gel using a 9/1 mixture of EtOAc/MeOH yielding the title compound (7.7 g, 38%) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ ppm 8.57 (s, 1H), 7.62–7.54 (m, 1H), 7.28 (d, <i>J</i> = 7.5 Hz, 1H), 6.65 (d, <i>J</i> = 7.5 Hz, 1H), 6.12–5.99 (m, 1H), 5.30–5.25 (m, 2H), 5.24–5.19 (m, 1H), 5.15–5.10 (m, 1H). MS (ESI): 202.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> Methyl 2-(Allyloxy)-5-fluorobenzoate (<b>80</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 6 and using compound <b>78</b> (5.5 g, 32.4 mmol) to give the title compound (3.1 g, 46%) as brown gum. MS (ESI): 211.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> Methyl 2-(Allyloxy)-4-fluorobenzoate (<b>81</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 6 and using compound <b>79</b> (4.6 g, 21.9 mmol) to give the title compound (5.0 g, 88%) as brown gum. MS (ESI): 211.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> 2-(Allyloxy)-5-fluorobenzoyl Chloride (<b>82</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 7 and using <b>80</b> (2.5 g, 12.7 mmol) to give the title compound (2.74 g, 100% over 2 steps) as a brown gum.</div></div><div id="sec4_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> 2-(Allyloxy)-4-fluorobenzoyl Chloride (<b>83</b>)</h3><div class="NLM_p last">The title compound was prepared according to procedure 7 and using <b>81</b> (5.0 g, 23.8 mmol) to give the product (5.03 g, 99% over 2 steps) as a brown gum.</div></div><div id="sec4_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> <i>N</i>-(6-(4-Allyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)-2-(allyloxy)-5-fluorobenzamide (<b>84</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 8 and using compound <b>77</b> (2.74 g, 13.6 mmol) and <b>82</b> to give the title compound (2.3 g, 47%) as a brown solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 10.42 (br s, 1H), 8.47 (d, <i>J</i> = 8.5 Hz, 1H), 8.22 (s, 1H), 8.09 (d, <i>J</i> = 8.0 Hz, 1H), 8.01 (dd, <i>J</i> = 9.5, 3.5 Hz ,1H), 7.9 (t, <i>J</i> = 8.01 Hz, 1H), 7.24–7.19 (m, 1H), 7.02 (dd, <i>J</i> = 9.0, 4.0 Hz, 1H), 6.00–6.18 (m, 2H), 5.51 (d, <i>J</i> = 17.5 Hz, 1H), 5.38 (d, <i>J</i> = 10.5 Hz, 1H), 5.30 (s, 1H), 5.28–5.23 (m, 1H), 5.22–5.18 (m, 2H), 4.77 (d, <i>J</i> = 5.5 Hz, 2H). MS (ESI): 379.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> <i>N</i>-(6-(4-Allyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)-2-(allyloxy)-4-fluorobenzamide (<b>85</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 8 and using compound <b>83</b> (3.0 g, 14.0 mmol) to give the title compound (1.8 g, 32%) as a yellow solid. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ ppm 8.32 (d, <i>J</i> = 8.0 Hz, 1H), 8.20 (s, 1H), 7.95 (t, <i>J</i> = 8.0 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 7.29 (dd, <i>J</i> = 8.0, 3.5 Hz, 1H), 7.14 (ddd, <i>J</i> = 9.0, 7.5, 3.0 Hz, 1H), 6.86 (dd, <i>J</i> = 9.0, 4.0 Hz, 1H), 6.06–5.93 (m, 2H), 5.44 (dd, <i>J</i> = 17.5, 1.5 Hz, 1H), 5.27 (dd, <i>J</i> = 10.5. 1.5 Hz, 1H), 5.22–5.18 (m, 1H), 5.16 (dd, <i>J</i> = 17.5, 1.0 Hz, 1H), 5.09 (br d, <i>J</i> = 6.0 Hz, 2H), 4.56 (d, <i>J</i> = 5.0 Hz, 2H), 1.24 (s, 9H). MS (ESI): 379.9 [M + H]<sup>+</sup>.</div></div><div id="sec4_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> <i>tert</i>-Butyl (6-(4-Allyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)(2-(allyloxy)-5-fluorobenzoyl)carbamate (<b>86</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 9 and using compound <b>84</b> (2.3 g, 6.1 mmol) to give the title compound (2.1 g, 72%) as a white solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 10.22 (br s, 1H), 8.48 (d, <i>J</i> = 8.4 Hz, 1H), 8.32 (dd, <i>J</i> = 8.4, 7.2 Hz, 1H), 8.22 (s, 1H), 8.07 (d, <i>J</i> = 7.6 Hz, 1H), 7.89 (t, <i>J</i> = 8.0 Hz, 1H), 6.93–6.83 (m, 1H), 6.77 (dd, <i>J</i> = 9.6, 2.4 Hz, 1H), 6.21–5.98 (m, 2H), 5.54 (br d, <i>J</i> = 16.4 Hz, 1H), 5.41 (d, <i>J</i> = 11.6 Hz, 1H), 5.29 (d, <i>J</i> = 10.0 Hz, 1H), 5.26–5.17 (m, 3H), 4.78 (br, d, <i>J</i> = 5.6 Hz, 2H). MS (ESI): 480.6 [M + H] + .</div></div><div id="sec4_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> <i>tert</i>-Butyl (6-(4-Allyl-4<i>H</i>-1,2,4-triazol-3-yl)pyridin-2-yl)(2-(allyloxy)-4-fluorobenzoyl)carbamate (<b>87</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 9 and using compound <b>85</b> (1.8 g, 4.8 mmol) to give the title compound (1.8 g, 79%) as a brown solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ ppm 8.30 (d, <i>J</i> = 7.6 Hz, 1H), 8.19 (s, 1H), 7.94 (t, <i>J</i> = 8.0 Hz, 1H), 7.59 (dd, <i>J</i> = 8.4, 6.8 Hz, 1H), 7.36 (d, <i>J</i> = 8.0 Hz, 1H), 6.76 (dt, <i>J</i> = 8.4, 2.0 Hz, 1H), 6.64 (dd, <i>J</i> = 10.4, 2.0 Hz, 1H), 6.06–5.90 (m, 2H), 5.45 (br d, <i>J</i> = 17.2 Hz, 1H), 5.28 (d, <i>J</i> = 10.8 Hz, 1H), 5.23–5.03 (m, 4H), 4.56 (br d, <i>J</i> = 4.8 Hz, 2H), 1.25 (s, 9H). MS (ESI): 480.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (<i>E</i>/<i>Z</i>)-<i>tert</i>-Butyl-5<sup>5</sup>-fluoro-4-oxo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-8-ene-3-carboxylate (<b>88</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 10 and using compound <b>86</b> (2 g, 4.2 mmol). The product was purified by column chromatography on silica (petroleum ether/EtOAc = 10/1 to 0/1) to give the title compound as a mixture of <i>E</i>- and <i>Z</i>-isomers (180 mg, 8%). MS (ESI): 474.3 [M + Na]<sup>+</sup>.</div></div><div id="sec4_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (<i>E</i>/<i>Z</i>)-<i>tert</i>-Butyl-5<sup>4</sup>-fluoro-4-oxo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphan-8-ene-3-carboxylate (<b>89</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 10 and using compound <b>87</b> (1.8 g, 3.8 mmol) to give the title compound as a mixture of <i>E</i>- and <i>Z</i>-isomers (600 mg, 35%) as a brown solid. MS (ESI): 452.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> <i>tert</i>-Butyl-5<sup>5</sup>-fluoro-4-oxo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphane-3-carboxylate (<b>90</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 11 and using <b>88</b> (300 mg, 0.7 mmol) to give the title compound (301 mg, 100%) as a brown solid. MS (ESI): 454.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> <i>tert</i>-Butyl-5<sup>4</sup>-fluoro-4-oxo-1<sup>4</sup><i>H</i>-6-oxa-3-aza-2(2,6)-pyridina-1(3,4)-triazola-5(1,2)-benzenacyclodecaphane-3-carboxylate (<b>91</b>)</h3><div class="NLM_p last">The reaction was carried out according to general procedure 11 and using <b>89</b> (400 mg, 0.89 mmol) to give the title compound (400 mg, 100%) as a brown oil. MS (ESI): 454.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> General Procedure 1</h3><div class="NLM_p last">A stirred solution of <b>32</b> or <b>33</b> (1 equiv.) and <b>34–41</b> (1.2 equiv) and PPh<sub>3</sub> (1.1 equiv) in THF (0.25 M) was treated with DIAD (1.05 equiv) at 0 °C for 30 min. The resulting mixture was stirred at 30 °C for 12 h. After this time the reaction was partitioned between EtOAc and water. The separated organic layer was washed with brine, dried over MgSO<sub>4</sub>, filtered, and evaporated under vacuum. The product was purified by column chromatography on silica gel to give the title compound.</div></div><div id="sec4_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> General Procedure 2</h3><div class="NLM_p last">A solution of the Boc-protected intermediate and TFA (100 equiv) in DCM (0.16 M) was stirred at 40 °C for 5 h. After this time, the mixture was concentrated under vacuum. The product was taken up in EtOAc and washed with sat. aq NaHCO<sub>3</sub>. The combined organic layers were concentrated under vacuum to give the title compound.</div></div><div id="sec4_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> General Procedure 3</h3><div class="NLM_p last">Step 1: A solution of intermediates <b>51–59</b> and (<i>E</i>)-<i>N′</i>-(6-(2-((<i>E</i>)-(dimethylamino)methylene)hydrazine-1-carbonyl)pyridin-2-yl)-<i>N</i>,<i>N</i>-dimethylformimidamide in CH<sub>3</sub>CN/AcOH (0.13 M, 1/1) was stirred at 90 °C for 24 h. After this time, the mixture was purified by column chromatography on silica gel using a gradient of elution, DCM/MeOH (100/1 to 1/1), to give the desired product as a mixture of partially hydrolyzed products, which was used without further purification in the next step. Step 2: A solution of the crude compound from step 1 and NaOH (2 equiv) in THF/MeOH (0.05 M, 1/1) was stirred at 70 °C for 10 h. After this time, the solvent was evaporated under vacuum to give the title compound.</div></div><div id="sec4_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> General Procedure 4</h3><div class="NLM_p last">A solution of intermediates <b>60–68</b> was treated with Et<sub>3</sub>N (0.38 M) and T<sub>3</sub>P (0.38 M, ≥50 wt % in EtOAc) and stirred at 80 <i>°</i>C for 4 h. After this time, the mixture was allowed to cool to room temperature and treated with MeOH (1 M). The resulting solid was filtered and dried under vacuum. The solid was then triturated with DCM at 30 <i>°</i>C for 1 h, and the resulting solid was filtered and dried under vacuum to give the title compound.</div></div><div id="sec4_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> General Procedure 5</h3><div class="NLM_p last">A reaction vial was charged with <b>69</b>, <b>20</b>, or <b>70–76</b>, and Pd(dtbpf)Cl<sub>2</sub> (0.2 equiv) was purged with N<sub>2</sub> for 10 min. After this time, THF (0.05 M) was added followed by Et<sub>3</sub>N (8.0 equiv) and triethylsilane (4.0 equiv) and the resulting reaction mixture was heated at 100 °C for 3 h. The reaction mixture was then allowed to cool to room temperature. DCM/MeOH (20/1) was added until a solid formed. The solids were filtered off, and the filtrate was concentrated under vacuum and purified by column chromatography (4 g silica gel, MeOH in DCM 0–15%) to give the crude product (19 mg, 94%). Further purification by HPLC (using a Sunfire Prep C18 OBD, 5 μm 30 × 50 mm column and water/CH<sub>3</sub>CN (containing 0.1% TFA) from 90/10 to 50/50 as the mobile phase at a flow rate of 50 mL/min) gave the title compound.</div></div><div id="sec4_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> General Procedure 6</h3><div class="NLM_p last">To a stirred mixture of compound <b>78</b> or <b>79</b> in DMF (0.3 M) was added NaH (2.0 equiv, 60% dispersion in oil). The mixture was stirred at 30 °C for 30 min after which allyl bromide (1.8 equiv) was added, and the reaction was stirred at 30 °C for another 2 h. After this time, the reaction was quenched with H<sub>2</sub>O and extracted with EtOAc. The combined organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to give the title compound (4 g, 100%) as a colorless oil, which was used in the next step without further purification.</div></div><div id="sec4_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> General Procedure 7</h3><div class="NLM_p last">Step 1: A mixture of <b>80</b> or <b>81</b> and NaOH (5.0 equiv) in MeOH/H<sub>2</sub>O (0.4 M, 5/1 v/v) was stirred at 30 °C for 17 h. After this time, the volatiles were removed under reduced pressure, and the crude product was dissolved in H<sub>2</sub>O and extracted with EtOAc. The pH of the separated aqueous phase was adjusted to 2 with concd aq HCl solution upon which a precipitate formed. The solid was collected by filtration and dried under vacuum to give the title compound as a white solid. Step 2: The intermediate from step 1 was dissolved in DCM (0.16 M), and ∼0.5 mL of DMF was added. To this solution was added oxalyl chloride (4.9 g, 32 mmol) dropwise, and the reaction mixture was stirred at 30 °C for 1 h. After this time, the reaction was evaporated to dryness to give the title compound as a brown gum, which was used in the next step without further purification.</div></div><div id="sec4_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> General Procedure 8</h3><div class="NLM_p last">A mixture of compound <b>77</b> (1.0 equiv) and compound <b>82</b> (1.0 equiv) or <b>83</b> (1.0 equiv) in DCM (0.32 M) and pyridine (4 equiv) was added DMAP (0.2 equiv), and the reaction was stirred at 32 °C for 1 h. After this time, the reaction mixture was quenched with water and extracted with DCM (2 × 50 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The product was dissolved in petroleum ether/EtOAc (50/1) and passed through a short plug of silica gel to give the title compound, which was used without further purification in the next step.</div></div><div id="sec4_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> General Procedure 9</h3><div class="NLM_p last">A mixture of compound <b>84</b> or <b>85</b> in DCM (0.09 M) was added Boc<sub>2</sub>O (5.0 equiv), and the reaction was stirred at 32 °C for 1 h. After this time, the reaction was quenched with sat. aq NH<sub>4</sub>Cl (50 mL) and extracted with DCM (2 × 50 mL). The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The product was dissolved in petroleum ether/EtOAc (50/1) and passed through a short plug of silica gel to give the title compound, which was used without further purification in the next step.</div></div><div id="sec4_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> General Procedure 10</h3><div class="NLM_p last">A mixture of compounds <b>86</b> or <b>87</b> in toluene (0.002 M) and the Hoveyda–Grubbs first-generation catalyst (0.2 equiv) was stirred under a N<sub>2</sub> atmosphere at 110 °C for 17 h. After this time, the solvent was evaporated, and the crude product was purified by column chromatography on silica using petroleum ether/EtOAc = 1/1 to 0/1 as an eluent to give the title compound as a white solid.</div></div><div id="sec4_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> General Procedure 11</h3><div class="NLM_p last">To a mixture of <i>E</i>- and <i>Z</i>-isomers, <b>88</b> or <b>89</b> in MeOH (0.4 M) was added Pd (0.05 equiv, 10% on C), and the mixture was stirred under a H<sub>2</sub> atmosphere at 30 °C for 1.5 h. After this time, the mixture was filtered, and the filtrate was concentrated under reduced pressure to give the title compound (300 mg) as a colorless gum, which was used in the next step without further purification.</div></div><div id="sec4_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> General Procedure 12</h3><div class="NLM_p last">To a mixture of compounds <b>90</b> or <b>91</b> in DCM (0.3 M) was added TFA (0.3 M), and the reaction was stirred at 30 °C for 1 h. After this time, the solvent was removed under reduced pressure to give the title compound as a white solid.</div></div><div id="sec4_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> General Procedure 13</h3><div class="NLM_p last">To a stirred solution of compound <b>20</b>, the amine partner (3.0 equiv), sodium <i>tert</i>-butoxide (2.5 equiv), and XPhos (0.2 equiv.) in a mixture of THF/DMF (0.07 M, 10/1 v/v) was added Pd<sub>2</sub>(dba)<sub>3</sub> (0.1 equiv) under a stream of N<sub>2</sub>, and the resulting reaction mixture was heated at reflux for 3 h. After this time, the reaction mixture was allowed to cool to room temperature, and EtOAc was added. The precipitates were filtered off, and the filtrate was concentrated under vacuum and purified by column chromatography.</div></div><div id="sec4_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> General Procedure 14</h3><div class="NLM_p last">A stirred solution of compound <b>20</b> (1.0 equiv), the boronic ester, K<sub>2</sub>CO<sub>3</sub> (2.0 equiv), and Pd(dppf)Cl<sub>2</sub> (0.1 equiv) in DMF/H<sub>2</sub>O (0.04 M, 5/1 v/v) was degassed with N<sub>2</sub>, and the mixture was heated to 100 °C for 2 h. After this time, the reaction was filtered, the volatiles were removed under vacuum, and the crude product was purified.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i105"><a href="/doi/suppl/10.1021/acs.jmedchem.9b01206" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_55222" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_55222" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.9b01206?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01206</a>. <ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">(i) Experimental conditions for the ASK1 in vitro biochemical and cellular assays, (ii) experimental conditions for crystallization, collection, and refinement statistics for compounds <b>4</b> and <b>11</b>, (iii) calculated IR and VCD spectra to assign absolute stereochemistry of compound <b>18</b>, (iv) calculated IR and VCD spectra to assign absolute stereochemistry of compound <b>19</b>, (v) kinase selectivity profile for compound <b>24</b>, and (vi) experimental details of <i>K</i><sub>puu</sub> studies (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and selected data (<a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf">jm9b01206_si_001.pdf (777.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_002.csv">jm9b01206_si_002.csv (2.26 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.9b01206" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65554" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65554" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Felix Gonzalez-Lopez de Turiso</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9736-0907" title="Orcid link">http://orcid.org/0000-0001-9736-0907</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#156160677c667a557278747c793b767a78"><span class="__cf_email__" data-cfemail="82f6f7f0ebf1edc2e5efe3ebeeace1edef">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Martin K. Himmelbauer</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhili Xin</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">J. Howard Jones</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Istvan Enyedy</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristopher King</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Douglas J. Marcotte</span> - <span class="hlFld-Affiliation affiliation">Physical Biochemistry
and Molecular Design, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paramasivam Murugan</span> - <span class="hlFld-Affiliation affiliation">Bioassays, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph C. Santoro</span> - <span class="hlFld-Affiliation affiliation">Bioassays, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Hesson</span> - <span class="hlFld-Affiliation affiliation">Bioassays, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kerri Spilker</span> - <span class="hlFld-Affiliation affiliation">Physical Biochemistry
and Molecular Design, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joshua L. Johnson</span> - <span class="hlFld-Affiliation affiliation">Drug Metabolism and Pharmacokinetics, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael J. Luzzio</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rab Gilfillan</span> - <span class="hlFld-Affiliation affiliation">Medicinal
Chemistry, , , and , Biotherapeutic
and Medicinal Science, Biogen. 225 Binney Street, Cambridge, Massachusetts 02142, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i106">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_20404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_20404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Kevin Barry for chiral separation support, Michael Dechantsreiter for parallel synthesis support, Sam Cziria for compound handling, Fengmei Zheng for compound formulation support, and JC Hus for NMR support. We thank Bo Wang from Biotools, Inc. for VCD experiments. We also thank Xiaoqing Wu, Xiaoping Wang, and Wenkui Zhao for efforts coordinating the synthesis of some of the compounds included in this manuscript. We also thank Kevin Guckian and Emily Peterson for proofreading this manuscript and Janaky Coomaraswamy for helpful discussions.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">AD</td><td class="NLM_def"><p class="first last">Alzheimer’s disease</p></td></tr><tr><td class="NLM_term">ALS</td><td class="NLM_def"><p class="first last">amyotrophic lateral sclerosis</p></td></tr><tr><td class="NLM_term">aq.</td><td class="NLM_def"><p class="first last">aqueous</p></td></tr><tr><td class="NLM_term">ASK1</td><td class="NLM_def"><p class="first last">apoptosis signal-regulating kinase 1</p></td></tr><tr><td class="NLM_term">CAN</td><td class="NLM_def"><p class="first last">ceric ammonium nitrate</p></td></tr><tr><td class="NLM_term">Cl</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CNS</td><td class="NLM_def"><p class="first last">central nervous system</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DMAP</td><td class="NLM_def"><p class="first last">4-dimethylaminopyridine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMF-DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide-dimethylacetal</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">dtbpf</td><td class="NLM_def"><p class="first last">1,1′-bis(di-<i>tert</i>-butylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">EAE</td><td class="NLM_def"><p class="first last">experimental autoimmune encephalomyelitis</p></td></tr><tr><td class="NLM_term">equiv</td><td class="NLM_def"><p class="first last">equivalent</p></td></tr><tr><td class="NLM_term">ER</td><td class="NLM_def"><p class="first last">efflux ratio</p></td></tr><tr><td class="NLM_term">ESI</td><td class="NLM_def"><p class="first last">electrospray ionization</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsomes</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high-performance liquid chromatography</p></td></tr><tr><td class="NLM_term">HPPB</td><td class="NLM_def"><p class="first last">human plasma protein binding</p></td></tr><tr><td class="NLM_term">JNK</td><td class="NLM_def"><p class="first last">c-Jun N-terminal kinase</p></td></tr><tr><td class="NLM_term">MAPK</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase</p></td></tr><tr><td class="NLM_term">MAP2K</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinase kinase</p></td></tr><tr><td class="NLM_term">MAP3K</td><td class="NLM_def"><p class="first last">mitogen-activated protein kinases kinase kinase</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin-Darby canine kidney cells</p></td></tr><tr><td class="NLM_term">MDR1</td><td class="NLM_def"><p class="first last">multidrug resistance 1</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">MS</td><td class="NLM_def"><p class="first last">multiple sclerosis</p></td></tr><tr><td class="NLM_term">NASH</td><td class="NLM_def"><p class="first last">nonalcoholic steatohepatitis</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">Parkinson’s disease</p></td></tr><tr><td class="NLM_term">PEPPSI</td><td class="NLM_def"><p class="first last">pyridine-enhanced precatalyst preparation stabilization and initiation</p></td></tr><tr><td class="NLM_term">PG</td><td class="NLM_def"><p class="first last">propylene glycol</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetic</p></td></tr><tr><td class="NLM_term">RLM</td><td class="NLM_def"><p class="first last">rat liver microsomes</p></td></tr><tr><td class="NLM_term">RPPB</td><td class="NLM_def"><p class="first last">rat plasma protein binding</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">sat.</td><td class="NLM_def"><p class="first last">saturated</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">SOD1</td><td class="NLM_def"><p class="first last">superoxide dismutase 1</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">VCD</td><td class="NLM_def"><p class="first last">vibrational circular dichroism</p></td></tr><tr><td class="NLM_term">XPhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,4′,6′-triisopropylbiphenyl.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12446" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12446" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 26 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">The ASK1-MAP Kinase Cascades in Mammalian Stress Response</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1093/jb/mvh134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1093%2Fjb%2Fmvh134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=15598880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFajtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2004&pages=261-265&author=J.+Matsukawaauthor=A.+Matsuzawaauthor=K.+Takedaauthor=H.+Ichijo&title=The+ASK1-MAP+Kinase+Cascades+in+Mammalian+Stress+Response&doi=10.1093%2Fjb%2Fmvh134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ASK1-MAP kinase cascades in mammalian stress response</span></div><div class="casAuthors">Matsukawa, Jun; Matsuzawa, Atsushi; Takeda, Kohsuke; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein (MAP) kinase cascades play essential roles in a variety of cell processes by influencing transcriptional or translational regulation.  ERKs play a central role in survival and mitogenic signaling, while JNKs and p38 MAP kinases are preferentially activated by environmental stresses and are actively involved in various stress responses including cell death, survival and differentiation.  Apoptosis signal-regulating kinase 1 (ASK1)-a serine/threonine protein kinase-is a member of the MAPKKK family and activates both JNK and p38 pathways.  It is well known that ASK1 is activated in cells treated with death receptor ligands and oxidant stress, such as that caused by hydrogen peroxide (H2O2).  Moreover, recent studies have revealed new mechanisms by which ASK1 is activated in response to various types of extracellular and intracellular signals, such as endoplasmic reticulum (ER) stress, calcium signaling, and G-protein coupled receptor (GPCR) signaling.  This review summarizes the regulatory mechanisms of ASK1 activity and the physiol. roles of ASK1-mediated signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyU2hD_AdpVbVg90H21EOLACvtfcHk0lgoPGhliu_ofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFajtb%252FK&md5=bb907f2433a82ec90ff395966fbbab57</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvh134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvh134%26sid%3Dliteratum%253Aachs%26aulast%3DMatsukawa%26aufirst%3DJ.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DThe%2520ASK1-MAP%2520Kinase%2520Cascades%2520in%2520Mammalian%2520Stress%2520Response%26jtitle%3DJ.%2520Biochem.%26date%3D2004%26volume%3D136%26spage%3D261%26epage%3D265%26doi%3D10.1093%2Fjb%2Fmvh134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawarazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 as a Therapeutic Target</span>. <i>Expert Opin. Ther. Targets.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.896903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1517%2F14728222.2014.896903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=24660755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=651-664&author=Y.+Kawarazakiauthor=H.+Ichijoauthor=I.+Naguro&title=Apoptosis+Signal-Regulating+Kinase+1+as+a+Therapeutic+Target&doi=10.1517%2F14728222.2014.896903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 as a therapeutic target</span></div><div class="casAuthors">Kawarazaki, Yosuke; Ichijo, Hidenori; Naguro, Isao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: All organisms are ordinarily exposed to various stresses.  It is important for organisms to possess appropriate stress response mechanisms and to maintain homeostasis because the disruption of a stress response system can cause various diseases.  Apoptosis signal-regulating kinase 1 (ASK1) is one of the stress-responsive MAP3Ks.  ASK1 plays an important role in the response to reactive oxygen species (ROS), endoplasmic reticulum stress and pro-inflammatory cytokines, and it is involved in the pathogenesis of various diseases.  Areas covered: In this review, the authors describe recent literature concerning the intricate and elaborate regulation system of ASK1, the function of ASK1 during a cellular stress response and the involvement of ASK1 in many diseases, including cancer, neurodegenerative diseases, infections, diabetes and cardiovascular diseases.  Expert opinion: In certain disease conditions, ASK1 plays a protective role, whereas ASK1 can exacerbate the pathol. of other diseases.  Although ASK1 is involved in various diseases, there is no therapy or drug that targets ASK1 for use in a clin. setting.  Recently, ASK1 inhibitors (K811 and MSC2032964A) have emerged, and their therapeutic potentials have been tested in vivo.  ASK1 is currently receiving considerable attention as a new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWfU5PZ2Eq7Vg90H21EOLACvtfcHk0lgoPGhliu_ofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlWgsr8%253D&md5=85423452f6b9e36c4b62986b5c086081</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.896903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.896903%26sid%3Dliteratum%253Aachs%26aulast%3DKawarazaki%26aufirst%3DY.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DNaguro%26aufirst%3DI.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520as%2520a%2520Therapeutic%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets.%26date%3D2014%26volume%3D18%26spage%3D651%26epage%3D664%26doi%3D10.1517%2F14728222.2014.896903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">ALS-Linked Mutant SOD1 Induces ER Stress- and ASK1-Dependent Motor Neuron Death by Targeting Derlin-1</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1101/gad.1640108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1101%2Fgad.1640108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=18519638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1451-1464&author=H.+Nishitohauthor=H.+Kadowakiauthor=A.+Nagaiauthor=T.+Maruyamaauthor=T.+Yokotaauthor=H.+Fukutomiauthor=T.+Noguchiauthor=A.+Matsuzawaauthor=K.+Takedaauthor=H.+Ichijo&title=ALS-Linked+Mutant+SOD1+Induces+ER+Stress-+and+ASK1-Dependent+Motor+Neuron+Death+by+Targeting+Derlin-1&doi=10.1101%2Fgad.1640108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1</span></div><div class="casAuthors">Nishitoh, Hideki; Kadowaki, Hisae; Nagai, Atsushi; Maruyama, Takeshi; Yokota, Takanori; Fukutomi, Hisashi; Noguchi, Takuya; Matsuzawa, Atsushi; Takeda, Kohsuke; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1451-1464</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Mutation in Cu/Zn-superoxide dismutase (SOD1) is a cause of familial amyotrophic lateral sclerosis (ALS).  Mutant SOD1 protein (SOD1mut) induces motor neuron death, although the mol. mechanism of SOD1mut-induced cell death remains controversial.  Here we show that SOD1mut specifically interacted with Derlin-1, a component of endoplasmic reticulum (ER)-assocd. degrdn. (ERAD) machinery and triggered ER stress through dysfunction of ERAD.  SOD1mut-induced ER stress activated the apoptosis signal-regulating kinase 1 (ASK1)-dependent cell death pathway.  Perturbation of binding between SOD1mut and Derlin-1 by Derlin-1-derived oligopeptide suppressed SOD1mut-induced ER stress, ASK1 activation, and motor neuron death.  Moreover, deletion of ASK1 mitigated the motor neuron loss and extended the life span of SOD1mut transgenic mice.  These findings demonstrate that ER stress-induced ASK1 activation, which is triggered by the specific interaction of Derlin-1 with SOD1mut, is crucial for disease progression of familial ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoZ3ENB4NipLVg90H21EOLACvtfcHk0lgoPGhliu_ofg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOlu78%253D&md5=bf2aae2e04868194e6f634d068da4321</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.1640108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1640108%26sid%3Dliteratum%253Aachs%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DKadowaki%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DH.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DALS-Linked%2520Mutant%2520SOD1%2520Induces%2520ER%2520Stress-%2520and%2520ASK1-Dependent%2520Motor%2520Neuron%2520Death%2520by%2520Targeting%2520Derlin-1%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D1451%26epage%3D1464%26doi%3D10.1101%2Fgad.1640108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namekata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinnen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorand-Lebrun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzerelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitte, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of the Severity of Neuroinflammation and Demyelination by TLR-ASK1-p 38 Pathways</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">515</span>, <span class="refDoi"> DOI: 10.1002/emmm.201000103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1002%2Femmm.201000103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=21064192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=504-515&author=X.+Guoauthor=C.+Haradaauthor=K.+Namekataauthor=A.+Matsuzawaauthor=M.+Campsauthor=H.+Jiauthor=D.+Swinnenauthor=C.+Jorand-Lebrunauthor=M.+Muzerelleauthor=P.-A.+Vitteauthor=T.+R%C3%BCckleauthor=A.+Kimuraauthor=K.+Kohyamaauthor=Y.+Matsumotoauthor=H.+Ichijoauthor=T.+Harada&title=Regulation+of+the+Severity+of+Neuroinflammation+and+Demyelination+by+TLR-ASK1-p+38+Pathways&doi=10.1002%2Femmm.201000103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway</span></div><div class="casAuthors">Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Matsuzawa, Atsushi; Camps, Monsterrat; Ji, Hong; Swinnen, Dominique; Jorand-Lebrun, Catherine; Muzerelle, Mathilde; Vitte, Pierre-Alain; Ruckle, Thomas; Kimura, Atsuko; Kohyama, Kuniko; Matsumoto, Yoh; Ichijo, Hidenori; Harada, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1) is an evolutionarily conserved mitogen-activated protein kinase (MAPK) kinase kinase which plays important roles in stress and immune responses.  Here, we show that ASK1 deficiency attenuates neuroinflammation in exptl. autoimmune encephalomyelitis (EAE), without affecting the proliferation capability of T cells.  Moreover, we found that EAE upregulates expression of Toll-like receptors (TLRs) in activated astrocytes and microglia, and that TLRs can synergize with ASK1-p38 MAPK signalling in the release of key chemokines from astrocytes.  Consequently, oral treatment with a specific small mol. wt. inhibitor of ASK1 suppressed EAE-induced autoimmune inflammation in both spinal cords and optic nerves.  These results suggest that the TLR-ASK1-p38 pathway in glial cells may serve as a valid therapeutic target for autoimmune demyelinating disorders including multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhOFTsN1800bVg90H21EOLACvtfcHk0ligiL-trk7-IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFeiuw%253D%253D&md5=f164a951b512af060b05b2906cbad96e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000103%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DHarada%26aufirst%3DC.%26aulast%3DNamekata%26aufirst%3DK.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSwinnen%26aufirst%3DD.%26aulast%3DJorand-Lebrun%26aufirst%3DC.%26aulast%3DMuzerelle%26aufirst%3DM.%26aulast%3DVitte%26aufirst%3DP.-A.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DKohyama%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520the%2520Severity%2520of%2520Neuroinflammation%2520and%2520Demyelination%2520by%2520TLR-ASK1-p%252038%2520Pathways%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D504%26epage%3D515%26doi%3D10.1002%2Femmm.201000103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, B.-N.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Silencing on Astroglial Inflammasomes in an Experimental Model of Ischemic Stroke</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2018.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.neuroscience.2018.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=30172704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gkt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2018&pages=218-230&author=S.+Y.+Cheonauthor=E.+J.+Kimauthor=S.+Y.+Kimauthor=J.+M.+Kimauthor=E.+H.+Kamauthor=J.-K.+Parkauthor=B.-N.+Koo&title=Apoptosis+Signal-Regulating+Kinase+1+Silencing+on+Astroglial+Inflammasomes+in+an+Experimental+Model+of+Ischemic+Stroke&doi=10.1016%2Fj.neuroscience.2018.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis Signal-regulating Kinase 1 Silencing on Astroglial Inflammasomes in an Experimental Model of Ischemic Stroke</span></div><div class="casAuthors">Cheon, So Yeong; Kim, Eun Jung; Kim, So Yeon; Kim, Jeong Min; Kam, Eun Hee; Park, Jong-Kwang; Koo, Bon-Nyeo</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-230</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the inflammasome complex contributes to the inflammatory response and cell death under pathol. conditions.  The nucleotide-binding oligomerization domain-like receptor pyrin domain-contg. 2 (NLRP2) inflammasome is activated in astrocytes after cerebral ischemia, which can aggravate ischemic damage.  Apoptosis signal-regulating kinase 1 (ASK1) is an early activator and immune-regulator after ischemic injury, that can lead to cell death.  The objective of the present study was to evaluate the role of ASK1 in controlling NLRP2 inflammasomes in astrocytes after cerebral ischemia.  In a mouse model of ischemic stroke, the levels of NLRP2 inflammasome components, and interleukin (IL)-1β and IL-18, were quantified in different brain regions.  In addn., an astrocyte cell line was subjected to oxygen-glucose deprivation and reperfusion (OGD/R) injury, and the levels of NLRP2 inflammasome factors, IL-1β and IL-18 were evaluated.  Ischemic brain injury activated astrocytes.  The levels of NLRP2 inflammasome components, IL-1β and IL-18 productions, and cell death increased in the cortex and striatum after ischemic injury.  In cultured astrocytes, NLRP2 inflammasome components, IL-1β and IL-18 levels were upregulated after OGD/R.  ASK1 silencing or inhibition efficiently reduced NLRP2 inflammasome components and pro-inflammatory cytokine levels in mice and cultured astrocytes.  Our findings identify a key role for ASK1 in regulating astroglial inflammasomes after cerebral ischemia.  We suggest ASK1 as one of the main targets for astroglial inflammasomes in ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ctqxVgaBwrVg90H21EOLACvtfcHk0ligiL-trk7-IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gkt7rL&md5=a59a5c25f3448c935e55327c9814c67e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2018.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2018.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DCheon%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKam%26aufirst%3DE.%2BH.%26aulast%3DPark%26aufirst%3DJ.-K.%26aulast%3DKoo%26aufirst%3DB.-N.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Silencing%2520on%2520Astroglial%2520Inflammasomes%2520in%2520an%2520Experimental%2520Model%2520of%2520Ischemic%2520Stroke%26jtitle%3DNeuroscience%26date%3D2018%26volume%3D390%26spage%3D218%26epage%3D230%26doi%3D10.1016%2Fj.neuroscience.2018.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal Regulating Kinase 1 Modulates the Phenotype of α-Synuclein Mice</span>. <i>Neurobiol Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.neurobiolaging.2014.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=25219466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSqsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=519-526&author=K.-W.+Leeauthor=J.-M.+Wooauthor=J.-Y.+Imauthor=E.+S.+Parkauthor=L.+Heauthor=H.+Ichijoauthor=E.+Junnauthor=M.+M.+Mouradian&title=Apoptosis+Signal+Regulating+Kinase+1+Modulates+the+Phenotype+of+%CE%B1-Synuclein+Mice&doi=10.1016%2Fj.neurobiolaging.2014.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice</span></div><div class="casAuthors">Lee, Kang-Woo; Woo, Jong-Min; Im, Joo-Young; Park, Eun S.; He, Liqiang; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">519-526</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">α-Synuclein is a key pathogenic protein in α-synucleinopathies including Parkinson's disease, and its overexpression and aggregation in model systems are assocd. with a neuroinflammatory response and increased oxidative stress.  Apoptosis signal-regulating kinase 1 (ASK1) is activated upon stress signaling events such as oxidative stress and is a central player linking oxidative stress with neuroinflammation.  Here, we demonstrate that overexpression of human α-synuclein activates ASK1 in both PC12 cells and in the brains of α-synuclein transgenic mice.  Deleting ASK1 in mice mitigates the neuronal damage and neuroinflammation induced by α-synuclein and improves performance of the animals on the rotarod.  ASK1 deletion does not impact the aggregation profile or phosphorylation state of α-synuclein in the mouse brain.  These results collectively implicate ASK1 in the cascade of events triggered by α-synuclein overexpression, likely because of the inflammatory response and oxidative stress that lead to ASK1 activation.  These conclusions raise the possibility that potent antioxidants and anti-inflammatory agents may ameliorate the phenotype of α-synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2OiaLl-V7fbVg90H21EOLACvtfcHk0ligiL-trk7-IQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSqsbrP&md5=1fff47caa09cdf4ffd087625e2796ab5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-W.%26aulast%3DWoo%26aufirst%3DJ.-M.%26aulast%3DIm%26aufirst%3DJ.-Y.%26aulast%3DPark%26aufirst%3DE.%2BS.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DApoptosis%2520Signal%2520Regulating%2520Kinase%25201%2520Modulates%2520the%2520Phenotype%2520of%2520%25CE%25B1-Synuclein%2520Mice%26jtitle%3DNeurobiol%2520Aging%26date%3D2015%26volume%3D36%26spage%3D519%26epage%3D526%26doi%3D10.1016%2Fj.neurobiolaging.2014.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonsalla, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">e29935</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0029935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1371%2Fjournal.pone.0029935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=22253830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12muro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=e29935&author=K.-W.+Leeauthor=X.+Zhaoauthor=J.-Y.+Imauthor=H.+Grossoauthor=W.+H.+Jangauthor=T.+W.+Chanauthor=P.+K.+Sonsallaauthor=D.+C.+Germanauthor=H.+Ichijoauthor=E.+Junnauthor=M.+M.+Mouradian&title=Apoptosis+Signal-Regulating+Kinase+1+Mediates+MPTP+Toxicity+and+Regulates+Glial+Activation&doi=10.1371%2Fjournal.pone.0029935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation</span></div><div class="casAuthors">Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Jang, Won Hee; Chan, Teresa W.; Sonsalla, Patricia K.; German, Dwight C.; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e29935</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated protein kinase 3 family, is activated by oxidative stress.  The death-signaling pathway mediated by ASK1 is inhibited by DJ-1, which is linked to recessively inherited Parkinson's disease (PD).  Considering that DJ-1 deficiency exacerbates the toxicity of the mitochondrial complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP), we sought to investigate the direct role and mechanism of ASK1 in MPTP-induced dopamine neuron toxicity.  In the present study, we found that MPTP administration to wild-type mice activates ASK1 in the midbrain.  In ASK1 null mice, MPTP-induced motor impairment was less profound, and striatal dopamine content and nigral dopamine neuron counts were relatively preserved compared to wild-type littermates.  Further, microglia and astrocyte activation seen in wild-type mice challenged with MPTP was markedly attenuated in ASK1-/- mice.  These data suggest that ASK1 is a key player in MPTP-induced glial activation linking oxidative stress with neuroinflammation, two well recognized pathogenetic factors in PD.  These findings demonstrate that ASK1 is an important effector of MPTP-induced toxicity and suggest that inhibiting this kinase is a plausible therapeutic strategy for protecting dopamine neurons in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDhH_jXxZcXrVg90H21EOLACvtfcHk0lh1YMX9aL_71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12muro%253D&md5=0e38b06f22f87e33d1bcb0d21fd85e58</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029935%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-W.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DIm%26aufirst%3DJ.-Y.%26aulast%3DGrosso%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DW.%2BH.%26aulast%3DChan%26aufirst%3DT.%2BW.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DGerman%26aufirst%3DD.%2BC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Mediates%2520MPTP%2520Toxicity%2520and%2520Regulates%2520Glial%2520Activation%26jtitle%3DPLoS%2520One%26date%3D2012%26spage%3De29935%26doi%3D10.1371%2Fjournal.pone.0029935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uekawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim-Mitsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer’s Disease and Brain Aging</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.3233/JAD-170645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.3233%2FJAD-170645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29154282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ivVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=259-263&author=Y.+Hasegawaauthor=K.+Toyamaauthor=K.+Uekawaauthor=H.+Ichijoauthor=S.+Kim-Mitsuyama&title=Role+of+ASK1%2Fp38+Cascade+in+a+Mouse+Model+of+Alzheimer%E2%80%99s+Disease+and+Brain+Aging&doi=10.3233%2FJAD-170645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging</span></div><div class="casAuthors">Hasegawa Yu; Toyama Kensuke; Uekawa Ken; Kim-Mitsuyama Shokei; Ichijo Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">259-263</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To examine the role of ASK1 in Alzheimer's disease (AD), we generated 5XFAD mice deficient in ASK1 and investigated the characteristics of old 5XFAD and wild-type mice with ASK1 deficiency.  ASK1 deficiency improved cognitive function in 24-month-old 5XFAD mice, which was associated with the reduction of phosphorylated p38.  Thus, ASK1/p38 cascade seems to play some role in the pathogenesis of AD in mice.  In 24-month-old wild-type mice, ASK1 deficiency increased cerebral vasoreactivity to acetazolamide and significantly reduced brain soluble Aβ, which were also associated with the reduction of phosphorylated p38.  Thus, ASK1/p38 cascade may contribute to brain aging of wild-type mice.  Collectively, our present results provided the evidence suggesting the involvement of ASK1/p38 cascade in AD and brain aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRc-Vk3ATQdTIvKgEt20y1XfW6udTcc2ea93REt_5UYBLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ivVKjsw%253D%253D&md5=5782dc35884efd7c9ee3a610625f9e1a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3233%2FJAD-170645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170645%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DY.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DUekawa%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DKim-Mitsuyama%26aufirst%3DS.%26atitle%3DRole%2520of%2520ASK1%252Fp38%2520Cascade%2520in%2520a%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Brain%2520Aging%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D259%26epage%3D263%26doi%3D10.3233%2FJAD-170645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namekata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">ASK1 in Neurodegeneration</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2017.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.jbior.2017.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=28882588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=63-71&author=X.+Guoauthor=K.+Namekataauthor=A.+Kimuraauthor=C.+Haradaauthor=T.+Harada&title=ASK1+in+Neurodegeneration&doi=10.1016%2Fj.jbior.2017.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 in neurodegeneration</span></div><div class="casAuthors">Guo, Xiaoli; Namekata, Kazuhiko; Kimura, Atsuko; Harada, Chikako; Harada, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases (NDDs) such as glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) are characterized by the progressive loss of neurons, causing irreversible damage to patients.  Longer lifespans may be leading to an increase in the no. of people affected by NDDs worldwide.  Among the pathways strongly impacting the pathogenesis of NDDs, oxidative stress, a condition that occurs because of an imbalance in oxidant and antioxidant levels, has been known to play a vital role in the pathophysiol. of NDDs.  One of the mols. activated by oxidative stress is apoptosis signal-regulating kinase 1 (ASK1), which has been shown to play a role in NDDs.  ASK1 activation is regulated by multiple steps, including oligomerization, phosphorylation, and protein-protein interactions.  In the oxidative stress state, reactive oxygen species (ROS) induce the dissocn. of thioredoxin, a protein regulating cellular redn. and oxidn. (redox), from the N-terminal region of ASK1, and ASK1 is subsequently activated by the oligomerization and phosphorylation of a crit. threonine residue, leading to cell death.  Here, we review exptl. evidence that links ASK1 signaling with the pathogenesis of several NDDs.  We propose that ASK1 may be a new point of therapeutic intervention to prevent or treat NDDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox2NJo6oiaK7Vg90H21EOLACvtfcHk0lh1YMX9aL_71g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL%252FJ&md5=57f3fe0d228fb0d4d889f0962b793cf0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2017.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2017.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DNamekata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DHarada%26aufirst%3DC.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DASK1%2520in%2520Neurodegeneration%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2017%26volume%3D66%26spage%3D63%26epage%3D71%26doi%3D10.1016%2Fj.jbior.2017.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakoji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">The ASK1-Specific Inhibitors K811 and K812 Prolong Survival in a Mouse Model of Amyotrophic Lateral Sclerosis</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1093%2Fhmg%2Fddv467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=26604152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2ltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=245-253&author=T.+Fujisawaauthor=M.+Takahashiauthor=Y.+Tsukamotoauthor=N.+Yamaguchiauthor=M.+Nakojiauthor=M.+Endoauthor=H.+Kodairaauthor=Y.+Hayashiauthor=H.+Nishitohauthor=I.+Naguroauthor=K.+Hommaauthor=H.+Ichijo&title=The+ASK1-Specific+Inhibitors+K811+and+K812+Prolong+Survival+in+a+Mouse+Model+of+Amyotrophic+Lateral+Sclerosis&doi=10.1093%2Fhmg%2Fddv467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Fujisawa, Takao; Takahashi, Motoo; Tsukamoto, Yuka; Yamaguchi, Namiko; Nakoji, Masayoshi; Endo, Megumi; Kodaira, Hiroshi; Hayashi, Yuki; Nishitoh, Hideki; Naguro, Isao; Homma, Kengo; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure.  To develop effective treatments for this devastating disease, an appropriate strategy for targeting the mol. responsible for the pathogenesis of ALS is needed.  We previously reported that mutant SOD1 protein causes motor neuron death through activation of ASK1, a mitogen-activated protein kinase kinase kinase.  Addnl., we recently developed K811 (I) and K812 (II), which are selective inhibitors for ASK1.  Here, we report the effect of K811 and K812 in a mouse model of ALS (SOD1G93A transgenic mice).  Oral administration of K811 or K812 significantly extended the life span of SOD1G93A transgenic mice (1.06 and 1.08% improvement in survival).  Moreover, ASK1 activation obsd. in the lumbar spinal cord of mice at the disease progression stage was markedly decreased in the K811- and K812-treated groups.  In parallel, immunohistochem. anal. revealed that K811 and K812 treatment inhibited glial activation in the lumbar spinal cord of SOD1G93A transgenic mice.  These results reinforce the importance of ASK1 as a therapeutic target for ALS treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkm5-whzU1LVg90H21EOLACvtfcHk0lhowi5qE4tePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2ltbvP&md5=cfa4702fbeed701f7e2640e3cb7931de</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv467%26sid%3Dliteratum%253Aachs%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DN.%26aulast%3DNakoji%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DNaguro%26aufirst%3DI.%26aulast%3DHomma%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DThe%2520ASK1-Specific%2520Inhibitors%2520K811%2520and%2520K812%2520Prolong%2520Survival%2520in%2520a%2520Mouse%2520Model%2520of%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D245%26epage%3D253%26doi%3D10.1093%2Fhmg%2Fddv467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Application of Apoptosis Signal-Regulating Kinase 1 Inhibitors</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2017.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.jbior.2017.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29066277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12rur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=85-90&author=T.+Fujisawa&title=Therapeutic+Application+of+Apoptosis+Signal-Regulating+Kinase+1+Inhibitors&doi=10.1016%2Fj.jbior.2017.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors</span></div><div class="casAuthors">Fujisawa, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-90</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis signal-regulating kinase 1 (ASK1) is a member of the stress-activated mitogen-activated protein kinase kinase kinase (MAP3K) family.  ASK1 is an attractive drug target, owing to its essential role in a wide variety of human diseases including neurodegenerative disorders, inflammatory diseases and cancer.  Recent studies have suggested that pharmacol. manipulations using small mol. ASK1 inhibitors may be beneficial in exptl. human disease models.  In this review, we highlight the current understanding of ASK1 inhibitors as a potential therapy for human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFxCLZJ-Pd8LVg90H21EOLACvtfcHk0lhowi5qE4tePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12rur7N&md5=91ed7baecfcf9fb42c0437fa8ebbf87a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2017.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DFujisawa%26aufirst%3DT.%26atitle%3DTherapeutic%2520Application%2520of%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520Inhibitors%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2017%26volume%3D66%26spage%3D85%26epage%3D90%26doi%3D10.1016%2Fj.jbior.2017.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanjul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Drug Design of Novel ASK1 Inhibitors Using an Integrated Lead Optimization Strategy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.bmcl.2017.02.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=28291695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1709-1713&author=T.+S.+Gibsonauthor=B.+Johnsonauthor=A.+Fanjulauthor=P.+Halkowyczauthor=D.+R.+Douganauthor=D.+Coleauthor=S.+Swann&title=Structure-Based+Drug+Design+of+Novel+ASK1+Inhibitors+Using+an+Integrated+Lead+Optimization+Strategy&doi=10.1016%2Fj.bmcl.2017.02.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy</span></div><div class="casAuthors">Gibson, Tony S.; Johnson, Benjamin; Fanjul, Andrea; Halkowycz, Petro; Dougan, Douglas R.; Cole, Derek; Swann, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1709-1713</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure-based drug design is an iterative process that is an established means to accelerate lead optimization, and is most powerful when integrated with information from different sources.  Herein is described the use of such methods in conjunction with deconstruction and re-optimization of a diverse series of ASK1 chemotypes along with high-throughput screening that lead to the identification of a novel series of efficient ASK1 inhibitors displaying robust MAP3K pathway inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAeTTx_WsXbVg90H21EOLACvtfcHk0lhowi5qE4tePA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFyhsrk%253D&md5=4985c0dacfb20c6d7a7d7a546038a469</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.079%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DT.%2BS.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DFanjul%26aufirst%3DA.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DSwann%26aufirst%3DS.%26atitle%3DStructure-Based%2520Drug%2520Design%2520of%2520Novel%2520ASK1%2520Inhibitors%2520Using%2520an%2520Integrated%2520Lead%2520Optimization%2520Strategy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1709%26epage%3D1713%26doi%3D10.1016%2Fj.bmcl.2017.02.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw-Pierce, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruvallath, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermolieff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyhonas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00481</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00481" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVSqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=316-320&author=M.+Lanierauthor=J.+Pickensauthor=S.+V.+Bigiauthor=E.+L.+Bradshaw-Pierceauthor=A.+Chambersauthor=Z.+S.+Cheruvallathauthor=D.+Coleauthor=D.+R.+Douganauthor=J.+Ermolieffauthor=T.+Gibsonauthor=P.+Halkowyczauthor=A.+Hirokawaauthor=A.+Ivetacauthor=J.+Miuraauthor=E.+Nunezauthor=M.+Sabatauthor=J.+Tyhonasauthor=H.+Wangauthor=X.+Wangauthor=S.+Swann&title=Structure-Based+Design+of+ASK1+Inhibitors+as+Potential+Agents+for+Heart+Failure&doi=10.1021%2Facsmedchemlett.6b00481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure</span></div><div class="casAuthors">Lanier, Marion; Pickens, Jason; Bigi, Simone V.; Bradshaw-Pierce, Erica L.; Chambers, Alison; Cole, Derek; Dougan, Douglas R.; Ermolieff, Jacques; Gibson, Tony; Halkowycz, Petro; Hirokawa, Aki; Ivetac, Anthony; Miura, Joanne; Nunez, Evan; Sabat, Mark; Tyhonas, John; Wang, Haixia; Wang, Xiaolun; Swann, Steve</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-320</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1/MAP3K) is a mitogen-activated protein kinase family member shown to contribute to acute ischemia/reperfusion injury.  Using structure-based drug design, deconstruction, and reoptimization of a known ASK1 inhibitor, a lead compd. was identified.  This compd. displayed robust MAP3K pathway inhibition and redn. of infarct size in an isolated perfused heart model of cardiac injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVRSL6eCLHCbVg90H21EOLACvtfcHk0lg76oMueiszQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVSqt7Y%253D&md5=f6118d66141ad3479dbb80c582819306</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00481%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DPickens%26aufirst%3DJ.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DBradshaw-Pierce%26aufirst%3DE.%2BL.%26aulast%3DChambers%26aufirst%3DA.%26aulast%3DCheruvallath%26aufirst%3DZ.%2BS.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DHirokawa%26aufirst%3DA.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DMiura%26aufirst%3DJ.%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTyhonas%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSwann%26aufirst%3DS.%26atitle%3DStructure-Based%2520Design%2520of%2520ASK1%2520Inhibitors%2520as%2520Potential%2520Agents%2520for%2520Heart%2520Failure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D316%26epage%3D320%26doi%3D10.1021%2Facsmedchemlett.6b00481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corkey, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budas, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdon, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinojosa-Kirschenbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badal, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castonguay, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papalia, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntzicker, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic-Paterson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altuhaifi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckenridge, D. G.</span></span> <span> </span><span class="NLM_article-title">ASK1 Contributes to Fibrosis and Dysfunction in Models of Kidney Disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4485</span>– <span class="NLM_lpage">4500</span>, <span class="refDoi"> DOI: 10.1172/JCI99768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1172%2FJCI99768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=30024858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4485-4500&author=J.+T.+Lilesauthor=B.+K.+Corkeyauthor=G.+T.+Notteauthor=G.+R.+Budasauthor=E.+B.+Lansdonauthor=F.+Hinojosa-Kirschenbaumauthor=S.+S.+Badalauthor=M.+Leeauthor=B.+E.+Schultzauthor=S.+Wiseauthor=S.+Pendemauthor=M.+Graupeauthor=L.+Castonguayauthor=K.+A.+Kochauthor=M.+H.+Wongauthor=G.+A.+Papaliaauthor=D.+M.+Frenchauthor=T.+Sullivanauthor=E.+G.+Huntzickerauthor=F.+Y.+Maauthor=D.+J.+Nikolic-Patersonauthor=T.+Altuhaifiauthor=H.+Yangauthor=A.+B.+Fogoauthor=D.+G.+Breckenridge&title=ASK1+Contributes+to+Fibrosis+and+Dysfunction+in+Models+of+Kidney+Disease&doi=10.1172%2FJCI99768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 contributes to fibrosis and dysfunction in models of kidney disease</span></div><div class="casAuthors">Liles John T; Corkey Britton K; Notte Gregory T; Budas Grant R; Lansdon Eric B; Hinojosa-Kirschenbaum Ford; Badal Shawn S; Lee Michael; Schultz Brian E; Wise Sarah; Pendem Swetha; Graupe Michael; Wong Melanie H; Papalia Giuseppe A; French Dorothy M; Sullivan Theodore; Huntzicker Erik G; Breckenridge David G; Castonguay Laurie; Koch Keith A; Ma Frank Y; Nikolic-Paterson David J; Altuhaifi Tareq; Yang Haichun; Fogo Agnes B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4485-4500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is an underlying component of acute and chronic kidney disease.  Apoptosis signal-regulating kinase 1 (ASK1) is a widely expressed redox-sensitive serine threonine kinase that activates p38 and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase kinases, and induces apoptotic, inflammatory, and fibrotic signaling in settings of oxidative stress.  We describe the discovery and characterization of a potent and selective small-molecule inhibitor of ASK1, GS-444217, and demonstrate the therapeutic potential of ASK1 inhibition to reduce kidney injury and fibrosis.  Activation of the ASK1 pathway in glomerular and tubular compartments was confirmed in renal biopsies from patients with diabetic kidney disease (DKD) and was decreased by GS-444217 in several rodent models of kidney injury and fibrosis that collectively represented the hallmarks of DKD pathology.  Treatment with GS-444217 reduced progressive inflammation and fibrosis in the kidney and halted glomerular filtration rate decline.  Combination of GS-444217 with enalapril, an angiotensin-converting enzyme inhibitor, led to a greater reduction in proteinuria and regression of glomerulosclerosis.  These results identify ASK1 as an important target for renal disease and support the clinical development of an ASK1 inhibitor for the treatment of DKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCz33HBHJmvH6oPH0mYWL1fW6udTcc2ebdskgUl-oywrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisw%253D%253D&md5=088f51fa49e871d1123a51d2331c2144</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1172%2FJCI99768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99768%26sid%3Dliteratum%253Aachs%26aulast%3DLiles%26aufirst%3DJ.%2BT.%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DBudas%26aufirst%3DG.%2BR.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DHinojosa-Kirschenbaum%26aufirst%3DF.%26aulast%3DBadal%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DWise%26aufirst%3DS.%26aulast%3DPendem%26aufirst%3DS.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DCastonguay%26aufirst%3DL.%26aulast%3DKoch%26aufirst%3DK.%2BA.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DHuntzicker%26aufirst%3DE.%2BG.%26aulast%3DMa%26aufirst%3DF.%2BY.%26aulast%3DNikolic-Paterson%26aufirst%3DD.%2BJ.%26aulast%3DAltuhaifi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFogo%26aufirst%3DA.%2BB.%26aulast%3DBreckenridge%26aufirst%3DD.%2BG.%26atitle%3DASK1%2520Contributes%2520to%2520Fibrosis%2520and%2520Dysfunction%2520in%2520Models%2520of%2520Kidney%2520Disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D4485%26epage%3D4500%26doi%3D10.1172%2FJCI99768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="cit10e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckenridge, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebofsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farhood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of Apoptosis Signal-Regulating Kinase 1 Protects Against Acetaminophen-Induced Liver Injury</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2015.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.taap.2015.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=25818599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFemtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2015&pages=1-9&author=Y.+Xieauthor=A.+Ramachandranauthor=D.+G.+Breckenridgeauthor=J.+T.+Lilesauthor=M.+Lebofskyauthor=A.+Farhoodauthor=H.+Jaeschke&title=Inhibitor+of+Apoptosis+Signal-Regulating+Kinase+1+Protects+Against+Acetaminophen-Induced+Liver+Injury&doi=10.1016%2Fj.taap.2015.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury</span></div><div class="casAuthors">Xie, Yuchao; Ramachandran, Anup; Breckenridge, David G.; Liles, John T.; Lebofsky, Margitta; Farhood, Anwar; Jaeschke, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Metabolic activation and oxidant stress are key events in the pathophysiol. of acetaminophen (APAP) hepatotoxicity.  The initial mitochondrial oxidative stress triggered by protein adduct formation is amplified by c-jun-N-terminal kinase (JNK), resulting in mitochondrial dysfunction and ultimately cell necrosis.  Apoptosis signal-regulating kinase 1 (ASK1) is considered the link between oxidant stress and JNK activation.  The objective of the current study was to assess the efficacy and mechanism of action of the small-mol. ASK1 inhibitor GS-459679 in a murine model of APAP hepatotoxicity.  APAP (300 mg/kg) caused extensive glutathione depletion, JNK activation and translocation to the mitochondria, oxidant stress and liver injury as indicated by plasma ALT activities and area of necrosis over a 24 h observation period.  Pretreatment with 30 mg/kg of GS-459679 almost completely prevented JNK activation, oxidant stress and injury without affecting the metabolic activation of APAP.  To evaluate the therapeutic potential of GS-459679, mice were treated with APAP and then with the inhibitor.  Given 1.5 h after APAP, GS-459679 was still protective, which was paralleled by reduced JNK activation and p-JNK translocation to mitochondria.  However, GS-459679 treatment was not more effective than N-acetylcysteine, and the combination of GS-459679 and N-acetylcysteine exhibited similar efficacy as N-acetylcysteine monotherapy, suggesting that GS-459769 and N-acetylcysteine affect the same pathway.  Importantly, inhibition of ASK1 did not impair liver regeneration as indicated by PCNA staining.  In conclusion, the ASK1 inhibitor GS-459679 protected against APAP toxicity by attenuating JNK activation and oxidant stress in mice and may have therapeutic potential for APAP overdose patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk5fRq1t9HuLVg90H21EOLACvtfcHk0lg76oMueiszQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFemtb0%253D&md5=dcac89460286b665a95affcda0ac16fa</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2015.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2015.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DA.%26aulast%3DBreckenridge%26aufirst%3DD.%2BG.%26aulast%3DLiles%26aufirst%3DJ.%2BT.%26aulast%3DLebofsky%26aufirst%3DM.%26aulast%3DFarhood%26aufirst%3DA.%26aulast%3DJaeschke%26aufirst%3DH.%26atitle%3DInhibitor%2520of%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520Protects%2520Against%2520Acetaminophen-Induced%2520Liver%2520Injury%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2015%26volume%3D286%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.taap.2015.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span> <i>ClinicalTrials.gov is a database of privately and
publicly funded
clinical studies conducted around the world</i>. Source: <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> (NCT02781584
and NCT03449446).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ClinicalTrials.gov+is+a+database+of+privately+and%0Apublicly+funded%0Aclinical+studies+conducted+around+the+world.+Source%3A+www.clinicaltrials.gov+%28NCT02781584%0Aand+NCT03449446%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DClinicalTrials.gov%2520is%2520a%2520database%2520of%2520privately%2520and%250Apublicly%2520funded%250Aclinical%2520studies%2520conducted%2520around%2520the%2520world" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span> <i>The biochemical potency
was determined at Reaction Biology corp using
the assay conditions described in</i>: <a href="http://www.reactionbiology.com/webapps/site/KinasePDFs/ASK1_MAP3K5.pdf" class="extLink">http://www.reactionbiology.com/webapps/site/KinasePDFs/ASK1_MAP3K5.pdf</a> (see also the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> for additional details).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+biochemical+potency%0Awas+determined+at+Reaction+Biology+corp+using%0Athe+assay+conditions+described+in%3A+http%3A%2F%2Fwww.reactionbiology.com%2Fwebapps%2Fsite%2FKinasePDFs%2FASK1_MAP3K5.pdf+%28see+also+the+Supporting+Information+for+additional+details%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520biochemical%2520potency%250Awas%2520determined%2520at%2520Reaction%2520Biology%2520corp%2520using%250Athe%2520assay%2520conditions%2520described%2520in" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">In this assay, HEK293 cells were transiently transfected with human ASK1, and inhibition of ASK1 phosphorylation at residue T878 was measured. Differences between the cellular potency in this assay and the data reported in the literature were noted. In general, this assay appeared to underestimate the potency of the analogs tested relative to the data from the literature (i.e., compound <b>4</b>: reported cell IC<sub>50</sub> = 2 nM in US2013/0197037 vs cell IC<sub>50</sub> = 20 nM using this format of the assay).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="note"><p class="first last">All in vivo PK studies were conducted in accordance with Biogen Institutional Animal Care and Use Committee (IACUC) guidelines.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Cl<sub>u</sub> = Cl/fraction unbound.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span> An MDCK NIH cell line
transfected with MDR1 was used as an in vitro predictor of CNS penetration.
Good correlation between the ER in this assay and brain exposure has
been reported when using this cell line. See:<span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span> <span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Efflux Ratio Can Predict the <i>In Vivo</i> Brain Penetration Regardless of Biopharmaceutics Drug Disposition Classification System Class</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1124%2Fdmd.113.053868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=24009309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2012-2017&author=R.+Kikuchiauthor=S.+M.+de+Moraisauthor=J.+C.+Kalvass&title=In+Vitro+P-Glycoprotein+Efflux+Ratio+Can+Predict+the+In+Vivo+Brain+Penetration+Regardless+of+Biopharmaceutics+Drug+Disposition+Classification+System+Class&doi=10.1124%2Fdmd.113.053868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span></div><div class="casAuthors">Kikuchi, Ryota; de Morais, Sonia M.; Kalvass, J. Cory</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2012-2017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is expressed at the blood-brain barrier (BBB) and restricts the penetration of its substrates into the central nervous system (CNS).  In vitro substrate assessment for P-gp is frequently used to predict the in vivo relevance of P-gp-mediated efflux at the BBB.  We have conducted a comprehensive review of literature focusing on the in vitro-in vivo correlation of P-gp efflux ratio (ER), and demonstrated that in vitro substrates of P-gp are also in vivo substrates at the BBB.  It was of note that the in vitro ER in the MDCK-MDR1 cell line from National Institutes of Health was found to be a better predictor of in vivo ER than that from Netherlands Cancer Institute, with r2 values of 0.813 and 0.531, resp.  Recently, a research group proposed that 98% of Biopharmaceutics Drug Disposition Classification System (BDDCS) class 1 drugs can penetrate the brain even when those compds. are shown as P-gp substrates in vitro.  However, our data anal. suggested that in vitro ER can predict the in vivo brain penetration regardless of the class in BDDCS.  Considering that very few marketed CNS drugs are in vivo substrates for P-gp, the in vitro substrate assessment of P-gp should be used in the early stages of drug discovery to select compds. that are most likely to penetrate the CNS to exert their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQtEu5USc2LVg90H21EOLACvtfcHk0lhQo_V306WcFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO&md5=f4e32455375b1bd684ba38174a71657c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053868%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Efflux%2520Ratio%2520Can%2520Predict%2520the%2520In%2520Vivo%2520Brain%2520Penetration%2520Regardless%2520of%2520Biopharmaceutics%2520Drug%2520Disposition%2520Classification%2520System%2520Class%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2012%26epage%3D2017%26doi%3D10.1124%2Fdmd.113.053868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">Analogs <b>1</b>–<b>3</b>, despite their reported efficacy in rodent models of neurological diseases, were found to be significantly less potent in our internal cellular assay and were not deemed as suitable starting points for further optimization.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span> The structure of the
human ASK1 kinase domain in complex with staurosporine has been previously
reported:<span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobott, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of the Human Protein Kinase ASK1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1215</span>, <span class="refDoi"> DOI: 10.1016/j.str.2007.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.str.2007.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=17937911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1215&author=G.+Bunkocziauthor=E.+Salahauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+M%C3%BCllerauthor=F.+Sobottauthor=S.+A.+Parkerauthor=H.+Zhangauthor=W.+Minauthor=B.+E.+Turkauthor=S.+Knapp&title=Structural+and+Functional+Characterization+of+the+Human+Protein+Kinase+ASK1&doi=10.1016%2Fj.str.2007.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Characterization of the Human Protein Kinase ASK1</span></div><div class="casAuthors">Bunkoczi, Gabor; Salah, Eidarus; Filippakopoulos, Panagis; Fedorov, Oleg; Mueller, Susanne; Sobott, Frank; Parker, Sirlester A.; Zhang, Haifeng; Wang, Min; Turk, Benjamin E.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1) plays an essential role in stress and immune response and has been linked to the development of several diseases.  Here, we present the structure of the human ASK1 catalytic domain in complex with staurosporine.  Anal. ultracentrifugation (AUC) and crystallog. anal. showed that ASK1 forms a tight dimer (Kd ∼ 0.2 μM) interacting in a head-to-tail fashion.  We found that the ASK1 phosphorylation motifs differ from known ASK1 phosphorylation sites but correspond well to autophosphorylation sites identified by mass spectrometry.  Reporter gene assays showed that all three identified in vitro autophosphorylation sites (Thr813, Thr838, Thr842) regulate ASK1 signaling, but site-directed mutants showed catalytic activities similar to wild-type ASK1, suggesting a regulatory mechanism independent of ASK1 kinase activity.  The detd. high-resoln. structure of ASK1 and identified ATP mimetic inhibitors will provide a first starting point for the further development of selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZBSVy1aKL7Vg90H21EOLACvtfcHk0lhwwr7dNozGaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhsLzM&md5=d005be68398be830550509044a54b8f3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DSalah%26aufirst%3DE.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DSobott%26aufirst%3DF.%26aulast%3DParker%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520the%2520Human%2520Protein%2520Kinase%2520ASK1%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D1215%26doi%3D10.1016%2Fj.str.2007.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">This binding mode was first proposed in reference <a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> and is identical to that predicted from our own docking experiments. The binding mode of compound <b>4</b> (GS-4997) is similar to that reported for GS-444217 in reference <a onclick="showRef(event, 'cit10d'); return false;" href="javascript:void(0);" class="ref cit10d">(10d)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="note"><p class="first last">This compound crystallized as a dimer and one of the N of the imidazole in <b>4</b> appeared to form an additional H-bond interaction with the hydroxyl group of Tyr814 of the second monomer. This interaction was initially considered as an artifact and was not predicted to significantly contribute to the binding affinity of these inhibitors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">CHAPTER 5. Designed Macrocyclic Kinase Inhibitors</span>. <i>RSC Drug Discov. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1039/9781782623113-00141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1039%2F9781782623113-00141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=141-205&author=A.+Poulsenauthor=A.+D.+Williamauthor=B.+W.+Dymock&title=CHAPTER+5.+Designed+Macrocyclic+Kinase+Inhibitors&doi=10.1039%2F9781782623113-00141"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2F9781782623113-00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252F9781782623113-00141%26sid%3Dliteratum%253Aachs%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DCHAPTER%25205.%2520Designed%2520Macrocyclic%2520Kinase%2520Inhibitors%26jtitle%3DRSC%2520Drug%2520Discov.%2520Ser.%26date%3D2015%26volume%3D5%26spage%3D141%26epage%3D205%26doi%3D10.1039%2F9781782623113-00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Turiso, F. G. L.</span>; <span class="NLM_string-name">Himmelbauer, M.</span>; <span class="NLM_string-name">Luzzio, M. J.</span></span> <span> </span><span class="NLM_article-title">Ask1 inhibiting agents</span>. <span class="NLM_year">2018</span>, <span class="NLM_patent">WO 2018148204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=F.+G.+L.+de+Turiso&author=M.+Himmelbauer&author=M.+J.+Luzzio&title=Ask1+inhibiting+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BTuriso%26aufirst%3DF.%2BG.%2BL.%26atitle%3DAsk1%2520inhibiting%2520agents%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span> This strategy was
recently used in:<span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span> <span> </span><span class="NLM_article-title">Rational Approach to Highly Potent and Selective Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.ejmech.2017.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29348070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVentLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=606-621&author=F.+Loveringauthor=P.+Morganauthor=C.+Allaisauthor=A.+Aulabaughauthor=J.+Brodfuehrerauthor=J.+Changauthor=J.+Coeauthor=W.+Dingauthor=H.+Dowtyauthor=M.+Flemingauthor=R.+Frisbieauthor=J.+Guzovaauthor=D.+Hepworthauthor=J.+Jastiauthor=S.+Kortumauthor=R.+Kurumbailauthor=S.+Mohanauthor=N.+Papaioannouauthor=J.+W.+Strohbachauthor=F.+Vincentauthor=K.+Leeauthor=C.+W.+Zapf&title=Rational+Approach+to+Highly+Potent+and+Selective+Apoptosis+Signal-Regulating+Kinase+1+%28ASK1%29+Inhibitors&doi=10.1016%2Fj.ejmech.2017.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors</span></div><div class="casAuthors">Lovering, Frank; Morgan, Paul; Allais, Christophe; Aulabaugh, Ann; Brodfuehrer, Joanne; Chang, Jeanne; Coe, Jotham; Ding, Wei Dong; Dowty, Heather; Fleming, Margaret; Frisbie, Richard; Guzova, Julia; Hepworth, David; Jasti, Jayasankar; Kortum, Steve; Kurumbail, Ravi; Mohan, Shashi; Papaioannou, Nikolaos; Strohbach, Joseph W.; Vincent, Fabien; Lee, Katherine; Zapf, Christoph W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">606-621</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Many diseases are believed to be driven by pathol. levels of reactive oxygen species (ROS) and oxidative stress has long been recognized as a driver for inflammatory disorders.  Apoptosis signal-regulating kinase 1 (ASK1) has been reported to be activated by intracellular ROS and its inhibition leads to a down regulation of p38-and JNK-dependent signaling.  Consequently, ASK1 inhibitors may have the potential to treat clin. important inflammatory pathologies including renal, pulmonary and liver diseases.  Anal. of the ASK1 ATP-binding site suggested that Gln756, an amino acid that rarely occurs at the GK+2 position, offered opportunities for achieving kinase selectivity for ASK1 which was applied to the design of a parallel medicinal chem. library that afforded inhibitors of ASK1 with nanomolar potency and excellent kinome selectivity.  A focused optimization strategy utilizing structure-based design resulted in the identification of ASK1 inhibitors with low nanomolar potency in a cellular assay, high selectivity when tested against kinase and broad pharmacol. screening panels, and attractive physicochem. properties.  The compds. we describe are attractive tool compds. to inform the therapeutic potential of ASK1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvA5qC6rcbMLVg90H21EOLACvtfcHk0lhwwr7dNozGaQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVentLY%253D&md5=2943f3bc9908637e5e4dedaf6637aaf7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DAllais%26aufirst%3DC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DDowty%26aufirst%3DH.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DGuzova%26aufirst%3DJ.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKortum%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26atitle%3DRational%2520Approach%2520to%2520Highly%2520Potent%2520and%2520Selective%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520%2528ASK1%2529%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D606%26epage%3D621%26doi%3D10.1016%2Fj.ejmech.2017.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="note"><p class="first last">To understand the kinase selectivity profile of this series of macrocyclic inhibitors, analog <b>24</b> was tested against a panel of 468 kinases at 100 nM, and the S(10) selectivity score was found to be 0.04. Complete data is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> (S(10) = (number of non-mutant kinases with %Ctrl <10)/(number of non-mutant kinases tested)).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Using DMA:EtOH:PG:water (1:1:3:5) as the vehicle.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Blood-Brain Barrier in Drug Discovery</i>. <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1002%2F9781118788523" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Di&author=E.+H.+Kerns&title=Blood-Brain+Barrier+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9781118788523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DBlood-Brain%2520Barrier%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">See also the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> for additional experimental details.</p></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10a','cit10b','cit10c','cit10d','cit10e'],'ref11':['cit11'],'ref12':['cit12'],'ref13':[],'ref14':[],'ref15':[],'ref16':['cit16'],'ref17':[],'ref18':['cit18'],'ref19':[],'ref20':[],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':[],'ref25':[],'ref26':['cit26']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 8 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Jennifer Alisa Amrhein, Stefan Knapp, <span class="NLM_string-name hlFld-ContribAuthor">Thomas Hanke</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Opportunities and Challenges for Macrocyclic Kinase Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 7991-8009. <a href="https://doi.org/10.1021/acs.jmedchem.1c00217" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00217</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00217&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00217%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252BOpportunities%252Band%252BChallenges%252Bfor%252BMacrocyclic%252BKinase%252BInhibitors%26aulast%3DAmrhein%26aufirst%3DJennifer%2BAlisa%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04022021%26date%3D02062021%26volume%3D64%26issue%3D12%26spage%3D7991%26epage%3D8009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhili Xin, Martin K. Himmelbauer, J. Howard Jones, Istvan Enyedy, Rab Gilfillan, Thomas Hesson, Kristopher King, Douglas J. Marcotte, Paramasivam Murugan, Joseph C. Santoro, <span class="NLM_string-name hlFld-ContribAuthor">Felix Gonzalez-Lopez de Turiso</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of CNS-Penetrant Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>11 </em>
                                    (4)
                                     , 485-490. <a href="https://doi.org/10.1021/acsmedchemlett.9b00611" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00611</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00611&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00611%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BCNS-Penetrant%252BApoptosis%252BSignal-Regulating%252BKinase%252B1%252B%252528ASK1%252529%252BInhibitors%26aulast%3DXin%26aufirst%3DZhili%26date%3D2020%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D16122019%26date%3D12022020%26date%3D18022020%26date%3D12022020%26volume%3D11%26issue%3D4%26spage%3D485%26epage%3D490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Hou</span>, <span class="hlFld-ContribAuthor ">Xiping  Yang</span>, <span class="hlFld-ContribAuthor ">Yuejing  Yang</span>, <span class="hlFld-ContribAuthor ">Yu  Tong</span>, <span class="hlFld-ContribAuthor ">Quanwei  Chen</span>, <span class="hlFld-ContribAuthor ">Boheng  Wan</span>, <span class="hlFld-ContribAuthor ">Ran  Wei</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Qinghua  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and biological evaluation of 1H-indazole derivatives as novel ASK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>220 </em>, 113482. <a href="https://doi.org/10.1016/j.ejmech.2021.113482" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113482%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B1H-indazole%252Bderivatives%252Bas%252Bnovel%252BASK1%252Binhibitors%26aulast%3DHou%26aufirst%3DShaohua%26date%3D2021%26volume%3D220%26spage%3D113482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Galyna P.  Volynets</span>, <span class="hlFld-ContribAuthor ">Larysa V.  Pletnova</span>, <span class="hlFld-ContribAuthor ">Vladislav M.  Sapelkin</span>, <span class="hlFld-ContribAuthor ">Oleksandr V.  Savytskyi</span>, <span class="hlFld-ContribAuthor ">Sergiy M.  Yarmoluk</span>. </span><span class="cited-content_cbyCitation_article-title">A computational analysis of the binding free energies of apoptosis signal-regulating kinase 1 inhibitors from different chemotypes. </span><span class="cited-content_cbyCitation_journal-name">Molecular Simulation</span><span> <strong>2021,</strong> <em>582 </em>, 1-11. <a href="https://doi.org/10.1080/08927022.2021.1922686" title="DOI URL">https://doi.org/10.1080/08927022.2021.1922686</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/08927022.2021.1922686&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F08927022.2021.1922686%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Simulation%26atitle%3DA%252Bcomputational%252Banalysis%252Bof%252Bthe%252Bbinding%252Bfree%252Benergies%252Bof%252Bapoptosis%252Bsignal-regulating%252Bkinase%252B1%252Binhibitors%252Bfrom%252Bdifferent%252Bchemotypes%26aulast%3DVolynets%26aufirst%3DGalyna%2BP.%26date%3D2021%26date%3D2021%26volume%3D582%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaohua  Hou</span>, <span class="hlFld-ContribAuthor ">Xiping  Yang</span>, <span class="hlFld-ContribAuthor ">Yu  Tong</span>, <span class="hlFld-ContribAuthor ">Yuejing  Yang</span>, <span class="hlFld-ContribAuthor ">Quanwei  Chen</span>, <span class="hlFld-ContribAuthor ">Boheng  Wan</span>, <span class="hlFld-ContribAuthor ">Ran  Wei</span>, <span class="hlFld-ContribAuthor ">Yuchen  Wang</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Bo  Kong</span>, <span class="hlFld-ContribAuthor ">Jianhang  Huang</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Qinghua  Hu</span>, <span class="hlFld-ContribAuthor ">Ding  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based discovery of 1H-indole-2-carboxamide derivatives as potent ASK1 inhibitors for potential treatment of ulcerative colitis. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>211 </em>, 113114. <a href="https://doi.org/10.1016/j.ejmech.2020.113114" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113114%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-based%252Bdiscovery%252Bof%252B1H-indole-2-carboxamide%252Bderivatives%252Bas%252Bpotent%252BASK1%252Binhibitors%252Bfor%252Bpotential%252Btreatment%252Bof%252Bulcerative%252Bcolitis%26aulast%3DHou%26aufirst%3DShaohua%26date%3D2021%26volume%3D211%26spage%3D113114" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zekeriya  Duzgun</span>, <span class="hlFld-ContribAuthor ">Zuhal  Eroglu</span>. </span><span class="cited-content_cbyCitation_article-title">Role of cardiac drugs and flavonoids on the IRE1–JNK pathway as revealed by re-ranked molecular docking scores, MM/PBSA and umbrella sampling. </span><span class="cited-content_cbyCitation_journal-name">Journal of Biomolecular Structure and Dynamics</span><span> <strong>2020,</strong> <em>425 </em>, 1-23. <a href="https://doi.org/10.1080/07391102.2020.1851299" title="DOI URL">https://doi.org/10.1080/07391102.2020.1851299</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/07391102.2020.1851299&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F07391102.2020.1851299%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Biomolecular%2520Structure%2520and%2520Dynamics%26atitle%3DRole%252Bof%252Bcardiac%252Bdrugs%252Band%252Bflavonoids%252Bon%252Bthe%252BIRE1%2525E2%252580%252593JNK%252Bpathway%252Bas%252Brevealed%252Bby%252Bre-ranked%252Bmolecular%252Bdocking%252Bscores%25252C%252BMM%25252FPBSA%252Band%252Bumbrella%252Bsampling%26aulast%3DDuzgun%26aufirst%3DZekeriya%26date%3D2020%26date%3D2020%26volume%3D425%26spage%3D1%26epage%3D23" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shiyan  Zhang</span>, <span class="hlFld-ContribAuthor ">Chaoying  Huang</span>, <span class="hlFld-ContribAuthor ">Xilin  Lyu</span>, <span class="hlFld-ContribAuthor ">Peipei  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Zang</span>, <span class="hlFld-ContribAuthor ">Zengtao  Wang</span>, <span class="hlFld-ContribAuthor ">Huan  Wang</span>, <span class="hlFld-ContribAuthor ">Jia  Li</span>, <span class="hlFld-ContribAuthor ">Yujun  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a 2-pyridinyl urea-containing compound YD57 as a potent inhibitor of apoptosis signal-regulating kinase 1 (ASK1). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112277. <a href="https://doi.org/10.1016/j.ejmech.2020.112277" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112277%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252B2-pyridinyl%252Burea-containing%252Bcompound%252BYD57%252Bas%252Ba%252Bpotent%252Binhibitor%252Bof%252Bapoptosis%252Bsignal-regulating%252Bkinase%252B1%252B%252528ASK1%252529%26aulast%3DZhang%26aufirst%3DShiyan%26date%3D2020%26volume%3D195%26spage%3D112277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0003.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0015.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Profile of selected ASK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. (a) Cocrystal structure of <b>4</b> (GS-4997, green) with the kinase domain of ASK1 highlighting key interactions in the active site (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYT">6OYT</a>). (b) Schematic representation of the binding mode of GS-4997 to the kinase domain of ASK1. The solvent-exposed region is in blue.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Strategy for the design of novel ASK1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Overlay of the cocrystal structure of <b>11</b> (magenta) with <b>4</b> (GS-4997, green) in the kinase domain of ASK1. (PDB code: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYW">6OYW</a>.)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0011.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of Linear Analogs<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) N<sub>2</sub>H<sub>4</sub>·H<sub>2</sub>O, MeOH, reflux, 5 h then DMF-DMA, reflux 2 d, 64% over 2 steps; (b) compound <b>30</b>: MeNH<sub>2</sub>, CH<sub>3</sub>CN/AcOH 4/1, μW 110 <i>°</i>C, 1 h then NaOH, MeOH, reflux, 3 h, 68%; compound <b>31</b>: isopropylamine, CH<sub>3</sub>CN/AcOH 4/1, reflux, 12 h then 1 M aq NaOH, 54%; (c) compound <b>5</b>: 2-fluoro-benzoylchloride, DMAP, DCM, rt, 4 h, 63%; and compounds <b>6</b> and <b>10</b>: 2-methoxybenzoic acid, Et<sub>3</sub>N, T<sub>3</sub>P, 60 <i>°</i>C, 2 h, 35–40%.</p></p></figure><figure data-id="sch2" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthesis of Macrocyclic Analogs Following a Macrolactamization Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) <b>34–41</b>, PPh<sub>3</sub>, DIAD, THF, 0–25 °C, 12 h, 46–100%; (b) <b>42–45</b>, <b>47</b> or <b>49</b>, TFA, DCM, 40 °C, 5 h, 89%–94%; (c) <b>46</b> or <b>48</b>, NH<sub>2</sub>NH<sub>2</sub>, EtOH, reflux, 70–90%; (d) <b>50</b>, 1. CAN; 2. TFA, 67%; (e) <b>29</b>, AcOH, CH<sub>3</sub>CN, reflux, 24 h, 60%; (f) NaOH, MeOH, THF, 70 °C, 10 h; (g) T<sub>3</sub>P, Et<sub>3</sub>N, EtOAc, 80 °C, 4 h, 23–45% over 2 steps; (h) <b>72</b>, <b>74</b>, and <b>76</b>, chiral separation by SFC; (i) Pd(dppf)Cl<sub>2</sub>, K<sub>2</sub>CO<sub>3</sub>, dioxane/water, 90 °C, 2 h; and (j) chiral separation by SFC.</p></p></figure><figure data-id="sch3" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Synthesis of Macrocyclic Analogs Following a Ring-Closing Metathesis Approach<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) AcOH, allyl amine, reflux, 38%; (b) allyl bromide, NaH, DMF, 46–88%; (c) NaOH (aq), MeOH; (d) (COCl)<sub>2</sub>, DCM, DMF (cat), 99–100% over 2 steps; (e) DMAP, DCM, 32–47%; (f) Boc<sub>2</sub>O, DMAP, DCM, 72–79%; (g) HG first generation, toluene, reflux, 8–35%; (h) H<sub>2</sub>(g), Pd/C, 100%; and (i) TFA, DCM, 29–32%.</p></p></figure><figure data-id="sch4" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Derivatization of Macrocyclic Inhibitors<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) analogs <b>21</b> and <b>22</b>: amine, Pd<sub>2</sub>(dba)<sub>3</sub>, XPhos, Na<i>t</i>BuO, 21–35%; (b) analog <b>23</b>: MeSO<sub>2</sub>Na, CuI, <span class="smallcaps smallerCapital">l</span>-proline sodium salt, 22%; and (c) analogs <b>24</b>–<b>27</b>: 4-methyl-1-imidazole, K<sub>2</sub>CO<sub>3</sub>, Pd(dtbpf)Cl<sub>2</sub> (<b>24</b>) or Boronic ester, Pd(dppf)Cl<sub>2</sub> (<b>25</b>–<b>27</b>), 13–66%.</p></p></figure><figure data-id="fig5" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/medium/jm9b01206_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0002.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Summary of identification and optimization of novel ASK1 macrocyclic inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2019/jmcmar.2019.62.issue-23/acs.jmedchem.9b01206/20191205/images/large/jm9b01206_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.9b01206&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i108">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_28404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_28404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 26 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Matsukawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">The ASK1-MAP Kinase Cascades in Mammalian Stress Response</span>. <i>J. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.1093/jb/mvh134</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1093%2Fjb%2Fmvh134" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=15598880" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtFajtb%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2004&pages=261-265&author=J.+Matsukawaauthor=A.+Matsuzawaauthor=K.+Takedaauthor=H.+Ichijo&title=The+ASK1-MAP+Kinase+Cascades+in+Mammalian+Stress+Response&doi=10.1093%2Fjb%2Fmvh134"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The ASK1-MAP kinase cascades in mammalian stress response</span></div><div class="casAuthors">Matsukawa, Jun; Matsuzawa, Atsushi; Takeda, Kohsuke; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biochemistry</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">261-265</span>CODEN:
                <span class="NLM_cas:coden">JOBIAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-924X</span>.
    
            (<span class="NLM_cas:orgname">Japanese Biochemical Society</span>)
        </div><div class="casAbstract">A review.  The mitogen-activated protein (MAP) kinase cascades play essential roles in a variety of cell processes by influencing transcriptional or translational regulation.  ERKs play a central role in survival and mitogenic signaling, while JNKs and p38 MAP kinases are preferentially activated by environmental stresses and are actively involved in various stress responses including cell death, survival and differentiation.  Apoptosis signal-regulating kinase 1 (ASK1)-a serine/threonine protein kinase-is a member of the MAPKKK family and activates both JNK and p38 pathways.  It is well known that ASK1 is activated in cells treated with death receptor ligands and oxidant stress, such as that caused by hydrogen peroxide (H2O2).  Moreover, recent studies have revealed new mechanisms by which ASK1 is activated in response to various types of extracellular and intracellular signals, such as endoplasmic reticulum (ER) stress, calcium signaling, and G-protein coupled receptor (GPCR) signaling.  This review summarizes the regulatory mechanisms of ASK1 activity and the physiol. roles of ASK1-mediated signal transduction.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqyU2hD_AdpVbVg90H21EOLACvtfcHk0ljDeybWdM5gkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtFajtb%252FK&md5=bb907f2433a82ec90ff395966fbbab57</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1093%2Fjb%2Fmvh134&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fjb%252Fmvh134%26sid%3Dliteratum%253Aachs%26aulast%3DMatsukawa%26aufirst%3DJ.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DThe%2520ASK1-MAP%2520Kinase%2520Cascades%2520in%2520Mammalian%2520Stress%2520Response%26jtitle%3DJ.%2520Biochem.%26date%3D2004%26volume%3D136%26spage%3D261%26epage%3D265%26doi%3D10.1093%2Fjb%2Fmvh134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawarazaki, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 as a Therapeutic Target</span>. <i>Expert Opin. Ther. Targets.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">651</span>– <span class="NLM_lpage">664</span>, <span class="refDoi"> DOI: 10.1517/14728222.2014.896903</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1517%2F14728222.2014.896903" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=24660755" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXotlWgsr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2014&pages=651-664&author=Y.+Kawarazakiauthor=H.+Ichijoauthor=I.+Naguro&title=Apoptosis+Signal-Regulating+Kinase+1+as+a+Therapeutic+Target&doi=10.1517%2F14728222.2014.896903"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 as a therapeutic target</span></div><div class="casAuthors">Kawarazaki, Yosuke; Ichijo, Hidenori; Naguro, Isao</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Targets</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">651-664</span>CODEN:
                <span class="NLM_cas:coden">EOTTAO</span>;
        ISSN:<span class="NLM_cas:issn">1472-8222</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: All organisms are ordinarily exposed to various stresses.  It is important for organisms to possess appropriate stress response mechanisms and to maintain homeostasis because the disruption of a stress response system can cause various diseases.  Apoptosis signal-regulating kinase 1 (ASK1) is one of the stress-responsive MAP3Ks.  ASK1 plays an important role in the response to reactive oxygen species (ROS), endoplasmic reticulum stress and pro-inflammatory cytokines, and it is involved in the pathogenesis of various diseases.  Areas covered: In this review, the authors describe recent literature concerning the intricate and elaborate regulation system of ASK1, the function of ASK1 during a cellular stress response and the involvement of ASK1 in many diseases, including cancer, neurodegenerative diseases, infections, diabetes and cardiovascular diseases.  Expert opinion: In certain disease conditions, ASK1 plays a protective role, whereas ASK1 can exacerbate the pathol. of other diseases.  Although ASK1 is involved in various diseases, there is no therapy or drug that targets ASK1 for use in a clin. setting.  Recently, ASK1 inhibitors (K811 and MSC2032964A) have emerged, and their therapeutic potentials have been tested in vivo.  ASK1 is currently receiving considerable attention as a new therapeutic target.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxWfU5PZ2Eq7Vg90H21EOLACvtfcHk0ljDeybWdM5gkQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXotlWgsr8%253D&md5=85423452f6b9e36c4b62986b5c086081</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1517%2F14728222.2014.896903&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F14728222.2014.896903%26sid%3Dliteratum%253Aachs%26aulast%3DKawarazaki%26aufirst%3DY.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DNaguro%26aufirst%3DI.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520as%2520a%2520Therapeutic%2520Target%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Targets.%26date%3D2014%26volume%3D18%26spage%3D651%26epage%3D664%26doi%3D10.1517%2F14728222.2014.896903" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadowaki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maruyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yokota, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fukutomi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noguchi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takeda, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">ALS-Linked Mutant SOD1 Induces ER Stress- and ASK1-Dependent Motor Neuron Death by Targeting Derlin-1</span>. <i>Genes Dev.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1451</span>– <span class="NLM_lpage">1464</span>, <span class="refDoi"> DOI: 10.1101/gad.1640108</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1101%2Fgad.1640108" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=18519638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD1cXnsVOlu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=1451-1464&author=H.+Nishitohauthor=H.+Kadowakiauthor=A.+Nagaiauthor=T.+Maruyamaauthor=T.+Yokotaauthor=H.+Fukutomiauthor=T.+Noguchiauthor=A.+Matsuzawaauthor=K.+Takedaauthor=H.+Ichijo&title=ALS-Linked+Mutant+SOD1+Induces+ER+Stress-+and+ASK1-Dependent+Motor+Neuron+Death+by+Targeting+Derlin-1&doi=10.1101%2Fgad.1640108"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1</span></div><div class="casAuthors">Nishitoh, Hideki; Kadowaki, Hisae; Nagai, Atsushi; Maruyama, Takeshi; Yokota, Takanori; Fukutomi, Hisashi; Noguchi, Takuya; Matsuzawa, Atsushi; Takeda, Kohsuke; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Genes & Development</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1451-1464</span>CODEN:
                <span class="NLM_cas:coden">GEDEEP</span>;
        ISSN:<span class="NLM_cas:issn">0890-9369</span>.
    
            (<span class="NLM_cas:orgname">Cold Spring Harbor Laboratory Press</span>)
        </div><div class="casAbstract">Mutation in Cu/Zn-superoxide dismutase (SOD1) is a cause of familial amyotrophic lateral sclerosis (ALS).  Mutant SOD1 protein (SOD1mut) induces motor neuron death, although the mol. mechanism of SOD1mut-induced cell death remains controversial.  Here we show that SOD1mut specifically interacted with Derlin-1, a component of endoplasmic reticulum (ER)-assocd. degrdn. (ERAD) machinery and triggered ER stress through dysfunction of ERAD.  SOD1mut-induced ER stress activated the apoptosis signal-regulating kinase 1 (ASK1)-dependent cell death pathway.  Perturbation of binding between SOD1mut and Derlin-1 by Derlin-1-derived oligopeptide suppressed SOD1mut-induced ER stress, ASK1 activation, and motor neuron death.  Moreover, deletion of ASK1 mitigated the motor neuron loss and extended the life span of SOD1mut transgenic mice.  These findings demonstrate that ER stress-induced ASK1 activation, which is triggered by the specific interaction of Derlin-1 with SOD1mut, is crucial for disease progression of familial ALS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpoZ3ENB4NipLVg90H21EOLACvtfcHk0lji_sPJ1VesIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXnsVOlu78%253D&md5=bf2aae2e04868194e6f634d068da4321</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1101%2Fgad.1640108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1101%252Fgad.1640108%26sid%3Dliteratum%253Aachs%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DKadowaki%26aufirst%3DH.%26aulast%3DNagai%26aufirst%3DA.%26aulast%3DMaruyama%26aufirst%3DT.%26aulast%3DYokota%26aufirst%3DT.%26aulast%3DFukutomi%26aufirst%3DH.%26aulast%3DNoguchi%26aufirst%3DT.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DTakeda%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DALS-Linked%2520Mutant%2520SOD1%2520Induces%2520ER%2520Stress-%2520and%2520ASK1-Dependent%2520Motor%2520Neuron%2520Death%2520by%2520Targeting%2520Derlin-1%26jtitle%3DGenes%2520Dev.%26date%3D2008%26volume%3D22%26spage%3D1451%26epage%3D1464%26doi%3D10.1101%2Fgad.1640108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namekata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuzawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Camps, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swinnen, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jorand-Lebrun, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Muzerelle, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vitte, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rückle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsumoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">Regulation of the Severity of Neuroinflammation and Demyelination by TLR-ASK1-p 38 Pathways</span>. <i>EMBO Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">504</span>– <span class="NLM_lpage">515</span>, <span class="refDoi"> DOI: 10.1002/emmm.201000103</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1002%2Femmm.201000103" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=21064192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFeiuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2010&pages=504-515&author=X.+Guoauthor=C.+Haradaauthor=K.+Namekataauthor=A.+Matsuzawaauthor=M.+Campsauthor=H.+Jiauthor=D.+Swinnenauthor=C.+Jorand-Lebrunauthor=M.+Muzerelleauthor=P.-A.+Vitteauthor=T.+R%C3%BCckleauthor=A.+Kimuraauthor=K.+Kohyamaauthor=Y.+Matsumotoauthor=H.+Ichijoauthor=T.+Harada&title=Regulation+of+the+Severity+of+Neuroinflammation+and+Demyelination+by+TLR-ASK1-p+38+Pathways&doi=10.1002%2Femmm.201000103"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Regulation of the severity of neuroinflammation and demyelination by TLR-ASK1-p38 pathway</span></div><div class="casAuthors">Guo, Xiaoli; Harada, Chikako; Namekata, Kazuhiko; Matsuzawa, Atsushi; Camps, Monsterrat; Ji, Hong; Swinnen, Dominique; Jorand-Lebrun, Catherine; Muzerelle, Mathilde; Vitte, Pierre-Alain; Ruckle, Thomas; Kimura, Atsuko; Kohyama, Kuniko; Matsumoto, Yoh; Ichijo, Hidenori; Harada, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">EMBO Molecular Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">504-515</span>CODEN:
                <span class="NLM_cas:coden">EMMMAM</span>;
        ISSN:<span class="NLM_cas:issn">1757-4684</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1) is an evolutionarily conserved mitogen-activated protein kinase (MAPK) kinase kinase which plays important roles in stress and immune responses.  Here, we show that ASK1 deficiency attenuates neuroinflammation in exptl. autoimmune encephalomyelitis (EAE), without affecting the proliferation capability of T cells.  Moreover, we found that EAE upregulates expression of Toll-like receptors (TLRs) in activated astrocytes and microglia, and that TLRs can synergize with ASK1-p38 MAPK signalling in the release of key chemokines from astrocytes.  Consequently, oral treatment with a specific small mol. wt. inhibitor of ASK1 suppressed EAE-induced autoimmune inflammation in both spinal cords and optic nerves.  These results suggest that the TLR-ASK1-p38 pathway in glial cells may serve as a valid therapeutic target for autoimmune demyelinating disorders including multiple sclerosis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhOFTsN1800bVg90H21EOLACvtfcHk0lji_sPJ1VesIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFeiuw%253D%253D&md5=f164a951b512af060b05b2906cbad96e</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1002%2Femmm.201000103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Femmm.201000103%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DHarada%26aufirst%3DC.%26aulast%3DNamekata%26aufirst%3DK.%26aulast%3DMatsuzawa%26aufirst%3DA.%26aulast%3DCamps%26aufirst%3DM.%26aulast%3DJi%26aufirst%3DH.%26aulast%3DSwinnen%26aufirst%3DD.%26aulast%3DJorand-Lebrun%26aufirst%3DC.%26aulast%3DMuzerelle%26aufirst%3DM.%26aulast%3DVitte%26aufirst%3DP.-A.%26aulast%3DR%25C3%25BCckle%26aufirst%3DT.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DKohyama%26aufirst%3DK.%26aulast%3DMatsumoto%26aufirst%3DY.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DRegulation%2520of%2520the%2520Severity%2520of%2520Neuroinflammation%2520and%2520Demyelination%2520by%2520TLR-ASK1-p%252038%2520Pathways%26jtitle%3DEMBO%2520Mol.%2520Med.%26date%3D2010%26volume%3D2%26spage%3D504%26epage%3D515%26doi%3D10.1002%2Femmm.201000103" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheon, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kam, E. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, J.-K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, B.-N.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Silencing on Astroglial Inflammasomes in an Experimental Model of Ischemic Stroke</span>. <i>Neuroscience</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>390</i></span>,  <span class="NLM_fpage">218</span>– <span class="NLM_lpage">230</span>, <span class="refDoi"> DOI: 10.1016/j.neuroscience.2018.08.020</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.neuroscience.2018.08.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=30172704" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhs1Gkt7rL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=390&publication_year=2018&pages=218-230&author=S.+Y.+Cheonauthor=E.+J.+Kimauthor=S.+Y.+Kimauthor=J.+M.+Kimauthor=E.+H.+Kamauthor=J.-K.+Parkauthor=B.-N.+Koo&title=Apoptosis+Signal-Regulating+Kinase+1+Silencing+on+Astroglial+Inflammasomes+in+an+Experimental+Model+of+Ischemic+Stroke&doi=10.1016%2Fj.neuroscience.2018.08.020"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis Signal-regulating Kinase 1 Silencing on Astroglial Inflammasomes in an Experimental Model of Ischemic Stroke</span></div><div class="casAuthors">Cheon, So Yeong; Kim, Eun Jung; Kim, So Yeon; Kim, Jeong Min; Kam, Eun Hee; Park, Jong-Kwang; Koo, Bon-Nyeo</div><div class="citationInfo"><span class="NLM_cas:title">Neuroscience (Amsterdam, Netherlands)</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">390</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">218-230</span>CODEN:
                <span class="NLM_cas:coden">NRSCDN</span>;
        ISSN:<span class="NLM_cas:issn">0306-4522</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Activation of the inflammasome complex contributes to the inflammatory response and cell death under pathol. conditions.  The nucleotide-binding oligomerization domain-like receptor pyrin domain-contg. 2 (NLRP2) inflammasome is activated in astrocytes after cerebral ischemia, which can aggravate ischemic damage.  Apoptosis signal-regulating kinase 1 (ASK1) is an early activator and immune-regulator after ischemic injury, that can lead to cell death.  The objective of the present study was to evaluate the role of ASK1 in controlling NLRP2 inflammasomes in astrocytes after cerebral ischemia.  In a mouse model of ischemic stroke, the levels of NLRP2 inflammasome components, and interleukin (IL)-1β and IL-18, were quantified in different brain regions.  In addn., an astrocyte cell line was subjected to oxygen-glucose deprivation and reperfusion (OGD/R) injury, and the levels of NLRP2 inflammasome factors, IL-1β and IL-18 were evaluated.  Ischemic brain injury activated astrocytes.  The levels of NLRP2 inflammasome components, IL-1β and IL-18 productions, and cell death increased in the cortex and striatum after ischemic injury.  In cultured astrocytes, NLRP2 inflammasome components, IL-1β and IL-18 levels were upregulated after OGD/R.  ASK1 silencing or inhibition efficiently reduced NLRP2 inflammasome components and pro-inflammatory cytokine levels in mice and cultured astrocytes.  Our findings identify a key role for ASK1 in regulating astroglial inflammasomes after cerebral ischemia.  We suggest ASK1 as one of the main targets for astroglial inflammasomes in ischemic stroke.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo_ctqxVgaBwrVg90H21EOLACvtfcHk0lji_sPJ1VesIw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhs1Gkt7rL&md5=a59a5c25f3448c935e55327c9814c67e</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2Fj.neuroscience.2018.08.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neuroscience.2018.08.020%26sid%3Dliteratum%253Aachs%26aulast%3DCheon%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DKim%26aufirst%3DS.%2BY.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKam%26aufirst%3DE.%2BH.%26aulast%3DPark%26aufirst%3DJ.-K.%26aulast%3DKoo%26aufirst%3DB.-N.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Silencing%2520on%2520Astroglial%2520Inflammasomes%2520in%2520an%2520Experimental%2520Model%2520of%2520Ischemic%2520Stroke%26jtitle%3DNeuroscience%26date%3D2018%26volume%3D390%26spage%3D218%26epage%3D230%26doi%3D10.1016%2Fj.neuroscience.2018.08.020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Woo, J.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">He, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal Regulating Kinase 1 Modulates the Phenotype of α-Synuclein Mice</span>. <i>Neurobiol Aging</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">519</span>– <span class="NLM_lpage">526</span>, <span class="refDoi"> DOI: 10.1016/j.neurobiolaging.2014.07.034</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.neurobiolaging.2014.07.034" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=25219466" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhsVSqsbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2015&pages=519-526&author=K.-W.+Leeauthor=J.-M.+Wooauthor=J.-Y.+Imauthor=E.+S.+Parkauthor=L.+Heauthor=H.+Ichijoauthor=E.+Junnauthor=M.+M.+Mouradian&title=Apoptosis+Signal+Regulating+Kinase+1+Modulates+the+Phenotype+of+%CE%B1-Synuclein+Mice&doi=10.1016%2Fj.neurobiolaging.2014.07.034"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 modulates the phenotype of α-synuclein transgenic mice</span></div><div class="casAuthors">Lee, Kang-Woo; Woo, Jong-Min; Im, Joo-Young; Park, Eun S.; He, Liqiang; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">Neurobiology of Aging</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">519-526</span>CODEN:
                <span class="NLM_cas:coden">NEAGDO</span>;
        ISSN:<span class="NLM_cas:issn">0197-4580</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">α-Synuclein is a key pathogenic protein in α-synucleinopathies including Parkinson's disease, and its overexpression and aggregation in model systems are assocd. with a neuroinflammatory response and increased oxidative stress.  Apoptosis signal-regulating kinase 1 (ASK1) is activated upon stress signaling events such as oxidative stress and is a central player linking oxidative stress with neuroinflammation.  Here, we demonstrate that overexpression of human α-synuclein activates ASK1 in both PC12 cells and in the brains of α-synuclein transgenic mice.  Deleting ASK1 in mice mitigates the neuronal damage and neuroinflammation induced by α-synuclein and improves performance of the animals on the rotarod.  ASK1 deletion does not impact the aggregation profile or phosphorylation state of α-synuclein in the mouse brain.  These results collectively implicate ASK1 in the cascade of events triggered by α-synuclein overexpression, likely because of the inflammatory response and oxidative stress that lead to ASK1 activation.  These conclusions raise the possibility that potent antioxidants and anti-inflammatory agents may ameliorate the phenotype of α-synucleinopathies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq2OiaLl-V7fbVg90H21EOLACvtfcHk0ljFKkyKuBB43w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhsVSqsbrP&md5=1fff47caa09cdf4ffd087625e2796ab5</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1016%2Fj.neurobiolaging.2014.07.034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.neurobiolaging.2014.07.034%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-W.%26aulast%3DWoo%26aufirst%3DJ.-M.%26aulast%3DIm%26aufirst%3DJ.-Y.%26aulast%3DPark%26aufirst%3DE.%2BS.%26aulast%3DHe%26aufirst%3DL.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DApoptosis%2520Signal%2520Regulating%2520Kinase%25201%2520Modulates%2520the%2520Phenotype%2520of%2520%25CE%25B1-Synuclein%2520Mice%26jtitle%3DNeurobiol%2520Aging%26date%3D2015%26volume%3D36%26spage%3D519%26epage%3D526%26doi%3D10.1016%2Fj.neurobiolaging.2014.07.034" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.-W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Im, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grosso, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jang, W. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, T. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sonsalla, P. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">German, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Junn, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mouradian, M. M.</span></span> <span> </span><span class="NLM_article-title">Apoptosis Signal-Regulating Kinase 1 Mediates MPTP Toxicity and Regulates Glial Activation</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_fpage">e29935</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0029935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1371%2Fjournal.pone.0029935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=22253830" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC38Xht12muro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&pages=e29935&author=K.-W.+Leeauthor=X.+Zhaoauthor=J.-Y.+Imauthor=H.+Grossoauthor=W.+H.+Jangauthor=T.+W.+Chanauthor=P.+K.+Sonsallaauthor=D.+C.+Germanauthor=H.+Ichijoauthor=E.+Junnauthor=M.+M.+Mouradian&title=Apoptosis+Signal-Regulating+Kinase+1+Mediates+MPTP+Toxicity+and+Regulates+Glial+Activation&doi=10.1371%2Fjournal.pone.0029935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6bR"><div class="casContent"><span class="casTitleNuber">6b</span><div class="casTitle"><span class="NLM_cas:atitle">Apoptosis signal-regulating kinase 1 mediates MPTP toxicity and regulates glial activation</span></div><div class="casAuthors">Lee, Kang-Woo; Zhao, Xin; Im, Joo-Young; Grosso, Hilary; Jang, Won Hee; Chan, Teresa W.; Sonsalla, Patricia K.; German, Dwight C.; Ichijo, Hidenori; Junn, Eunsung; Mouradian, M. Maral</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e29935</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1), a member of the mitogen-activated protein kinase 3 family, is activated by oxidative stress.  The death-signaling pathway mediated by ASK1 is inhibited by DJ-1, which is linked to recessively inherited Parkinson's disease (PD).  Considering that DJ-1 deficiency exacerbates the toxicity of the mitochondrial complex I inhibitor 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP), we sought to investigate the direct role and mechanism of ASK1 in MPTP-induced dopamine neuron toxicity.  In the present study, we found that MPTP administration to wild-type mice activates ASK1 in the midbrain.  In ASK1 null mice, MPTP-induced motor impairment was less profound, and striatal dopamine content and nigral dopamine neuron counts were relatively preserved compared to wild-type littermates.  Further, microglia and astrocyte activation seen in wild-type mice challenged with MPTP was markedly attenuated in ASK1-/- mice.  These data suggest that ASK1 is a key player in MPTP-induced glial activation linking oxidative stress with neuroinflammation, two well recognized pathogenetic factors in PD.  These findings demonstrate that ASK1 is an important effector of MPTP-induced toxicity and suggest that inhibiting this kinase is a plausible therapeutic strategy for protecting dopamine neurons in PD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrDhH_jXxZcXrVg90H21EOLACvtfcHk0ljFKkyKuBB43w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xht12muro%253D&md5=0e38b06f22f87e33d1bcb0d21fd85e58</span></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0029935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0029935%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DK.-W.%26aulast%3DZhao%26aufirst%3DX.%26aulast%3DIm%26aufirst%3DJ.-Y.%26aulast%3DGrosso%26aufirst%3DH.%26aulast%3DJang%26aufirst%3DW.%2BH.%26aulast%3DChan%26aufirst%3DT.%2BW.%26aulast%3DSonsalla%26aufirst%3DP.%2BK.%26aulast%3DGerman%26aufirst%3DD.%2BC.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DJunn%26aufirst%3DE.%26aulast%3DMouradian%26aufirst%3DM.%2BM.%26atitle%3DApoptosis%2520Signal-Regulating%2520Kinase%25201%2520Mediates%2520MPTP%2520Toxicity%2520and%2520Regulates%2520Glial%2520Activation%26jtitle%3DPLoS%2520One%26date%3D2012%26spage%3De29935%26doi%3D10.1371%2Fjournal.pone.0029935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasegawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uekawa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim-Mitsuyama, S.</span></span> <span> </span><span class="NLM_article-title">Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer’s Disease and Brain Aging</span>. <i>J. Alzheimers Dis.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">263</span>, <span class="refDoi"> DOI: 10.3233/JAD-170645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.3233%2FJAD-170645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29154282" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A280%3ADC%252BC1M3ivVKjsw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=259-263&author=Y.+Hasegawaauthor=K.+Toyamaauthor=K.+Uekawaauthor=H.+Ichijoauthor=S.+Kim-Mitsuyama&title=Role+of+ASK1%2Fp38+Cascade+in+a+Mouse+Model+of+Alzheimer%E2%80%99s+Disease+and+Brain+Aging&doi=10.3233%2FJAD-170645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Role of ASK1/p38 Cascade in a Mouse Model of Alzheimer's Disease and Brain Aging</span></div><div class="casAuthors">Hasegawa Yu; Toyama Kensuke; Uekawa Ken; Kim-Mitsuyama Shokei; Ichijo Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Alzheimer's disease : JAD</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">259-263</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">To examine the role of ASK1 in Alzheimer's disease (AD), we generated 5XFAD mice deficient in ASK1 and investigated the characteristics of old 5XFAD and wild-type mice with ASK1 deficiency.  ASK1 deficiency improved cognitive function in 24-month-old 5XFAD mice, which was associated with the reduction of phosphorylated p38.  Thus, ASK1/p38 cascade seems to play some role in the pathogenesis of AD in mice.  In 24-month-old wild-type mice, ASK1 deficiency increased cerebral vasoreactivity to acetazolamide and significantly reduced brain soluble Aβ, which were also associated with the reduction of phosphorylated p38.  Thus, ASK1/p38 cascade may contribute to brain aging of wild-type mice.  Collectively, our present results provided the evidence suggesting the involvement of ASK1/p38 cascade in AD and brain aging.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRc-Vk3ATQdTIvKgEt20y1XfW6udTcc2eZDI2fIb5sA1Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1M3ivVKjsw%253D%253D&md5=5782dc35884efd7c9ee3a610625f9e1a</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.3233%2FJAD-170645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3233%252FJAD-170645%26sid%3Dliteratum%253Aachs%26aulast%3DHasegawa%26aufirst%3DY.%26aulast%3DToyama%26aufirst%3DK.%26aulast%3DUekawa%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26aulast%3DKim-Mitsuyama%26aufirst%3DS.%26atitle%3DRole%2520of%2520ASK1%252Fp38%2520Cascade%2520in%2520a%2520Mouse%2520Model%2520of%2520Alzheimer%25E2%2580%2599s%2520Disease%2520and%2520Brain%2520Aging%26jtitle%3DJ.%2520Alzheimers%2520Dis.%26date%3D2018%26volume%3D61%26spage%3D259%26epage%3D263%26doi%3D10.3233%2FJAD-170645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Namekata, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimura, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span> <span> </span><span class="NLM_article-title">ASK1 in Neurodegeneration</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">71</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2017.08.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.jbior.2017.08.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=28882588" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=63-71&author=X.+Guoauthor=K.+Namekataauthor=A.+Kimuraauthor=C.+Haradaauthor=T.+Harada&title=ASK1+in+Neurodegeneration&doi=10.1016%2Fj.jbior.2017.08.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 in neurodegeneration</span></div><div class="casAuthors">Guo, Xiaoli; Namekata, Kazuhiko; Kimura, Atsuko; Harada, Chikako; Harada, Takayuki</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">63-71</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Neurodegenerative diseases (NDDs) such as glaucoma, multiple sclerosis (MS), Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and Huntington's disease (HD) are characterized by the progressive loss of neurons, causing irreversible damage to patients.  Longer lifespans may be leading to an increase in the no. of people affected by NDDs worldwide.  Among the pathways strongly impacting the pathogenesis of NDDs, oxidative stress, a condition that occurs because of an imbalance in oxidant and antioxidant levels, has been known to play a vital role in the pathophysiol. of NDDs.  One of the mols. activated by oxidative stress is apoptosis signal-regulating kinase 1 (ASK1), which has been shown to play a role in NDDs.  ASK1 activation is regulated by multiple steps, including oligomerization, phosphorylation, and protein-protein interactions.  In the oxidative stress state, reactive oxygen species (ROS) induce the dissocn. of thioredoxin, a protein regulating cellular redn. and oxidn. (redox), from the N-terminal region of ASK1, and ASK1 is subsequently activated by the oligomerization and phosphorylation of a crit. threonine residue, leading to cell death.  Here, we review exptl. evidence that links ASK1 signaling with the pathogenesis of several NDDs.  We propose that ASK1 may be a new point of therapeutic intervention to prevent or treat NDDs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox2NJo6oiaK7Vg90H21EOLACvtfcHk0lgSULUuFAiHyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhsVeisL%252FJ&md5=57f3fe0d228fb0d4d889f0962b793cf0</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2017.08.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2017.08.003%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DNamekata%26aufirst%3DK.%26aulast%3DKimura%26aufirst%3DA.%26aulast%3DHarada%26aufirst%3DC.%26aulast%3DHarada%26aufirst%3DT.%26atitle%3DASK1%2520in%2520Neurodegeneration%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2017%26volume%3D66%26spage%3D63%26epage%3D71%26doi%3D10.1016%2Fj.jbior.2017.08.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takahashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsukamoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamaguchi, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakoji, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Endo, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kodaira, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayashi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishitoh, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Naguro, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Homma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ichijo, H.</span></span> <span> </span><span class="NLM_article-title">The ASK1-Specific Inhibitors K811 and K812 Prolong Survival in a Mouse Model of Amyotrophic Lateral Sclerosis</span>. <i>Hum. Mol. Genet.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">245</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1093/hmg/ddv467</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1093%2Fhmg%2Fddv467" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=26604152" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtF2ltbvP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2016&pages=245-253&author=T.+Fujisawaauthor=M.+Takahashiauthor=Y.+Tsukamotoauthor=N.+Yamaguchiauthor=M.+Nakojiauthor=M.+Endoauthor=H.+Kodairaauthor=Y.+Hayashiauthor=H.+Nishitohauthor=I.+Naguroauthor=K.+Hommaauthor=H.+Ichijo&title=The+ASK1-Specific+Inhibitors+K811+and+K812+Prolong+Survival+in+a+Mouse+Model+of+Amyotrophic+Lateral+Sclerosis&doi=10.1093%2Fhmg%2Fddv467"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">The ASK1-specific inhibitors K811 and K812 prolong survival in a mouse model of amyotrophic lateral sclerosis</span></div><div class="casAuthors">Fujisawa, Takao; Takahashi, Motoo; Tsukamoto, Yuka; Yamaguchi, Namiko; Nakoji, Masayoshi; Endo, Megumi; Kodaira, Hiroshi; Hayashi, Yuki; Nishitoh, Hideki; Naguro, Isao; Homma, Kengo; Ichijo, Hidenori</div><div class="citationInfo"><span class="NLM_cas:title">Human Molecular Genetics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">245-253</span>CODEN:
                <span class="NLM_cas:coden">HMGEE5</span>;
        ISSN:<span class="NLM_cas:issn">0964-6906</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease with no cure.  To develop effective treatments for this devastating disease, an appropriate strategy for targeting the mol. responsible for the pathogenesis of ALS is needed.  We previously reported that mutant SOD1 protein causes motor neuron death through activation of ASK1, a mitogen-activated protein kinase kinase kinase.  Addnl., we recently developed K811 (I) and K812 (II), which are selective inhibitors for ASK1.  Here, we report the effect of K811 and K812 in a mouse model of ALS (SOD1G93A transgenic mice).  Oral administration of K811 or K812 significantly extended the life span of SOD1G93A transgenic mice (1.06 and 1.08% improvement in survival).  Moreover, ASK1 activation obsd. in the lumbar spinal cord of mice at the disease progression stage was markedly decreased in the K811- and K812-treated groups.  In parallel, immunohistochem. anal. revealed that K811 and K812 treatment inhibited glial activation in the lumbar spinal cord of SOD1G93A transgenic mice.  These results reinforce the importance of ASK1 as a therapeutic target for ALS treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFkm5-whzU1LVg90H21EOLACvtfcHk0lgSULUuFAiHyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtF2ltbvP&md5=cfa4702fbeed701f7e2640e3cb7931de</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1093%2Fhmg%2Fddv467&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fhmg%252Fddv467%26sid%3Dliteratum%253Aachs%26aulast%3DFujisawa%26aufirst%3DT.%26aulast%3DTakahashi%26aufirst%3DM.%26aulast%3DTsukamoto%26aufirst%3DY.%26aulast%3DYamaguchi%26aufirst%3DN.%26aulast%3DNakoji%26aufirst%3DM.%26aulast%3DEndo%26aufirst%3DM.%26aulast%3DKodaira%26aufirst%3DH.%26aulast%3DHayashi%26aufirst%3DY.%26aulast%3DNishitoh%26aufirst%3DH.%26aulast%3DNaguro%26aufirst%3DI.%26aulast%3DHomma%26aufirst%3DK.%26aulast%3DIchijo%26aufirst%3DH.%26atitle%3DThe%2520ASK1-Specific%2520Inhibitors%2520K811%2520and%2520K812%2520Prolong%2520Survival%2520in%2520a%2520Mouse%2520Model%2520of%2520Amyotrophic%2520Lateral%2520Sclerosis%26jtitle%3DHum.%2520Mol.%2520Genet.%26date%3D2016%26volume%3D25%26spage%3D245%26epage%3D253%26doi%3D10.1093%2Fhmg%2Fddv467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Fujisawa, T.</span></span> <span> </span><span class="NLM_article-title">Therapeutic Application of Apoptosis Signal-Regulating Kinase 1 Inhibitors</span>. <i>Adv. Biol. Regul.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">85</span>– <span class="NLM_lpage">90</span>, <span class="refDoi"> DOI: 10.1016/j.jbior.2017.10.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.jbior.2017.10.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29066277" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10a&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhs12rur7N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2017&pages=85-90&author=T.+Fujisawa&title=Therapeutic+Application+of+Apoptosis+Signal-Regulating+Kinase+1+Inhibitors&doi=10.1016%2Fj.jbior.2017.10.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10aR"><div class="casContent"><span class="casTitleNuber">10a</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic application of apoptosis signal-regulating kinase 1 inhibitors</span></div><div class="casAuthors">Fujisawa, Takao</div><div class="citationInfo"><span class="NLM_cas:title">Advances in Biological Regulation</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">85-90</span>CODEN:
                <span class="NLM_cas:coden">ABRDE5</span>;
        ISSN:<span class="NLM_cas:issn">2212-4934</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  Apoptosis signal-regulating kinase 1 (ASK1) is a member of the stress-activated mitogen-activated protein kinase kinase kinase (MAP3K) family.  ASK1 is an attractive drug target, owing to its essential role in a wide variety of human diseases including neurodegenerative disorders, inflammatory diseases and cancer.  Recent studies have suggested that pharmacol. manipulations using small mol. ASK1 inhibitors may be beneficial in exptl. human disease models.  In this review, we highlight the current understanding of ASK1 inhibitors as a potential therapy for human diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFxCLZJ-Pd8LVg90H21EOLACvtfcHk0lgdr0NQf3bz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhs12rur7N&md5=91ed7baecfcf9fb42c0437fa8ebbf87a</span></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=10.1016%2Fj.jbior.2017.10.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jbior.2017.10.004%26sid%3Dliteratum%253Aachs%26aulast%3DFujisawa%26aufirst%3DT.%26atitle%3DTherapeutic%2520Application%2520of%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520Inhibitors%26jtitle%3DAdv.%2520Biol.%2520Regul.%26date%3D2017%26volume%3D66%26spage%3D85%26epage%3D90%26doi%3D10.1016%2Fj.jbior.2017.10.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fanjul, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Drug Design of Novel ASK1 Inhibitors Using an Integrated Lead Optimization Strategy</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1709</span>– <span class="NLM_lpage">1713</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2017.02.079</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.bmcl.2017.02.079" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=28291695" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXktFyhsrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2017&pages=1709-1713&author=T.+S.+Gibsonauthor=B.+Johnsonauthor=A.+Fanjulauthor=P.+Halkowyczauthor=D.+R.+Douganauthor=D.+Coleauthor=S.+Swann&title=Structure-Based+Drug+Design+of+Novel+ASK1+Inhibitors+Using+an+Integrated+Lead+Optimization+Strategy&doi=10.1016%2Fj.bmcl.2017.02.079"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-based drug design of novel ASK1 inhibitors using an integrated lead optimization strategy</span></div><div class="casAuthors">Gibson, Tony S.; Johnson, Benjamin; Fanjul, Andrea; Halkowycz, Petro; Dougan, Douglas R.; Cole, Derek; Swann, Steven</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1709-1713</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Structure-based drug design is an iterative process that is an established means to accelerate lead optimization, and is most powerful when integrated with information from different sources.  Herein is described the use of such methods in conjunction with deconstruction and re-optimization of a diverse series of ASK1 chemotypes along with high-throughput screening that lead to the identification of a novel series of efficient ASK1 inhibitors displaying robust MAP3K pathway inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGovAeTTx_WsXbVg90H21EOLACvtfcHk0lgdr0NQf3bz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXktFyhsrk%253D&md5=4985c0dacfb20c6d7a7d7a546038a469</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2017.02.079&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2017.02.079%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DT.%2BS.%26aulast%3DJohnson%26aufirst%3DB.%26aulast%3DFanjul%26aufirst%3DA.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DSwann%26aufirst%3DS.%26atitle%3DStructure-Based%2520Drug%2520Design%2520of%2520Novel%2520ASK1%2520Inhibitors%2520Using%2520an%2520Integrated%2520Lead%2520Optimization%2520Strategy%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D27%26spage%3D1709%26epage%3D1713%26doi%3D10.1016%2Fj.bmcl.2017.02.079" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10c"><span><span class="NLM_label">(c) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Lanier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pickens, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bigi, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradshaw-Pierce, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chambers, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheruvallath, Z. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cole, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dougan, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ermolieff, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halkowycz, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirokawa, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ivetac, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miura, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nunez, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sabat, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyhonas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, S.</span></span> <span> </span><span class="NLM_article-title">Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">316</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00481</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00481" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref10/cit10c&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2sXisVSqt7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=316-320&author=M.+Lanierauthor=J.+Pickensauthor=S.+V.+Bigiauthor=E.+L.+Bradshaw-Pierceauthor=A.+Chambersauthor=Z.+S.+Cheruvallathauthor=D.+Coleauthor=D.+R.+Douganauthor=J.+Ermolieffauthor=T.+Gibsonauthor=P.+Halkowyczauthor=A.+Hirokawaauthor=A.+Ivetacauthor=J.+Miuraauthor=E.+Nunezauthor=M.+Sabatauthor=J.+Tyhonasauthor=H.+Wangauthor=X.+Wangauthor=S.+Swann&title=Structure-Based+Design+of+ASK1+Inhibitors+as+Potential+Agents+for+Heart+Failure&doi=10.1021%2Facsmedchemlett.6b00481"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10cR"><div class="casContent"><span class="casTitleNuber">10c</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-Based Design of ASK1 Inhibitors as Potential Agents for Heart Failure</span></div><div class="casAuthors">Lanier, Marion; Pickens, Jason; Bigi, Simone V.; Bradshaw-Pierce, Erica L.; Chambers, Alison; Cole, Derek; Dougan, Douglas R.; Ermolieff, Jacques; Gibson, Tony; Halkowycz, Petro; Hirokawa, Aki; Ivetac, Anthony; Miura, Joanne; Nunez, Evan; Sabat, Mark; Tyhonas, John; Wang, Haixia; Wang, Xiaolun; Swann, Steve</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">316-320</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1/MAP3K) is a mitogen-activated protein kinase family member shown to contribute to acute ischemia/reperfusion injury.  Using structure-based drug design, deconstruction, and reoptimization of a known ASK1 inhibitor, a lead compd. was identified.  This compd. displayed robust MAP3K pathway inhibition and redn. of infarct size in an isolated perfused heart model of cardiac injury.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVRSL6eCLHCbVg90H21EOLACvtfcHk0lgdr0NQf3bz0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXisVSqt7Y%253D&md5=f6118d66141ad3479dbb80c582819306</span></div><a href="/servlet/linkout?suffix=cit10c&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00481&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00481%26sid%3Dliteratum%253Aachs%26aulast%3DLanier%26aufirst%3DM.%26aulast%3DPickens%26aufirst%3DJ.%26aulast%3DBigi%26aufirst%3DS.%2BV.%26aulast%3DBradshaw-Pierce%26aufirst%3DE.%2BL.%26aulast%3DChambers%26aufirst%3DA.%26aulast%3DCheruvallath%26aufirst%3DZ.%2BS.%26aulast%3DCole%26aufirst%3DD.%26aulast%3DDougan%26aufirst%3DD.%2BR.%26aulast%3DErmolieff%26aufirst%3DJ.%26aulast%3DGibson%26aufirst%3DT.%26aulast%3DHalkowycz%26aufirst%3DP.%26aulast%3DHirokawa%26aufirst%3DA.%26aulast%3DIvetac%26aufirst%3DA.%26aulast%3DMiura%26aufirst%3DJ.%26aulast%3DNunez%26aufirst%3DE.%26aulast%3DSabat%26aufirst%3DM.%26aulast%3DTyhonas%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DSwann%26aufirst%3DS.%26atitle%3DStructure-Based%2520Design%2520of%2520ASK1%2520Inhibitors%2520as%2520Potential%2520Agents%2520for%2520Heart%2520Failure%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D316%26epage%3D320%26doi%3D10.1021%2Facsmedchemlett.6b00481" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10d"><span><span class="NLM_label">(d) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corkey, B. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Notte, G. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Budas, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lansdon, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hinojosa-Kirschenbaum, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Badal, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schultz, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wise, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pendem, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graupe, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Castonguay, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koch, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wong, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papalia, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">French, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huntzicker, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ma, F. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nikolic-Paterson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Altuhaifi, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fogo, A. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckenridge, D. G.</span></span> <span> </span><span class="NLM_article-title">ASK1 Contributes to Fibrosis and Dysfunction in Models of Kidney Disease</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>128</i></span>,  <span class="NLM_fpage">4485</span>– <span class="NLM_lpage">4500</span>, <span class="refDoi"> DOI: 10.1172/JCI99768</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1172%2FJCI99768" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=30024858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10d&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=128&publication_year=2018&pages=4485-4500&author=J.+T.+Lilesauthor=B.+K.+Corkeyauthor=G.+T.+Notteauthor=G.+R.+Budasauthor=E.+B.+Lansdonauthor=F.+Hinojosa-Kirschenbaumauthor=S.+S.+Badalauthor=M.+Leeauthor=B.+E.+Schultzauthor=S.+Wiseauthor=S.+Pendemauthor=M.+Graupeauthor=L.+Castonguayauthor=K.+A.+Kochauthor=M.+H.+Wongauthor=G.+A.+Papaliaauthor=D.+M.+Frenchauthor=T.+Sullivanauthor=E.+G.+Huntzickerauthor=F.+Y.+Maauthor=D.+J.+Nikolic-Patersonauthor=T.+Altuhaifiauthor=H.+Yangauthor=A.+B.+Fogoauthor=D.+G.+Breckenridge&title=ASK1+Contributes+to+Fibrosis+and+Dysfunction+in+Models+of+Kidney+Disease&doi=10.1172%2FJCI99768"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10dR"><div class="casContent"><span class="casTitleNuber">10d</span><div class="casTitle"><span class="NLM_cas:atitle">ASK1 contributes to fibrosis and dysfunction in models of kidney disease</span></div><div class="casAuthors">Liles John T; Corkey Britton K; Notte Gregory T; Budas Grant R; Lansdon Eric B; Hinojosa-Kirschenbaum Ford; Badal Shawn S; Lee Michael; Schultz Brian E; Wise Sarah; Pendem Swetha; Graupe Michael; Wong Melanie H; Papalia Giuseppe A; French Dorothy M; Sullivan Theodore; Huntzicker Erik G; Breckenridge David G; Castonguay Laurie; Koch Keith A; Ma Frank Y; Nikolic-Paterson David J; Altuhaifi Tareq; Yang Haichun; Fogo Agnes B</div><div class="citationInfo"><span class="NLM_cas:title">The Journal of clinical investigation</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">128</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">4485-4500</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Oxidative stress is an underlying component of acute and chronic kidney disease.  Apoptosis signal-regulating kinase 1 (ASK1) is a widely expressed redox-sensitive serine threonine kinase that activates p38 and c-Jun N-terminal kinase (JNK) mitogen-activated protein kinase kinases, and induces apoptotic, inflammatory, and fibrotic signaling in settings of oxidative stress.  We describe the discovery and characterization of a potent and selective small-molecule inhibitor of ASK1, GS-444217, and demonstrate the therapeutic potential of ASK1 inhibition to reduce kidney injury and fibrosis.  Activation of the ASK1 pathway in glomerular and tubular compartments was confirmed in renal biopsies from patients with diabetic kidney disease (DKD) and was decreased by GS-444217 in several rodent models of kidney injury and fibrosis that collectively represented the hallmarks of DKD pathology.  Treatment with GS-444217 reduced progressive inflammation and fibrosis in the kidney and halted glomerular filtration rate decline.  Combination of GS-444217 with enalapril, an angiotensin-converting enzyme inhibitor, led to a greater reduction in proteinuria and regression of glomerulosclerosis.  These results identify ASK1 as an important target for renal disease and support the clinical development of an ASK1 inhibitor for the treatment of DKD.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTCz33HBHJmvH6oPH0mYWL1fW6udTcc2eYdxw7ioLgMi7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3c%252FpvVGisw%253D%253D&md5=088f51fa49e871d1123a51d2331c2144</span></div><a href="/servlet/linkout?suffix=cit10d&amp;dbid=16384&amp;doi=10.1172%2FJCI99768&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI99768%26sid%3Dliteratum%253Aachs%26aulast%3DLiles%26aufirst%3DJ.%2BT.%26aulast%3DCorkey%26aufirst%3DB.%2BK.%26aulast%3DNotte%26aufirst%3DG.%2BT.%26aulast%3DBudas%26aufirst%3DG.%2BR.%26aulast%3DLansdon%26aufirst%3DE.%2BB.%26aulast%3DHinojosa-Kirschenbaum%26aufirst%3DF.%26aulast%3DBadal%26aufirst%3DS.%2BS.%26aulast%3DLee%26aufirst%3DM.%26aulast%3DSchultz%26aufirst%3DB.%2BE.%26aulast%3DWise%26aufirst%3DS.%26aulast%3DPendem%26aufirst%3DS.%26aulast%3DGraupe%26aufirst%3DM.%26aulast%3DCastonguay%26aufirst%3DL.%26aulast%3DKoch%26aufirst%3DK.%2BA.%26aulast%3DWong%26aufirst%3DM.%2BH.%26aulast%3DPapalia%26aufirst%3DG.%2BA.%26aulast%3DFrench%26aufirst%3DD.%2BM.%26aulast%3DSullivan%26aufirst%3DT.%26aulast%3DHuntzicker%26aufirst%3DE.%2BG.%26aulast%3DMa%26aufirst%3DF.%2BY.%26aulast%3DNikolic-Paterson%26aufirst%3DD.%2BJ.%26aulast%3DAltuhaifi%26aufirst%3DT.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DFogo%26aufirst%3DA.%2BB.%26aulast%3DBreckenridge%26aufirst%3DD.%2BG.%26atitle%3DASK1%2520Contributes%2520to%2520Fibrosis%2520and%2520Dysfunction%2520in%2520Models%2520of%2520Kidney%2520Disease%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2018%26volume%3D128%26spage%3D4485%26epage%3D4500%26doi%3D10.1172%2FJCI99768" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div>. </div><div class="NLM_citation" id="rightTab-cit10e"><span><span class="NLM_label">(e) </span> <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ramachandran, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breckenridge, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liles, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebofsky, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Farhood, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, H.</span></span> <span> </span><span class="NLM_article-title">Inhibitor of Apoptosis Signal-Regulating Kinase 1 Protects Against Acetaminophen-Induced Liver Injury</span>. <i>Toxicol. Appl. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>286</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">9</span>, <span class="refDoi"> DOI: 10.1016/j.taap.2015.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.taap.2015.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=25818599" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10e&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC2MXlsFemtb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=286&publication_year=2015&pages=1-9&author=Y.+Xieauthor=A.+Ramachandranauthor=D.+G.+Breckenridgeauthor=J.+T.+Lilesauthor=M.+Lebofskyauthor=A.+Farhoodauthor=H.+Jaeschke&title=Inhibitor+of+Apoptosis+Signal-Regulating+Kinase+1+Protects+Against+Acetaminophen-Induced+Liver+Injury&doi=10.1016%2Fj.taap.2015.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10eR"><div class="casContent"><span class="casTitleNuber">10e</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibitor of apoptosis signal-regulating kinase 1 protects against acetaminophen-induced liver injury</span></div><div class="casAuthors">Xie, Yuchao; Ramachandran, Anup; Breckenridge, David G.; Liles, John T.; Lebofsky, Margitta; Farhood, Anwar; Jaeschke, Hartmut</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology and Applied Pharmacology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">286</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1-9</span>CODEN:
                <span class="NLM_cas:coden">TXAPA9</span>;
        ISSN:<span class="NLM_cas:issn">0041-008X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Metabolic activation and oxidant stress are key events in the pathophysiol. of acetaminophen (APAP) hepatotoxicity.  The initial mitochondrial oxidative stress triggered by protein adduct formation is amplified by c-jun-N-terminal kinase (JNK), resulting in mitochondrial dysfunction and ultimately cell necrosis.  Apoptosis signal-regulating kinase 1 (ASK1) is considered the link between oxidant stress and JNK activation.  The objective of the current study was to assess the efficacy and mechanism of action of the small-mol. ASK1 inhibitor GS-459679 in a murine model of APAP hepatotoxicity.  APAP (300 mg/kg) caused extensive glutathione depletion, JNK activation and translocation to the mitochondria, oxidant stress and liver injury as indicated by plasma ALT activities and area of necrosis over a 24 h observation period.  Pretreatment with 30 mg/kg of GS-459679 almost completely prevented JNK activation, oxidant stress and injury without affecting the metabolic activation of APAP.  To evaluate the therapeutic potential of GS-459679, mice were treated with APAP and then with the inhibitor.  Given 1.5 h after APAP, GS-459679 was still protective, which was paralleled by reduced JNK activation and p-JNK translocation to mitochondria.  However, GS-459679 treatment was not more effective than N-acetylcysteine, and the combination of GS-459679 and N-acetylcysteine exhibited similar efficacy as N-acetylcysteine monotherapy, suggesting that GS-459769 and N-acetylcysteine affect the same pathway.  Importantly, inhibition of ASK1 did not impair liver regeneration as indicated by PCNA staining.  In conclusion, the ASK1 inhibitor GS-459679 protected against APAP toxicity by attenuating JNK activation and oxidant stress in mice and may have therapeutic potential for APAP overdose patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpk5fRq1t9HuLVg90H21EOLACvtfcHk0lhYJFUqOFXN0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXlsFemtb0%253D&md5=dcac89460286b665a95affcda0ac16fa</span></div><a href="/servlet/linkout?suffix=cit10e&amp;dbid=16384&amp;doi=10.1016%2Fj.taap.2015.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.taap.2015.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DXie%26aufirst%3DY.%26aulast%3DRamachandran%26aufirst%3DA.%26aulast%3DBreckenridge%26aufirst%3DD.%2BG.%26aulast%3DLiles%26aufirst%3DJ.%2BT.%26aulast%3DLebofsky%26aufirst%3DM.%26aulast%3DFarhood%26aufirst%3DA.%26aulast%3DJaeschke%26aufirst%3DH.%26atitle%3DInhibitor%2520of%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520Protects%2520Against%2520Acetaminophen-Induced%2520Liver%2520Injury%26jtitle%3DToxicol.%2520Appl.%2520Pharmacol.%26date%3D2015%26volume%3D286%26spage%3D1%26epage%3D9%26doi%3D10.1016%2Fj.taap.2015.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span> <i>ClinicalTrials.gov is a database of privately and
publicly funded
clinical studies conducted around the world</i>. Source: <a href="http://www.clinicaltrials.gov" class="extLink">www.clinicaltrials.gov</a> (NCT02781584
and NCT03449446).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+ClinicalTrials.gov+is+a+database+of+privately+and%0Apublicly+funded%0Aclinical+studies+conducted+around+the+world.+Source%3A+www.clinicaltrials.gov+%28NCT02781584%0Aand+NCT03449446%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DClinicalTrials.gov%2520is%2520a%2520database%2520of%2520privately%2520and%250Apublicly%2520funded%250Aclinical%2520studies%2520conducted%2520around%2520the%2520world" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span> <i>The biochemical potency
was determined at Reaction Biology corp using
the assay conditions described in</i>: <a href="http://www.reactionbiology.com/webapps/site/KinasePDFs/ASK1_MAP3K5.pdf" class="extLink">http://www.reactionbiology.com/webapps/site/KinasePDFs/ASK1_MAP3K5.pdf</a> (see also the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> for additional details).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+biochemical+potency%0Awas+determined+at+Reaction+Biology+corp+using%0Athe+assay+conditions+described+in%3A+http%3A%2F%2Fwww.reactionbiology.com%2Fwebapps%2Fsite%2FKinasePDFs%2FASK1_MAP3K5.pdf+%28see+also+the+Supporting+Information+for+additional+details%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweblink%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520biochemical%2520potency%250Awas%2520determined%2520at%2520Reaction%2520Biology%2520corp%2520using%250Athe%2520assay%2520conditions%2520described%2520in" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">In this assay, HEK293 cells were transiently transfected with human ASK1, and inhibition of ASK1 phosphorylation at residue T878 was measured. Differences between the cellular potency in this assay and the data reported in the literature were noted. In general, this assay appeared to underestimate the potency of the analogs tested relative to the data from the literature (i.e., compound <b>4</b>: reported cell IC<sub>50</sub> = 2 nM in US2013/0197037 vs cell IC<sub>50</sub> = 20 nM using this format of the assay).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="note"><p class="first last">All in vivo PK studies were conducted in accordance with Biogen Institutional Animal Care and Use Committee (IACUC) guidelines.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Cl<sub>u</sub> = Cl/fraction unbound.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span> An MDCK NIH cell line
transfected with MDR1 was used as an in vitro predictor of CNS penetration.
Good correlation between the ER in this assay and brain exposure has
been reported when using this cell line. See:<span class="NLM_contrib-group"><span class="NLM_string-name">Kikuchi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Morais, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalvass, J. C.</span></span> <span> </span><span class="NLM_article-title">In Vitro P-Glycoprotein Efflux Ratio Can Predict the <i>In Vivo</i> Brain Penetration Regardless of Biopharmaceutics Drug Disposition Classification System Class</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>41</i></span>,  <span class="NLM_fpage">2012</span>– <span class="NLM_lpage">2017</span>, <span class="refDoi"> DOI: 10.1124/dmd.113.053868</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1124%2Fdmd.113.053868" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=24009309" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=41&publication_year=2013&pages=2012-2017&author=R.+Kikuchiauthor=S.+M.+de+Moraisauthor=J.+C.+Kalvass&title=In+Vitro+P-Glycoprotein+Efflux+Ratio+Can+Predict+the+In+Vivo+Brain+Penetration+Regardless+of+Biopharmaceutics+Drug+Disposition+Classification+System+Class&doi=10.1124%2Fdmd.113.053868"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein efflux ratio can predict the in vivo brain penetration regardless of biopharmaceutics drug disposition classification system class</span></div><div class="casAuthors">Kikuchi, Ryota; de Morais, Sonia M.; Kalvass, J. Cory</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism & Disposition</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">41</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2012-2017</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">1521-009X</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">P-glycoprotein (P-gp) is expressed at the blood-brain barrier (BBB) and restricts the penetration of its substrates into the central nervous system (CNS).  In vitro substrate assessment for P-gp is frequently used to predict the in vivo relevance of P-gp-mediated efflux at the BBB.  We have conducted a comprehensive review of literature focusing on the in vitro-in vivo correlation of P-gp efflux ratio (ER), and demonstrated that in vitro substrates of P-gp are also in vivo substrates at the BBB.  It was of note that the in vitro ER in the MDCK-MDR1 cell line from National Institutes of Health was found to be a better predictor of in vivo ER than that from Netherlands Cancer Institute, with r2 values of 0.813 and 0.531, resp.  Recently, a research group proposed that 98% of Biopharmaceutics Drug Disposition Classification System (BDDCS) class 1 drugs can penetrate the brain even when those compds. are shown as P-gp substrates in vitro.  However, our data anal. suggested that in vitro ER can predict the in vivo brain penetration regardless of the class in BDDCS.  Considering that very few marketed CNS drugs are in vivo substrates for P-gp, the in vitro substrate assessment of P-gp should be used in the early stages of drug discovery to select compds. that are most likely to penetrate the CNS to exert their pharmacol. action.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqFQtEu5USc2LVg90H21EOLACvtfcHk0lgGqi1Fd8CHpQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvVCjtbvO&md5=f4e32455375b1bd684ba38174a71657c</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1124%2Fdmd.113.053868&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.113.053868%26sid%3Dliteratum%253Aachs%26aulast%3DKikuchi%26aufirst%3DR.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26aulast%3DKalvass%26aufirst%3DJ.%2BC.%26atitle%3DIn%2520Vitro%2520P-Glycoprotein%2520Efflux%2520Ratio%2520Can%2520Predict%2520the%2520In%2520Vivo%2520Brain%2520Penetration%2520Regardless%2520of%2520Biopharmaceutics%2520Drug%2520Disposition%2520Classification%2520System%2520Class%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2013%26volume%3D41%26spage%3D2012%26epage%3D2017%26doi%3D10.1124%2Fdmd.113.053868" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">Analogs <b>1</b>–<b>3</b>, despite their reported efficacy in rodent models of neurological diseases, were found to be significantly less potent in our internal cellular assay and were not deemed as suitable starting points for further optimization.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span> The structure of the
human ASK1 kinase domain in complex with staurosporine has been previously
reported:<span class="NLM_contrib-group"><span class="NLM_string-name">Bunkoczi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Salah, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Filippakopoulos, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fedorov, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sobott, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parker, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Turk, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span> <span> </span><span class="NLM_article-title">Structural and Functional Characterization of the Human Protein Kinase ASK1</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1215</span>, <span class="refDoi"> DOI: 10.1016/j.str.2007.08.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.str.2007.08.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=17937911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFKhsLzM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2007&pages=1215&author=G.+Bunkocziauthor=E.+Salahauthor=P.+Filippakopoulosauthor=O.+Fedorovauthor=S.+M%C3%BCllerauthor=F.+Sobottauthor=S.+A.+Parkerauthor=H.+Zhangauthor=W.+Minauthor=B.+E.+Turkauthor=S.+Knapp&title=Structural+and+Functional+Characterization+of+the+Human+Protein+Kinase+ASK1&doi=10.1016%2Fj.str.2007.08.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Functional Characterization of the Human Protein Kinase ASK1</span></div><div class="casAuthors">Bunkoczi, Gabor; Salah, Eidarus; Filippakopoulos, Panagis; Fedorov, Oleg; Mueller, Susanne; Sobott, Frank; Parker, Sirlester A.; Zhang, Haifeng; Wang, Min; Turk, Benjamin E.; Knapp, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Structure (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1215-1226</span>CODEN:
                <span class="NLM_cas:coden">STRUE6</span>;
        ISSN:<span class="NLM_cas:issn">0969-2126</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Apoptosis signal-regulating kinase 1 (ASK1) plays an essential role in stress and immune response and has been linked to the development of several diseases.  Here, we present the structure of the human ASK1 catalytic domain in complex with staurosporine.  Anal. ultracentrifugation (AUC) and crystallog. anal. showed that ASK1 forms a tight dimer (Kd ∼ 0.2 μM) interacting in a head-to-tail fashion.  We found that the ASK1 phosphorylation motifs differ from known ASK1 phosphorylation sites but correspond well to autophosphorylation sites identified by mass spectrometry.  Reporter gene assays showed that all three identified in vitro autophosphorylation sites (Thr813, Thr838, Thr842) regulate ASK1 signaling, but site-directed mutants showed catalytic activities similar to wild-type ASK1, suggesting a regulatory mechanism independent of ASK1 kinase activity.  The detd. high-resoln. structure of ASK1 and identified ATP mimetic inhibitors will provide a first starting point for the further development of selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGohZBSVy1aKL7Vg90H21EOLACvtfcHk0liNqHePWLxw4w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFKhsLzM&md5=d005be68398be830550509044a54b8f3</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.str.2007.08.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.str.2007.08.011%26sid%3Dliteratum%253Aachs%26aulast%3DBunkoczi%26aufirst%3DG.%26aulast%3DSalah%26aufirst%3DE.%26aulast%3DFilippakopoulos%26aufirst%3DP.%26aulast%3DFedorov%26aufirst%3DO.%26aulast%3DM%25C3%25BCller%26aufirst%3DS.%26aulast%3DSobott%26aufirst%3DF.%26aulast%3DParker%26aufirst%3DS.%2BA.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DMin%26aufirst%3DW.%26aulast%3DTurk%26aufirst%3DB.%2BE.%26aulast%3DKnapp%26aufirst%3DS.%26atitle%3DStructural%2520and%2520Functional%2520Characterization%2520of%2520the%2520Human%2520Protein%2520Kinase%2520ASK1%26jtitle%3DStructure%26date%3D2007%26volume%3D15%26spage%3D1215%26doi%3D10.1016%2Fj.str.2007.08.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">This binding mode was first proposed in reference <a onclick="showRef(event, 'cit10c'); return false;" href="javascript:void(0);" class="ref cit10c">(10c)</a> and is identical to that predicted from our own docking experiments. The binding mode of compound <b>4</b> (GS-4997) is similar to that reported for GS-444217 in reference <a onclick="showRef(event, 'cit10d'); return false;" href="javascript:void(0);" class="ref cit10d">(10d)</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="note"><p class="first last">This compound crystallized as a dimer and one of the N of the imidazole in <b>4</b> appeared to form an additional H-bond interaction with the hydroxyl group of Tyr814 of the second monomer. This interaction was initially considered as an artifact and was not predicted to significantly contribute to the binding affinity of these inhibitors.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Poulsen, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">William, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dymock, B. W.</span></span> <span> </span><span class="NLM_article-title">CHAPTER 5. Designed Macrocyclic Kinase Inhibitors</span>. <i>RSC Drug Discov. Ser.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1039/9781782623113-00141</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1039%2F9781782623113-00141" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=141-205&author=A.+Poulsenauthor=A.+D.+Williamauthor=B.+W.+Dymock&title=CHAPTER+5.+Designed+Macrocyclic+Kinase+Inhibitors&doi=10.1039%2F9781782623113-00141"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1039%2F9781782623113-00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252F9781782623113-00141%26sid%3Dliteratum%253Aachs%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DCHAPTER%25205.%2520Designed%2520Macrocyclic%2520Kinase%2520Inhibitors%26jtitle%3DRSC%2520Drug%2520Discov.%2520Ser.%26date%3D2015%26volume%3D5%26spage%3D141%26epage%3D205%26doi%3D10.1039%2F9781782623113-00141" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">de Turiso, F. G. L.</span>; <span class="NLM_string-name">Himmelbauer, M.</span>; <span class="NLM_string-name">Luzzio, M. J.</span></span> <span> </span><span class="NLM_article-title">Ask1 inhibiting agents</span>. <span class="NLM_year">2018</span>, <span class="NLM_patent">WO 2018148204</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=F.+G.+L.+de+Turiso&author=M.+Himmelbauer&author=M.+J.+Luzzio&title=Ask1+inhibiting+agents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3Dde%2BTuriso%26aufirst%3DF.%2BG.%2BL.%26atitle%3DAsk1%2520inhibiting%2520agents%26date%3D2018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span> This strategy was
recently used in:<span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morgan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allais, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aulabaugh, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brodfuehrer, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coe, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowty, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frisbie, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guzova, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hepworth, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jasti, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kortum, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kurumbail, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohan, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Papaioannou, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strohbach, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vincent, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zapf, C. W.</span></span> <span> </span><span class="NLM_article-title">Rational Approach to Highly Potent and Selective Apoptosis Signal-Regulating Kinase 1 (ASK1) Inhibitors</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>145</i></span>,  <span class="NLM_fpage">606</span>– <span class="NLM_lpage">621</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.12.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1016%2Fj.ejmech.2017.12.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=29348070" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVentLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=145&publication_year=2018&pages=606-621&author=F.+Loveringauthor=P.+Morganauthor=C.+Allaisauthor=A.+Aulabaughauthor=J.+Brodfuehrerauthor=J.+Changauthor=J.+Coeauthor=W.+Dingauthor=H.+Dowtyauthor=M.+Flemingauthor=R.+Frisbieauthor=J.+Guzovaauthor=D.+Hepworthauthor=J.+Jastiauthor=S.+Kortumauthor=R.+Kurumbailauthor=S.+Mohanauthor=N.+Papaioannouauthor=J.+W.+Strohbachauthor=F.+Vincentauthor=K.+Leeauthor=C.+W.+Zapf&title=Rational+Approach+to+Highly+Potent+and+Selective+Apoptosis+Signal-Regulating+Kinase+1+%28ASK1%29+Inhibitors&doi=10.1016%2Fj.ejmech.2017.12.041"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Rational approach to highly potent and selective apoptosis signal-regulating kinase 1 (ASK1) inhibitors</span></div><div class="casAuthors">Lovering, Frank; Morgan, Paul; Allais, Christophe; Aulabaugh, Ann; Brodfuehrer, Joanne; Chang, Jeanne; Coe, Jotham; Ding, Wei Dong; Dowty, Heather; Fleming, Margaret; Frisbie, Richard; Guzova, Julia; Hepworth, David; Jasti, Jayasankar; Kortum, Steve; Kurumbail, Ravi; Mohan, Shashi; Papaioannou, Nikolaos; Strohbach, Joseph W.; Vincent, Fabien; Lee, Katherine; Zapf, Christoph W.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">145</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">606-621</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Many diseases are believed to be driven by pathol. levels of reactive oxygen species (ROS) and oxidative stress has long been recognized as a driver for inflammatory disorders.  Apoptosis signal-regulating kinase 1 (ASK1) has been reported to be activated by intracellular ROS and its inhibition leads to a down regulation of p38-and JNK-dependent signaling.  Consequently, ASK1 inhibitors may have the potential to treat clin. important inflammatory pathologies including renal, pulmonary and liver diseases.  Anal. of the ASK1 ATP-binding site suggested that Gln756, an amino acid that rarely occurs at the GK+2 position, offered opportunities for achieving kinase selectivity for ASK1 which was applied to the design of a parallel medicinal chem. library that afforded inhibitors of ASK1 with nanomolar potency and excellent kinome selectivity.  A focused optimization strategy utilizing structure-based design resulted in the identification of ASK1 inhibitors with low nanomolar potency in a cellular assay, high selectivity when tested against kinase and broad pharmacol. screening panels, and attractive physicochem. properties.  The compds. we describe are attractive tool compds. to inform the therapeutic potential of ASK1 inhibition.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvA5qC6rcbMLVg90H21EOLACvtfcHk0lgIZUFD2qUjEg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVentLY%253D&md5=2943f3bc9908637e5e4dedaf6637aaf7</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.12.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.12.041%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DMorgan%26aufirst%3DP.%26aulast%3DAllais%26aufirst%3DC.%26aulast%3DAulabaugh%26aufirst%3DA.%26aulast%3DBrodfuehrer%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DCoe%26aufirst%3DJ.%26aulast%3DDing%26aufirst%3DW.%26aulast%3DDowty%26aufirst%3DH.%26aulast%3DFleming%26aufirst%3DM.%26aulast%3DFrisbie%26aufirst%3DR.%26aulast%3DGuzova%26aufirst%3DJ.%26aulast%3DHepworth%26aufirst%3DD.%26aulast%3DJasti%26aufirst%3DJ.%26aulast%3DKortum%26aufirst%3DS.%26aulast%3DKurumbail%26aufirst%3DR.%26aulast%3DMohan%26aufirst%3DS.%26aulast%3DPapaioannou%26aufirst%3DN.%26aulast%3DStrohbach%26aufirst%3DJ.%2BW.%26aulast%3DVincent%26aufirst%3DF.%26aulast%3DLee%26aufirst%3DK.%26aulast%3DZapf%26aufirst%3DC.%2BW.%26atitle%3DRational%2520Approach%2520to%2520Highly%2520Potent%2520and%2520Selective%2520Apoptosis%2520Signal-Regulating%2520Kinase%25201%2520%2528ASK1%2529%2520Inhibitors%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2018%26volume%3D145%26spage%3D606%26epage%3D621%26doi%3D10.1016%2Fj.ejmech.2017.12.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="note"><p class="first last">To understand the kinase selectivity profile of this series of macrocyclic inhibitors, analog <b>24</b> was tested against a panel of 468 kinases at 100 nM, and the S(10) selectivity score was found to be 0.04. Complete data is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> (S(10) = (number of non-mutant kinases with %Ctrl <10)/(number of non-mutant kinases tested)).</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Using DMA:EtOH:PG:water (1:1:3:5) as the vehicle.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Di, L.</span>; <span class="NLM_string-name">Kerns, E. H.</span></span> <i>Blood-Brain Barrier in Drug Discovery</i>. <span class="NLM_publisher-name">Wiley</span>: <span class="NLM_year">2015</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;key=10.1002%2F9781118788523" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=L.+Di&author=E.+H.+Kerns&title=Blood-Brain+Barrier+in+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1002%2F9781118788523&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26id%3Ddoi%3A10.1002%252F9781118788523%26sid%3Dliteratum%253Aachs%26aulast%3DDi%26aufirst%3DL.%26btitle%3DBlood-Brain%2520Barrier%2520in%2520Drug%2520Discovery%26pub%3DWiley%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="note"><p class="first last">See also the <a href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf" class="ext-link">Supporting Information</a> for additional experimental details.</p></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYT','PDB','6OYT'); return false;">PDB: 6OYT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6OYW','PDB','6OYW'); return false;">PDB: 6OYW</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i105"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01206">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_52484"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.9b01206?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.9b01206</a>. <ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">(i) Experimental conditions for the ASK1 in vitro biochemical and cellular assays, (ii) experimental conditions for crystallization, collection, and refinement statistics for compounds <b>4</b> and <b>11</b>, (iii) calculated IR and VCD spectra to assign absolute stereochemistry of compound <b>18</b>, (iv) calculated IR and VCD spectra to assign absolute stereochemistry of compound <b>19</b>, (v) kinase selectivity profile for compound <b>24</b>, and (vi) experimental details of <i>K</i><sub>puu</sub> studies (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings and selected data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_001.pdf">jm9b01206_si_001.pdf (777.31 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.9b01206/suppl_file/jm9b01206_si_002.csv">jm9b01206_si_002.csv (2.26 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.9b01206&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.9b01206%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2019.62.issue-23" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.9b01206" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679932feab283d00","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
